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ABSTRACT. Background. Infant and under-5 child-
hood mortality rates in developing countries have de-
clined significantly in the past 2 to 3 decades. However,
2 critical indicators, maternal and newborn mortality,
have hardly changed. World leaders at the United Na-
tions Millennium Summit in September 2000 agreed on a
critical goal to reduce deaths of children <5 years by
two thirds, but this may be unattainable without halv-
ing newborn deaths, which now comprise 40% of all
under-5 deaths. Greater emphasis on wide-scale imple-
mentation of proven, cost-effective measures is required
to save women’s and newborns’ lives. Approximately
99% of neonatal deaths take place in developing coun-
tries, mostly in homes and communities. A comprehen-
sive review of the evidence base for impact of interven-
tions on neonatal health and survival in developing-
country communities has not been reported.
Objective. This review of community-based antena-
tal, intrapartum, and postnatal intervention trials in de-
veloping countries aimed to identify (1) key behaviors
and interventions for which the weight of evidence is
sufficient to recommend their inclusion in community-
based neonatal care programs and (2) key gaps in knowl-
edge and priority areas for future research and program
learning.
Methods. Available published and unpublished data
on the impact of community-based strategies and inter-
ventions on perinatal and neonatal health status out-
comes were reviewed. Evidence was summarized system-
atically and categorized into 4 levels of evidence based
on study size, location, design, and reported impact, par-
ticularly on perinatal or neonatal mortality. The evidence
was placed in the context of biological plausibility of the
intervention; evidence from relevant developed-country
studies; health care program experience in implementa-
tion; and recommendations from the World Health Or-
ganization and other leading agencies.
Results. A paucity of community-based data was
found from developing-country studies on health status
impact for many interventions currently being consid-
ered for inclusion in neonatal health programs. However,
review of the evidence and consideration of the broader
context of knowledge, experience, and recommendations
regarding these interventions enabled us to categorize
them according to the strength of the evidence base and
confidence regarding their inclusion now in programs.
This article identifies a package of priority interventions
to include in programs and formulates research priorities
for advancing the state of the art in neonatal health care.
Conclusions. This review emphasizes some new find-
ings while recommending an integrated approach to safe
motherhood and newborn health. The results of this
study provide a foundation for policies and programs
related to maternal and newborn health and emphasizes
the importance of health systems research and evaluation
of interventions. The review offers compelling support
for using research to identify the most effective measures
to save newborn lives. It also may facilitate dialogue with
policy makers about the importance of investing in neo-
natal health. Pediatrics 2005;115:519–617.
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EXECUTIVE SUMMARY
Background
Although there has been considerable im-provement in child health globally, it is in-creasingly evident that important gaps and
disparities remain. In particular, it is apparent that a
disproportionate burden of infant and under-5 child-
hood mortality relates to deaths within the neonatal
period, which frequently occur within the first few
days after birth. Moreover, the vast majority of peri-
natal and neonatal deaths occur in conditions of
socioeconomic deprivation in developing countries.
As the health of the newborn infant is inexorably tied
to the health of the mother, strategies to improve the
health and care of women in low-resource commu-
nities and countries are also expected to improve
both pregnancy and neonatal health outcomes. How-
ever, although it is true that poverty, illiteracy, poor
status and care of women, as well as dysfunctional
health systems are critical underlying factors that
adversely affect maternal and child health in many
developing countries, these factors are relatively dif-
ficult to change in the short term. Moreover, in sub-
Saharan Africa, the devastating epidemic of human
immunodeficiency virus (HIV)/acquired immuno-
deficiency syndrome (AIDS) threatens to reverse
many of the gains achieved during decades of child
health programming. This review does not attempt
to evaluate the benefits of investing in social devel-
opment, reducing inequity, and promoting economic
growth among impoverished populations of devel-
oping countries. Although these are important long-
term goals, pragmatic reality in most developing
countries dictates the need for wide-scale implemen-
tation now of evidence-based, cost-effective health
programs and interventions to improve child health
outcomes. Moreover, achievement of Millennium
Development Goal 4 to reduce under-5 mortality by
two thirds by the year 2015 is critically dependent on
a substantial reduction in neonatal mortality over the
next decade.
The objectives of this review of community-based
antenatal, intrapartum and postnatal intervention
trials in developing countries were to (1) identify key
behaviors and interventions for which the weight of
evidence is sufficient to recommend their inclusion
in community-based neonatal care programs and
(2) identify key gaps in knowledge and priority areas
for future research and program learning.
Methods
Current practice of summarizing evidence for the
impact of interventions through meta-analyses of
randomized, controlled trials (RCTs), although of
high scientific validity, has more limited relevance
when applied to research in developing countries,
because most studies meeting the rigorous criteria
for inclusion in such analyses were conducted in
developed-country settings. In addition, the evi-
dence base made up of interventions deriving from
effectiveness trials in health system settings is scanty.
In this review, we evaluated the available evidence
in the global literature for the benefits and impact of
various community-based interventions during the
antenatal, intrapartum, and postnatal periods on
perinatal and neonatal health status outcomes. The
selection of interventions was based on biological
plausibility and inclusion as a component in pro-
grams of maternal and/or perinatal health care. We
did not, however, review the evidence for impact
of skilled birth attendants, because this is the sub-
ject of other reviews.1–4 The scientific evidence avail-
able from individual interventions or combinations
thereof was reviewed, and information from pro-
grams and effectiveness trials that used packages of
interventions was specifically solicited and analyzed.
Although our principal focus was to seek informa-
tion from community-based RCTs, we extended the
evaluation to include studies with a variety of other,
less rigorous designs. A few studies with a quasi-
experimental trial (QT) design were included, espe-
cially if they represented information from develop-
ing countries and pertained to an intervention with
little other evidence base. Community was defined
as extending from the household to the peripheral
health facility level; in general, studies at secondary
or tertiary referral-level health facilities were ex-
cluded. However, where evidence for key interven-
tions from community-based settings was sparse or
not available, information was included from facili-
ty-based settings in developing countries and occa-
sionally from the developed world. The evidence
from developed-country studies, however, was used
primarily to provide perspective and context for con-
clusions drawn from developing-country data. Evi-
dence from the Cochrane database of RCTs and the
World Health Organization (WHO) Reproductive
Health Library was also considered, and studies
from developing countries that were included in the
Cochrane Reference Library were specifically evalu-
ated. We also complemented the review of the sci-
entific evidence based on intervention trials in devel-
oping countries with an assessment of public health
programs and interventions currently in place; rec-
ommendations from the WHO and other expert in-
stitutions and individuals; and biological plausibility
and evidence from developed-country studies.
Sources for potentially eligible studies included
journal articles, book chapters, technical reports, con-
ference proceedings, and theses. The search for com-
munity-based evidence encompassed all available
electronic health and social science reference libraries
(including indexed and nonindexed journals), and
manual reviews of Safe Motherhood and Child Sur-
vival books and technical reports. Additional details
were solicited directly from most agencies and insti-
tutions involved in community-based care in devel-
oping countries, especially Reproductive Health,
Safe Motherhood, or Child Survival programs. Most
leading global public health researchers in the field
of perinatal and maternal care were also individually
approached for information and unpublished mate-
rial. It is important to underscore that, although we
specifically sought evidence from RCTs, we were
cognizant of the danger of relying on RCTs as the
sole source of evidence for interventions,5 especially
in terms of consistency6 and external validity.7 This
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is especially true for those interventions that must be
nested within health systems.8
The principal reviewers independently evaluated
the data, and a common reporting matrix was used
in summarizing the findings. Studies were evaluated
for size, setting, quality, and design, ie, either effi-
cacy or effectiveness trials.9 The final categorization
and assessment of evidence for impact of the inter-
ventions was made by mutual agreement and con-
sensus. Emphasis was placed on assessment of im-
pact on perinatal or neonatal primary health status
outcomes. However, for some interventions for
which data on primary health status outcomes were
lacking, other indicators were considered.
The evidence from various interventions was cat-
egorized as follows:
1. No evidence of benefit: These interventions had
been evaluated and found to have no demonstra-
ble benefit either singly or in combination with
other measures. In some cases, there was evidence
of an adverse effect of the intervention. Therefore,
these interventions were not recommended for
inclusion in neonatal health care strategies.
2. Uncertain evidence of benefit: This category in-
cluded interventions for which there was some
evidence of benefit, but contradictory evidence or
issues such as study design, location, or size pre-
cluded any firm conclusions. These interventions
merited additional evaluation or research in de-
veloping-country community settings using well-
designed protocols.
3. Some evidence of benefit: These interventions
had some positive impact on perinatal and/or
neonatal outcomes, but the evidence remained
preliminary or the location of studies was not
representative of the developing world at large.
Furthermore, the trial designs were mostly effi-
cacy studies, and therefore their effectiveness, if
any, in large-scale programmatic interventions re-
mained to be assessed. Inclusion of interventions
in this category in neonatal health programs was
considered optional, but a recommendation was
made to evaluate the benefits whenever these in-
terventions were implemented.
4. Clear evidence of benefit: This category of inter-
ventions was of incontrovertible benefit to moth-
ers and/or newborn infants, and thus it was rec-
ommended that they be included in community-
based intervention programs for maternal and
neonatal care.
This report principally presents the initial analysis
of the data based on quality and availability of the
evidence. We do not report the projections of the
impact of these interventions, either singly or com-
bined as packages, on the global or regional burden
of neonatal mortality. A preliminary exercise of this
nature on a limited number of maternal and neonatal
interventions was conducted by the Bellagio Child
Survival Study Group,10 and a comprehensive anal-
ysis is forthcoming in the Lancet Neonatal Survival
Series in March 2005.
Results
We found a paucity of data from community-
based settings in developing countries and a remark-
able lack of large-scale effectiveness trials of a num-
ber of key interventions, especially in relevant health
system settings. A total of 186 studies from develop-
ing countries were identified for in-depth review, of
which only 64 were community-based studies re-
porting primary perinatal/neonatal health status
outcomes such as stillbirths and perinatal and/or
neonatal mortality, and 74 were community-based
studies reporting secondary perinatal/neonatal
health outcomes such as low birth weight (LBW)
and/or anthropometrics, preterm birth, breastfeed-
ing rates, and morbidities (Table 1). Of these studies
reporting health outcomes, there were very few
RCTs: 31 community-based RCTs reported primary
neonatal health outcomes, and 40 reported second-
ary neonatal health outcomes. Only 10 studies were
interventions conducted in health system settings, or
effectiveness trials. Most interventions had been
tested on relatively small numbers of individuals.
There was also wide variation in the quality, size,
location, design, and publication source of studies.
This variability was considered while summarizing
the information, although we refrain from direct
comment on the quality of the evidence in individual
studies, Table 2 (summarizing the strength of the
evidence) represents a categorical ranking of inter-
ventions based on review of individual studies. In
addition, however, as noted above, the evidence was
placed in the context of biological plausibility and
knowledge from developed countries, experience
with the intervention in the context of health pro-
grams, and recommendations from the WHO and
other leading maternal and child health agencies.
Discussion
Appropriate perinatal and neonatal care in any
given circumstance in developing countries requires
an integrated and holistic program of interventions
at various levels. Interventions must not only include
health-related measures that have a direct bearing on
perinatal and/or neonatal outcomes but several
other ancillary measures of equal importance. These
measures include poverty alleviation; improved op-
portunities for female education; and improvement
of women’s social status, including empowerment
and improvement of women’s decision-making abil-
ity. Family size and short interpregnancy intervals
are also critical factors in perinatal health.11–13
Implications for Programs
This review of evidence from developing-country
community-based trials for impact of antenatal, in-
trapartum, and postnatal interventions on perinatal
and neonatal outcomes highlights the paucity of
available information, particularly from RCTs. Cost-
effectiveness data were found to be almost entirely
unavailable. The relative paucity of evidence for im-
pact of interventions on neonatal mortality was also
apparent in the recent analysis of the Bellagio Child
Survival Study Group,10 which nevertheless in-
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cluded several neonatal interventions because of
their proven impact on infant and child survival. Not
withstanding the above exercise, to broaden the rel-
evance of the conclusions that can be drawn from the
available data, we attempted to place the evidence in
the context of biological plausibility, data from stud-
ies in developed countries, programmatic experi-
ence, and recommendations by the WHO and other
leading child health agencies. In so doing, it is clear
that the evidence for benefit of a number of interven-
tions (Table 2) warrants their broad programmatic
implementation (Fig 1). Interestingly, this group of
evidence-based interventions closely resembles those
advocated by the WHO14–16 and also identified re-
cently through a strategic planning process at the
international level and in multiple countries, led by
the Saving Newborn Lives Initiative of Save the Chil-
dren/USA.17 Thus, there seems to be broad conver-
gence of expert opinion and the evidence base re-
garding priority interventions to advance perinatal
and neonatal health and survival at the community
level. Considering past experience of child health
programs in implementation of various interventions
and current recommendations of the WHO and lead-
ing child health agencies, a few additional interven-
tions (marked with an asterisk) have been added to
Fig 1 despite the lack of rigorous, prospective scien-
tific evidence for their impact. These interventions
include birth preparedness; recognition of and ap-
propriate response to danger signs in the antenatal
period; skilled health care at delivery (evidence re-
viewed elsewhere); recognition of and response to
intrapartum danger signs; and early postnatal visita-
tion for provision of anticipatory guidance and rec-
ognition/management of maternal and newborn ill-
ness. Many of these interventions have been
included in comprehensive packages of maternal
and newborn interventions but have not been eval-
uated per se for their specific contribution to the total
impact of the package of care. Such evaluations must
now be regarded as a priority, especially in health
system settings.
Effective interventions span maternal and neonatal
care, as anticipated when one considers that preg-
nancy-related causes, delivery-related causes, and
infections each account for approximately one third
of neonatal deaths.18 This need for a continuum of
care serves to illustrate the importance of integrating
maternal and neonatal care while avoiding vertical
programs for either the mother or the newborn.
Moreover, although we emphasize impact on peri-
natal and neonatal outcomes (summarized in Tables
4–42), this review has further illustrated the princi-
ple that interventions in the antenatal and intrapar-
tum periods frequently benefit both mother and
newborn simultaneously.19 Moreover, a coordinated
approach to postpartum care for mother and new-
born would similarly benefit both. Thus, one would
Fig 1. Summary of priority antepartum, intrapartum, and postnatal interventions for inclusion in programs of maternal and neonatal
health care, based on assessment of available evidence for impact on perinatal and neonatal health status. * indicates essential elements
of the Saving Newborn Lives conceptual framework for advancing newborn health and survival, which either were not reviewed in this
report or for which evidence is lacking (see “Methods”).
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anticipate that an approach to maternal and neonatal
health integrated within Safe Motherhood and Child
Survival programs would not only foster continuity
of care across the life cycle but also enhance the
cost-effectiveness of packages of interventions.
Research Gaps
Although a number of interventions have been
shown to reduce perinatal and/or neonatal mortal-
ity, there are fundamental gaps in our knowledge of
how to most effectively improve perinatal and neo-
natal outcomes in developing-country communities.
We know that implementation of comprehensive
neonatal care programs can substantially reduce
perinatal and/or neonatal mortality, but there is an
urgent need to adapt and evaluate culturally and
regionally appropriate packages of interventions in a
variety of settings. Among these gaps in our knowl-
edge is the critical issue of the determinants of family
and community practices and their influence on
newborn care and care-seeking behaviors. Better
documentation of how behavior-change interven-
tions are implemented and evaluation of these meth-
ods is needed to develop better tools for building
individual, household, and community capacity for
appropriate self-care and care seeking. In the context
of the many parts of the developing world in which
gender inequity and female feticide are major issues,
this need for effective behavior-change approaches
extends to newborn care and outcomes.
Pivotal questions regarding implementation of
neonatal health care programs that demand addi-
tional operational research include: Which cadre of
health workers in various settings can most effec-
tively deliver the needed services for newborns at the
community level, and how can they be linked effec-
tively with referral facilities to provide care for ma-
ternal and neonatal illness? How will these workers
be trained and supervised in a sustainable manner at
scale, and what are the most effective methods for
preservice and in-service training? What will be the
scope of their service delivery (eg, with regard to
client age, breadth of services, and geographic
reach)? Is a team of skilled birth attendants and
newborn care providers needed at the community
level to provide simultaneous care for the mother
and newborn during the critical intrapartum period?
The Save the Children/USA conceptual frame-
work for newborn care at the community level17 calls
for provision of both preventive and curative care,
particularly for birth asphyxia and infections. How-
ever, in many settings, provision of curative care for
these major causes of neonatal mortality is beyond
the capacity of current health care systems. Thus,
critical unanswered questions are: Can effective im-
plementation of a behavior-change communications
package at the domiciliary level, without active iden-
tification and management of newborn illness, im-
prove neonatal outcomes? What is the added benefit
and cost-effectiveness of active identification and
management of neonatal illness, particularly serious
bacterial infections and intrapartum hypoxia/birth
asphyxia? What are the most feasible and effective
ways to deliver life-saving newborn resuscitation
and antibiotic therapy in the community? How can
barriers to care seeking for newborn illness be over-
come most effectively so that home-based care and
care seeking can be effectively linked with referral-
level care at facilities? What is the impact and cost-
effectiveness of postnatal visitation for promotion of
healthful behaviors and recognition of neonatal ill-
ness? Can the same worker address the postnatal
needs of both mothers and newborns? What is the
optimal timing and number of routine visits with a
health care provider?
Skilled care during delivery is universally recog-
nized as a major long-term priority for improving the
care of mothers and newborns, and plans for advanc-
ing health system capabilities for providing this care
are paramount. Based on a consideration of the fact
that most births and neonatal deaths occur at home
during the early neonatal period, due to birth as-
phyxia and/or infections, and among LBW infants,
the following emerge as major research gaps:
1. Understanding and improving household and
community practices and their determinants: Lo-
cal formative research is needed to better under-
stand local beliefs and practices and the reasons
behind them so that effective behavior-change
strategies can be developed and evaluated.23 This
must be followed by appropriate research to de-
velop intervention strategies to improve care-
seeking behaviors at the household and commu-
nity levels.
2. Improving health systems’ capacity for providing
essential preventive and special curative neonatal
health care: As noted above, some of the most
challenging questions in neonatal health care re-
late to how to most effectively deliver services to
newborns in an integrated way within existing
programs for maternal and child health.20–22 Al-
though difficult, determining the answers to these
questions requires that many packages and com-
binations of interventions be tested through effec-
tiveness trials in health system settings.
3. Preventing and improving recognition and man-
agement of birth asphyxia: Identification of
sustainable interventions for management of in-
trapartum hypoxia/birth asphyxia is urgently
needed at the community level.24 Solutions must
allow for immediate response at the time of deliv-
ery in a cost-effective manner and necessarily will
require integration with skilled health care for
mothers at delivery16 and links with referral facil-
ities.
4. Preventing and improving recognition and man-
agement of infections: There is an urgent need to
identify how the burden and severity of maternal
infections relate to perinatal outcomes. These in-
fections may range from subclinical intrauterine
infection and bacterial vaginosis to overt genital
tract infections that may lead to preterm labor.
The true burden of bacterial neonatal infections in
community settings is also unclear, because many
clinical bacterial infections may represent viral
infections. Narrowing this information gap is vi-
tal; to devise optimal antibiotic treatment strate-
SUPPLEMENT 525
 by guest on October 27, 2017http://pediatrics.aappublications.org/Downloaded from 
gies for neonatal infections,25 we need to know the
agents of life-threatening infections in the commu-
nity and their antibiotic susceptibility patterns.26
There is additional need for validated algorithms
for accurate and rapid identification of infected
neonates by community health workers (CHWs)
and caregivers. We also must advance antibiotic-
treatment strategies for serious infections, which
may include simplified antibiotic-delivery sys-
tems and/or regimens. The potential develop-
ment and evaluation of simplified oral treatment
regimens that include oral administration will be
a major advance for public health programs.
5. Preventing and improving care for LBW infants:
Given that the majority of newborns who die in
many developing countries are LBW, improved
strategies for both prevention of and care for LBW
infants are urgently needed. These strategies in-
clude interventions to reduce preterm births and
the incidence of intrauterine growth restriction
(IUGR) or combinations thereof. Prevention may
be achieved by improved maternal nutrition and
detection and treatment of maternal infections.
Improved postnatal care of LBW infants may be
achieved in part by behavior-change communica-
tions, topical emollient therapy, breastfeeding
promotion, and widespread implementation of
culturally adapted methods for skin-to-skin care
(or variations thereof) with the mother and (when
indicated) other household members. The devel-
opment, validation, and availability of low-cost
technology for the care of LBW infants in primary
and secondary health care facilities is an impor-
tant adjunct to community-based management
strategies.
6. Improving information on the magnitude and
causes of neonatal mortality: Lack of accurate
global, regional, and country-specific data on the
magnitude and causes of perinatal and neonatal
morbidity and mortality currently is limiting ad-
vocacy and program planning in newborn health.
Strengthening of information systems, including
birth and death registration, and dissemination of
information at local levels about causes of new-
born morbidity and mortality (and their determi-
nants), are needed to guide resource allocation
and program and research priorities. Moreover, as
programs incorporate newborn care, their impact
must be monitored and accurate data fed back to
those involved in health policy and program de-
cision-making to enable them to use scarce re-
sources more effectively. Integral to documenting
and monitoring newborn health status is the need
for improved verbal autopsy instruments to en-
able more accurate determination of causes of
perinatal and neonatal deaths in the community
and to assess the contribution of sociocultural
and logistic factors. Perinatal audit may also be a
powerful tool for identifying avoidable factors in
deaths and mobilizing change in communities to
improve maternal and neonatal health care.
7. Cost-effectiveness analyses: Assessment of cost-
effectiveness must be incorporated into neonatal
health research to guide selection of interventions
and stimulate investment in neonatal health.
8. Development of indicators and simple manage-
ment tools for assessing and monitoring health
system performance for perinatal and newborn
care at the national level: An important impedi-
ment to wider implementation of neonatal health
programming is lack of inclusion of perinatal and
neonatal health indicators among global indica-
tors for measuring progress in child survival (eg,
Millennium Development goals). Moreover, pro-
grams too often fail to monitor adequately and
demonstrate the effectiveness of their programs.
Tools for rapidly assessing the situation, prioritiz-
ing program activities, and accurately monitoring
and documenting program effectiveness are ur-
gently needed.
A major factor currently limiting our ability to
identify effective interventions is the wide variation
in study designs and indicators for assessing impact
and the almost complete absence of cost-effective-
ness data. In 2001, a group of neonatal health re-
searchers met to discuss a common agenda and
methodologies for neonatal health research in devel-
oping-country communities.27 Our review further
highlights the need, as recommended at that time,
for dialogue among researchers, policy makers, pro-
gram managers, and donors in the selection of re-
search priorities, use of common (and, whenever
possible, rigorous) study designs, and for sharing of
data-collection instruments and research results.
Conclusions
A paucity of community-based data are available
from developing countries on health status impact of
many interventions that are currently considered for
inclusion in health programs for newborns. How-
ever, a review of the evidence and consideration of
the broader context of knowledge, experience, and
recommendations regarding these interventions en-
abled us to categorize the interventions according to
the strength of the evidence base and confidence that
the intervention could be implemented widely and
would improve perinatal and/or neonatal survival.
As a result, a package of priority interventions for
inclusion in programs was identified, and research
priorities for advancing the state-of-the-art in neona-
tal health care were formulated. Thus, this review
can serve as a guide for development of evidence-
based maternal and newborn health care program-
ming at the community level and for selection of
research to advance community-based neonatal care.
It also may facilitate dialogue with policy makers
about the importance of investing in newborn health.
Clearly, there is ample evidence for benefit of sev-
eral interventions, and, in many cases, operational
questions of how to implement the intervention(s) in
an affordable and acceptable manner at scale were of
overriding concern. Thus, although there is great
need for continued research on the cost-effectiveness
of a number of interventions, it must not hamper
implementation now of many interventions of
known impact at wider scale. However, it is impor-
526 COMMUNITY-BASED INTERVENTIONS FOR IMPROVING HEALTH OUTCOMES
 by guest on October 27, 2017http://pediatrics.aappublications.org/Downloaded from 
tant that these intervention packages be structured as
integrated maternal and newborn care strategies that
can be implemented in appropriate health system
settings. Close communication between program
managers as they gain experience with intervention
implementation, the researchers who can provide
answers to operational questions, and the donors
who fund the work will be critical to advancing
maternal and neonatal health care at the community
level.
INTRODUCTION AND BACKGROUND
Infant and under-5 childhood mortality rates in
developing countries have declined significantly in
the past 2 to 3 decades, whereas neonatal mortality
rates (NMRs) have remained relatively static.18,20,24,28
Neonatal mortality, amounting to an estimated 4
million deaths worldwide each year, now comprises
nearly two thirds and two fifths of infant and un-
der-5 childhood mortality, respectively, in develop-
ing countries,29 and 98% of global neonatal mortality
occurs in developing countries.30 An equal number
of deaths are thought to occur during the last tri-
mester of pregnancy, although data precisely quan-
tifying the burden of stillbirths are lacking. Unfortu-
nately, most of the countries with high rates of
perinatal and neonatal deaths also have the lowest
rates of vital registration of births and deaths.31,32
Moreover, the likelihood of missing live births is
highest for very low birth weight (VLBW) infants,33
and rates of LBW are highest in developing coun-
tries, especially Asia.18 In addition, neonatal health
indicators are seldom included in Safe Motherhood
or Child Survival program evaluations, nor are they
among the outcomes of interest of global agencies
and initiatives. Thus, current estimates of perinatal
and neonatal mortality, although startlingly high,
may nevertheless underestimate the true burden.
It is now recognized that reducing perinatal and
neonatal mortality is of paramount importance for
additional gains in child survival to be real-
ized.20,26,32,34,35 Moreover, because the majority of
perinatal and neonatal deaths in developing coun-
tries occur in the home, there is an urgent need to
identify solutions at the community level.18,20,22,26 To
achieve Millennium Development Goal 4 of halving
child mortality by the year 2015, major advances in
neonatal survival must be achieved through wide-
scale implementation of cost-effective interventions
in the community.22
There is little debate that perinatal and neonatal
mortality are profoundly affected by proximal fac-
tors that influence maternal health such as socioeco-
nomic deprivation, gender bias, illiteracy, and high
fertility rates, and redress of these factors is critical to
improving maternal and neonatal health in develop-
ing countries.4,36 However, these elements are rela-
tively resistant to change in the short term.37–42
Moreover, as a consequence of such systematic ne-
glect, a sense of fatalism and inevitability of adverse
fetal and neonatal outcomes sets in and further im-
pedes care seeking.22,43,44 This in itself is a major
barrier to improvement in perinatal and neonatal
outcomes. The concept that all people possess equal
rights to health, education, and social services is a
key factor in creating demand for better allocation of
health care resources for women and newborns. This
must be coupled with greater participation of indi-
viduals and communities in planning and meeting
their own health care needs, particularly women
within traditional societies through empowering
them to participate in decision-making processes.
Because the health of the mother and newborn are
intimately entwined, they must be considered to-
gether when planning strategies to improve perinatal
and neonatal outcomes. It is important to highlight
that the peak period of vulnerability for both the
mother and newborn is around pregnancy and child-
birth. Thus, interventions must largely focus on ad-
dressing joint outcomes. There is evidence, however,
that this has not been widely adopted, that Safe
Motherhood interventions have not adequately ad-
dressed the newborn period, and that newborn in-
terventions rarely focus on integration with existing
maternal care programs and services.
To redress the burden of perinatal and neonatal
mortality, several factors are required: (1) political
commitment to newborn health at the global, re-
gional, national, and local levels; (2) increased focus
on the newborn within existing Safe Motherhood
and Child Survival programs; (3) efficient allocation
of resources; (4) effective implementation of cost-
effective interventions; and (5) clear documentation
of impact.18 To aid in garnering political and pro-
grammatic will and action to improve perinatal and
neonatal health care and status, the magnitude of the
problem and evidence for effectiveness of interven-
tions to prevent and manage adverse outcomes must
be documented clearly. A recent analysis of the neo-
natal burden of disease in south Asia and sub-Sa-
haran Africa, in which approximately three fourths
of neonatal deaths occur, highlighted the dearth of
information available on neonatal outcomes in devel-
oping countries, particularly at the community lev-
el.28 Similarly, a recent meeting of neonatal health
researchers highlighted the need for a review of
available evidence for impact of interventions on
perinatal and neonatal health and survival.27
Neonatal health experts agree that improving neo-
natal health and survival in developing countries
depends in large measure on more effectively im-
plementing what has already been shown to
work.18,26,34,35 Moreover, a number of health inter-
ventions for the mother and her newborn have been
proposed by the WHO and others as global priorities
for programmatic implementation.14,18,26,34,35,45,46 Al-
though many advances in obstetric and neonatal care
are costly and require technologies that are unavail-
able in resource-poor countries, a substantial propor-
tion of perinatal and neonatal morbidity and mortal-
ity in developing countries could be prevented
through appropriate adaptations and applications of
inexpensive, relatively simple methods to improve
antenatal, obstetric, and neonatal care. The fact re-
mains that improvements in care are often limited
more by lack of adequate knowledge and its appro-
priate application than by technologic barriers. In
other cases, however, additional research is needed
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to devise, adapt, and evaluate sustainable solutions,
particularly at the community level. Although re-
views of the impact of certain antepartum, intrapar-
tum, and postnatal interventions have been con-
ducted, evidence for proven benefit, or lack thereof,
of the many interventions that one might include in
a neonatal health program at the community level
has never been systematically evaluated and summa-
rized. Major evidence gaps include lack of objective
data on the methodologies of introducing interven-
tions within health system settings and evaluating
hard outcomes through effectiveness-trial designs.
The limitations of the strictly randomized-trial de-
sign have been recognized in health systems research
and interventions.8
This review of community-based antenatal, intra-
partum, and postnatal intervention trials in develop-
ing countries was undertaken to (1) identify key
behaviors and interventions for which the weight of
evidence is sufficient to recommend their inclusion
in community-based neonatal care programs and
(2) identify key gaps in knowledge and priority areas
for future research and program learning. We did
not focus on long-term solutions of established and
indisputable value in improving maternal and peri-
natal outcomes, such as poverty reduction, gender
equity, fertility regulation and control, and improved
health system performance. Rather, the focus of this
review was on specific targeted interventions that
may impact perinatal and neonatal health status out-
comes, primarily perinatal and neonatal mortality.
METHODOLOGY USED FOR LITERATURE
SEARCH AND REVIEW
This review aimed to consider all available pub-
lished and unpublished data on the impact of com-
munity-based strategies and interventions on peri-
natal and neonatal health status outcomes. The
community was defined as extending from the
household to peripheral health facilities.
The search methodology included review of the
following sources of information:
1. All available electronic reference libraries of in-
dexed medical journals and analytical reviews
2. Electronic reference libraries of nonindexed med-
ical journals
3. Nonindexed journals not available in electronic
libraries
4. Pertinent books, monographs, and theses
5. Project documents and reports
Electronic Reference Sources
The following principal sources of electronic refer-
ence libraries were searched to access the available
data on community-based intervention studies:
Cochrane Reference Libraries, the WHO Reproduc-
tive Health Libraries, Medline, PubMed, ExtraMed,
Embase, and Popline. Several search strategies were
employed using key words, combinations, and med-
ical subject headings (MeSH) words including “com-
munity-based care,” “community care,” “newborn or
neonatal care,” “perinatal care,” “interventions,” “in-
tervention strategies,” “perinatal or newborn care
programs,” “newborn survival,” “perinatal out-
comes,” and “neonatal outcomes,” among others.
Manual Literature Search
A detailed examination of cross-references and
bibliographies of available data and publications was
performed to identify additional sources of informa-
tion. In particular, this search extended to reviewing
the gray literature in nonindexed and nonelectronic
sources. The bibliographies of 37 recently published
textbooks or books with sections pertaining to com-
munity-based maternal and/or newborn care were
also searched manually. Requests for information
were sent to major development and aid agencies
including the World Bank, United Nations Chil-
dren’s Fund (UNICEF), WHO, Department for Inter-
national Development, United Nations Development
Programme, United States Agency for International
Development, MotherCare, JHPIEGO, the Wellcome
Trust, LINKAGES, John Snow Inc, National Institute
of Child Health and Human Development, National
Institutes of Health (NIH) Institute of Medicine,
CARE, Save the Children/USA, and several other
nongovernmental organizations. In particular, re-
quests for information were made to regionally ac-
tive development agencies and research councils. In
addition, personal requests for information on com-
munity-based perinatal and neonatal interventions
were made to leading public health scientists in the
field.
For in-depth review, we selected 186 studies from
developing countries that directly related to the re-
search question of health status impact of communi-
ty-based perinatal and neonatal health care. These
studies were analyzed in detail and summarized in
the tables according to a standardized, prearranged
evaluation format as to their location, size, design,
nature of intervention, and outcome. The informa-
tion was categorized according to whether the target
group consisted of mothers, newborn infants, or
both.
The following categorization of interventions was
made:
Maternal Interventions
1. Maternal schooling/health education
2. Antenatal care packages
3. Protein supplementation




8. Antenatal vitamin A supplementation
9. Zinc supplementation
10. Multiple micronutrient supplementation
11. Malaria chemoprophylaxis or intermittent pre-
sumptive treatment (IPT)
12. Malaria protection using insecticide-treated bed
nets (ITNs)
13. Deworming
14. Syphilis screening and treatment
15. Antibiotics for asymptomatic bacteriuria
16. Antibiotics for bacterial vaginosis
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17. Antibiotics for preterm labor
18. Antibiotics for preterm premature rupture of
membranes (PPROM)
19. Tetanus toxoid (TT) immunization and clean de-
livery
20. Maternal pneumococcal immunization
21. Promotion of smoking cessation during pregnancy
Composite Interventions
In addition to the specific community-based inter-
ventions noted above, some studies evaluated pack-
ages of maternal interventions in community set-
tings:
22. Maternal care packages
Intrapartum Interventions
1. Maternal vaginal and newborn skin antisepsis
Postnatal Interventions
1. Newborn resuscitation
2. Delayed umbilical cord clamping
3. Umbilical cord antisepsis
4. Hypothermia prevention and management
5. Hypoglycemia prevention and management
6. Breastfeeding
7. Prevention and treatment of ophthalmia neona-
torum
8. Vitamin K prophylaxis
9. Hepatitis B vaccination
10. Neonatal vitamin A supplementation
11. Kangaroo mother care (KMC)
12. Topical emollient therapy
13. Hyperbilirubinemia screening
14. Traditional birth attendant (TBA)/CHW training
15. Pneumonia case management
Composite Interventions
Apart from community interventions focusing on
the aforementioned specific areas, some studies eval-
uated packages of postnatal interventions or the
functioning of hospitals in the community and inter-
ventions performed within them, including use of
alternative methods of care to compensate for mea-
ger resources and facilities:
16. Neonatal care packages
17. Care in peripheral health facilities
Exclusions
Some interventions were excluded from this re-
view because other investigators were evaluating the
evidence base for their impact. Interventions ex-
cluded included the following:
1. Roles of skilled birth attendants
2. Family planning and birth spacing
3. Safe Motherhood strategies such as prevention
and treatment for pre-eclampsia, pregnancy-in-
duced hypertension, and antepartum hemor-
rhage; newer strategies for prevention of preterm
labor (eg, magnesium, calcium, fish oil); emer-
gency obstetric care; emergency transport serv-
ices; communications strategies; community wait-
ing homes; and use of fetal partograph
4. HIV prevention and mother-to-child transmission
reduction strategies
5. Maternal tuberculosis treatment
Synthesis of Evidence
The principal reviewers independently evaluated
all the data, and a common reporting matrix was
used in summarizing the findings. Emphasis was
placed on assessment of impact on perinatal or neo-
natal primary health status outcomes. For some in-
terventions, however, for which data on primary
health status outcomes were lacking, other indicators
were considered.
The final categorization of the interventions was
done by mutual agreement and consensus as follows:
1. No evidence of benefit: These interventions had
been evaluated and found to have no demonstra-
ble benefit either singly or in combination with
other measures. In some cases, there was evidence
of an adverse effect of the intervention. Therefore,
these interventions were not recommended for
inclusion in any neonatal health care strategy.
2. Uncertain evidence of benefit: This category in-
cluded interventions for which there was some
evidence of benefit, but contradictory evidence or
issues such as study design, quality, location or
size precluded any firm conclusions. These inter-
ventions merited additional evaluation or re-
search using well-designed protocols and designs.
3. Some evidence of benefit: These interventions had
some positive impact on perinatal or neonatal out-
comes, but the evidence remained preliminary or
the location of the studies was not representative
of the developing world at large. Furthermore, the
trial designs were mostly efficacy studies; there-
fore, their effectiveness, if any, in large-scale pro-
grammatic interventions remained to be assessed.
Their inclusion in intervention programs was con-
sidered optional, but a recommendation was
made to include an evaluation of benefits when-
ever they were included.
4. Clear evidence of benefit: This category of inter-
ventions was of incontrovertible benefit to moth-
ers and/or newborn infants, and thus it was rec-
ommended that they be included in community-
based intervention programs for maternal and
perinatal care.
When categorizing the evidence for impact of in-
terventions, we considered a variety of factors in-
cluding the study size, location, and rigor of design;
consistency and magnitude of impact reported, par-
ticularly on perinatal or neonatal mortality; biologi-
cal plausibility of the intervention; evidence from
relevant developed-country studies; experience with
implementing the intervention in health care pro-
grams; and recommendations from the WHO and
other leading agencies in maternal and child health.
Thus, the evidence was put into a broader context to
reach a composite assessment that was agreed on by
the principal investigators (Z.A.B. and G.L.D.).
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REVIEW AND ANALYSIS OF AVAILABLE DATA
Antenatal Interventions
Maternal Schooling/Health Education
background. The relationship between maternal
antenatal education and perinatal and neonatal out-
comes is well established. Caldwell and McDonald47
demonstrated the close relationship between mater-
nal education level (ie, schooling) and infant mortal-
ity from observations in Nigeria. Since then, this
association has been borne out through a number of
reviews.40,48–51 Victora et al,39 in a review of cause-
specific infant mortality rates (IMRs) in Pelotas, Bra-
zil, found a significant inverse relationship between
maternal schooling and deaths from perinatal condi-
tions, particularly infectious diseases. The associa-
tion between increased maternal education and de-
creased infant mortality, particularly in reducing
postneonatal deaths, was further strengthened by a
review of 34 cross-sectional World Fertility Surveys
between 1974 and 1980,52 although the association
was weakened when the data were corrected for
socioeconomic status53,54 (Table 3). The association
between maternal education and neonatal survival
was also corroborated by analysis of data from 11
Demographic and Health Surveys; in this review, the
association held even after correction for socioeco-
nomic status.38,55 More recently, the importance of
maternal education in reducing birth weight–specific
perinatal mortality in Nigeria was further stressed by
Harrison,42 and the association between educational
level of the maternal grandmother and utilization of
health services for prenatal care and delivery by a
skilled attendant was also demonstrated.56
There are surprisingly few intervention studies on
the specific impact of maternal health education on
perinatal and newborn outcomes. Kramer57 evalu-
ated the evidence, including that from an interven-
tion trial in Greece,58 of the potential benefit of ma-
ternal nutritional advice during pregnancy on
several outcomes. Although an increase in energy
and protein intake during pregnancy was notable,
the overall impact on maternal, perinatal, and neo-
natal outcomes was unclear.
Reasons for improved survival of neonates born to
more highly educated mothers is not clear, but the
association is only partly explained by the economic
advantages and access to health care afforded by
education. Potential links between maternal educa-
tion and reduced perinatal and neonatal mortality
also include appropriate birth spacing and health-
seeking behavior, particularly for prenatal care.
There is strong evidence supporting the importance
of community- and hospital-based maternal educa-
tion and support programs on breastfeeding prac-
tices59–62; these programs are reviewed below (see
“Breastfeeding”).
community-based evidence. Although there are
data available from developed countries on maternal
educational strategies specifically aimed to improve
perinatal and neonatal outcomes,63–65 there are few
systematic studies that have prospectively evaluated
their impact,57 particularly from developing coun-
tries. Woods and Theron66,67 in South Africa demon-
strated a significant improvement in cognitive
knowledge of midwives who participated in an ex-
tended perinatal education program; however, im-
pact on perinatal outcomes was not reported. In con-
trast, providing postnatal maternal education in
Nepal through a limited didactic educational inter-
action met with little success in improving knowl-
edge and practices, except for family-planning prac-
tices.68 Although the impact of the didactic form of
education was not found to be effective, the authors
of the latter study subsequently concluded that com-
munity participation was a key to the success of
educational strategies. These intervention strategies
include the development of intervention strategies
by community members themselves, based on their
understanding of barriers to care seeking for new-
born care.69,70
conclusions. Maternal educational level is
clearly associated with improved perinatal and neo-
natal survival. Thus, building the capacity of moth-
ers through basic education is a key long-term strat-
egy to improve perinatal and neonatal health in
developing-country communities. More work is
needed, however, to develop and test shorter-term
maternal educational strategies targeted toward im-
proving pregnancy outcomes in developing coun-
tries, particularly at the community level. The exact
nature and content of the educational package, roles
of different cadres of health workers, and ways to
convey the messages at the community level most
effectively may best be developed and evaluated
considering the principles of appropriate and partic-
ipatory community-based research.71
Antenatal Care Packages
background. Antenatal care is well regarded as 1
of the 4 main pillars of Safe Motherhood by the
WHO.14 Although the beneficial effects of antenatal
care for maternal health and outcomes are well rec-
ognized and the practice is well established, there
have been few systematic studies of the impact of
“standardized” antenatal care programs on perinatal
and neonatal outcomes.72,73 No intervention studies
are available that directly compared groups of
women who received antenatal care and those who
did not, thus limiting conclusions regarding the ex-
tent to which antenatal care improves perinatal/neo-
natal outcomes.
The benefits of antenatal care for maternal and
newborn outcomes, including assessment of the
most effective components, were addressed in sys-
TABLE 3. Association of Maternal Education With RR of
Neonatal Death (52)
RRs Years of Schooling
0 1–3 4–6 7
Neonatal mortality
Unadjusted 1.00 0.87 0.76 0.57
Adjusted for socioeconomic factors 1.00 0.98 0.90 0.86
Postneonatal mortality
Unadjusted 1.00 0.82 0.73 0.45
Adjusted for socioeconomic factors 1.00 0.98 0.90 0.78
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tematic analyses by Bergsjo and Villar72,74 and Car-
roli et al.75 Some of the major interventions intro-
duced during antenatal care and their impact on
pregnancy outcomes are detailed in Table 4. TT im-
munization, iron-folate supplementation, detection
and management of pre-eclampsia, screening and
treatment for bacteriuria, and where appropriate,
screening and treatment for syphilis and malaria are
priority activities. Although some studies have indi-
cated that antenatal care alone may be insufficient for
the identification of pregnant women at risk of ob-
stetric complications and emergencies,76–78 there is
observational evidence from a variety of geographic
settings that lack of antenatal care is associated with
increased risk for late fetal death.79,80 Although the
evidence is somewhat mixed, the overall consensus
is that quality antenatal care provided by a trained
attendant within a functional health system reduces
the risk of maternal mortality and adverse pregnancy
outcomes.81
Although there is some evidence that antenatal
care works, there is little consensus on critical related
issues such as the minimum number of visits and the
most cost-effective components of antenatal care. In
an evaluation of antenatal care models in the United
States, McDuffie et al82 found comparable pregnancy
outcomes among women who had attended a mod-
ified program of 2.7 fewer visits, on average, com-
pared with the traditional program of 7 antenatal
visits. To further evaluate whether a reduced system
of 4 antenatal care visits was as effective as a pro-
gram with more frequent visits, the WHO organized
a multicenter trial involving urban centers in Saudi
Arabia, Argentina, Cuba, and Thailand (Table 5).83,84
No impact was observed in this large trial on either
preterm birth or IUGR.84 Women who received in-
formation about breastfeeding antenatally were
more likely to initiate breastfeeding after birth. Those
assigned to the reduced-visit model had similar ma-
ternal (ie, morbidity index, urinary tract infection
[UTI], and anemia rates) and neonatal (ie, perinatal
mortality rate [PMR], NMR, LBW rate) outcomes as
those who were given standard antenatal care, al-
though women who had 4 antenatal visits were
more likely to feed their infants colostrum. The par-
ticipants of the trials were generally satisfied with
the quality of care in the new, modified system of
antenatal care.85
A recent systematic review of randomized trials
also yielded no strong evidence that the content,
frequency, or timing of currently recommended an-
tenatal care visits has an effect on reducing the inci-
dence of IUGR or preterm delivery.75 This systematic
review of pooled data on alternative models of re-
duced numbers of antenatal care visits showed sim-
ilar odds of multiple health outcomes compared with
the standard care model, including pre-eclampsia
(odds ratio [OR]: 0.91; 95% confidence interval [CI]:
0.66–1.26), UTIs (OR: 0.93; CI: 0.79–1.1), maternal
mortality (OR: 0.91; CI: 0.55–1.51), incidence of LBW
(OR: 1.04; CI: 0.93–1.17), and overall perinatal mor-
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conclusions. The benefits and importance of an-
tenatal care in improving maternal health and preg-
nancy outcomes are widely accepted, yet little direct
evidence of impact exists from intervention trials. An
antenatal care package that consists of fewer but
qualitatively better and more goal-oriented visits is
recognized to be more cost-effective than the “con-
ventional” antenatal care packages promoted previ-
ously, which involved more frequent visits. How-
ever, this evaluation was also not undertaken as an
effectiveness trial in health system settings. It is also
important to point out that there are no studies eval-
uating different community-based models of ante-
natal care using primary heath care workers and
CHWs.
The exact margin of improvement in neonatal
mortality after antenatal care is unclear, and we
could not cite a specific figure based on objective
evidence and controlled trials. Moreover, a con-
trolled trial to determine the level of effect would
now be unethical. The exact contents of such a pack-
age would need to be based on evidence of the
efficacy of each individual component of the package
plus the cost-effectiveness and relative ease of imple-
mentation by primary care workers. Based on the
available evidence elaborated in this review, the an-
tenatal care package should contain, at a minimum,
TT immunization, iron-folate supplementation, and
promotion of clean delivery and exclusive breast-
feeding. Based on health system capacity, the pack-
age should also include supplementation with iodine
and screening and treatment for bacteriuria, pre-
eclampsia, and syphilis.
Nutrition Interventions in Pregnancy
Maternal malnutrition is widespread in develop-
ing countries and is an underlying factor in fetal
malnutrition and LBW as well as other adverse preg-
nancy outcomes such as premature births, abruptio
placentae, and stillbirths.86,87 A large proportion
(16%) of births in developing countries are LBW,
which is a major underlying risk factor for morbidity
and mortality in the perinatal and neonatal periods
and later in infancy.86,88 Poor maternal nutritional
status is associated with adverse birth outcomes,11,89
but the association with fetal mortality is less clear.
Given the recognized association between maternal
malnutrition and LBW, there has been considerable
interest in nutritional interventions that may im-
prove birth weight as well as other adverse preg-
nancy outcomes.87 With the emerging evidence of
the long-term implications of fetal malnutrition, nu-
trition transition, and adverse metabolic outcomes
such as diabetes,90 it becomes even more imperative
to improve maternal and fetal nutrition in develop-
ing countries. Two recent reviews evaluated the im-
pact of nutrition interventions on prematurity91 and
pregnancy outcomes92 and underscored the fact that
few studies have addressed this problem in commu-
nity settings in developing countries.
Evidence for impact of nutritional interventions on
maternal, perinatal, and neonatal outcomes has been
reviewed extensively, largely within the Cochrane
collaboration using meta-analyses of RCTs. Avail-
able data have also been reviewed recently as part of
an evaluation of the evidence base for Safe Mother-
hood strategies93 and a review of the efficacy and
effectiveness of nutrition interventions.94 Our evalu-
ation of the evidence was drawn largely from these
sources, especially the individual community-based
studies in developing countries within the Cochrane
reviews. In addition, we evaluated recent studies
that have not yet been included in the Cochrane
reviews and others with a quasi-experimental design
that were not considered as part of the meta-analy-
ses.
Protein Supplementation
background. Benefits of unbalanced protein sup-
plementation in pregnancy were largely refuted re-
cently in a meta-analysis of available evidence.95
Such interventions have been tried historically in a
variety of malnourished and at-risk populations in-
cluding poor communities in developed coun-
tries.96,97 In 3 studies among Asian women in the
United Kingdom and Chile, where the usual mater-
nal energy intake was isocalorically replaced with
10% to 11% protein,98–100 there was no effect on
pregnancy outcomes, although there was a trend
toward reduced birth weight. Even higher levels of
protein supplementation (25% of energy) in rela-
tively well-nourished populations failed to show
any benefit on pregnancy outcomes and birth
weight.101,102 Thus, protein supplementation alone is
no longer viewed as a viable intervention during
pregnancy.103
conclusions. Based on a large body of evidence,
pure or high levels of dietary protein supplementa-
tion cannot be recommended as an antenatal inter-
vention, nor is additional research warranted on this
intervention.
Balanced Protein-Energy Supplementation
background. Balanced protein-energy supple-
ments, by definition, provide 25% of their total
energy content in the form of protein. A systematic
review done by the Cochrane collaboration on the
effect of antenatal maternal balanced protein-energy
supplementation95 concluded that this intervention
significantly improved fetal growth and reduced the
risk of fetal and neonatal death. The findings of this
review, however, were largely influenced by 1 large
trial undertaken in The Gambia that indicated a sig-
nificant reduction in perinatal mortality.104 How-
ever, this efficacy study also included micronutrient
supplementation in addition to balanced protein-en-
ergy intake. Excluding this single study drastically
altered the conclusions of this meta-analysis, leaving
no demonstrable impact.
community-based evidence. A review of the lit-
erature identified 19 studies, 12 of which were un-
dertaken in community settings and discussed preg-
nancy outcomes, thus fulfilling our criteria for
selection. The details of these studies are given in
Table 6. These trials were largely conducted in de-
veloping countries and inner-city populations in in-
dustrialized countries. Inconsistent results may have
been related to the variability in the background
rates of maternal malnutrition in the different study
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TABLE 6. Antenatal Balanced Protein-Energy Supplementation
Source Location and Type
of Trial





Treatment group consisted of pregnant
women who received high–protein
energy biscuits; the control group
consisted of women who did not
receive the supplement (247 normal
singleton live births among 1460
women; treatment group: 1010 live
births; control group: 1037 live
births).
Incidence of stillbirths decreased
by 53% in the intervention
group (OR: 0.47; CI: 0.23–0.99;
P  .05); a 46% decrease was
recorded in the number of
deaths occurring in the first
week of life (OR: 0.54; CI:
0.35–0.85; P  .01), but there
was no effect on mortality
rates after 7 d of life (P  .2);
there was a significant
increase in birth weight of
infants born to mothers in the
intervention group (mean
increase: 136 g; P  .001); a
39% decrease was seen in
LBW rates among the infants






Pregnant women (n  542) were
assigned to low- and high-energy
supplementation groups.
For women who consumed the
supplements for 45 d, there
was a significant difference in
birth weight (463 g) between
the 2 groups; a difference of
421 g (P  .017) was seen in









Pregnant women (n  741) in 3
villages were assigned to a high-
energy (n  272) or low-energy (n 
265) group; there were 204
noncompliers excluded from these
groups; among these, 6 additional
groups were formed according to
the number of energy packets
consumed during the trial.
No difference in weight
gain was seen among
the women of the 2
groups compared
with noncompliers.
There was no significant effect
of the supplementation on
birth weight and LBW rates
when compared to the







169 mothers and their offspring were
enrolled during 2 consecutive
pregnancies and the interim
lactation period; 2 types of
supplements (atole, a high-protein
and high-calorie gruel, and fresco, a
no-protein/low-calorie cold liquid
drink) were offered to pregnant
and/or lactating women.
There was an impact of the
supplement on birth weight,
with a linear trend for
increased (P  .05) birth
weight from the highest (atole)






Women (n  43) in their third
trimester were divided into 3
groups: groups 1 and 2 (14 in each
group) received 2 different levels of
supplementation, whereas group 3
(n  15) acted as controls; group 2
had the highest protein and calorie
content in their supplement.
There was a significant increase
in birth weight of infants born
to women in group 1
(3089  308 g; P  .025) and
group 2 (3104  259 g; P 
.025) compared to the group 3
controls (2853  247.9 g); the
placental weights also were
significantly higher in the 2
supplemented groups
(630  669 and 616  68 g in
groups 1 and 2, respectively;
P  .005) that were sup-
plemented compared to the







Pregnant women (n  20) were
recruited for the study: 1 group (n 
10) was supplemented in the last
trimester with sesame cakes, jaggery
(raw sugar), and oil; women in the
control group (n  10) were not
given the supplement.
There was no difference









increase in Hb levels.
There was no significant
difference in birth weight and
length at birth of infants born
to the 2 groups of women.
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TABLE 6. Continued
Source Location and Type
of Trial





Pregnant women who were, on
average, in their 16th wk of
gestation were supplemented with
peanut-based biscuits and a vitamin-
fortified tea drink (n  652
nonsupplemented women and 577
supplemented women).
Infants born to the
supplemented mothers were
significantly heavier (101 g)
than those born to
nonsupplemented mothers (P
 .05); this beneficial effect of
supplementation was seen
only in the wet season, not
during the dry season; a
67.5% decrease was observed
in the proportion of LBW
infants in the supplemented
group over the year (P  .01);
this effect was greater in the
wet season, during which
there was a decrease of 83.3%
in the proportion of LBW
infants (P  .01);
supplementation also seemed
to contribute to increased





Women (n  212) were distributed
randomly to groups A (n  107) and
B (n  105); pregnant women in
group A were given high-protein
and -calorie liquid supplements, and
the supplement was provided to
group B was low in calories and had
no protein; the trial started after the
birth of the “first study infant,” and
the women were supplemented until
onset of lactation of the “second
study infant.”
There was no difference in the
incidence of fetal deaths
among the “first” and
“second” study infants of the
2 groups; a mean increase in
birth weight of 161.4 g was
observed in the second study
infants in group A (P  .05);
LBW rates decreased to 2.8%
for the second infant in group
A (statistically insignificant),
whereas it remained the same
for group B at 6.8%; there was






3 groups of villages were randomized
into nutrition care (NUT), nutrition
care plus medical care (NUT  MC),
or medical care (MC); a fourth
group (emergency care only) served
as the control group; nutrition care
was comprised of nutrition
education, surveillance, and food
supplementation (1675 J and 11 g of
protein per day, fortified with iron
and folate) through special feeding
centers; medical care included
immunization, health education,
early diagnosis, and treatment
through frequent surveillance,
provided singly and combined as
needed; monitoring from birth to
age 36 mo was done through
longitudinal anthropometry,
morbidity, and vital statistics.
There was a 41.3% decrease in
PMR in the nutrition group
compared to the control
group; this decrease was
higher among the 3
intervention groups (MED,
NUT, and MED  NUT
groups) compared to controls;
the decrease in NMR was
highest in the nutrition
intervention group (41%)






Women (n  456) in their third
trimester and from a family having
at least 50% of children
malnourished were given dry milk,






P  .05) among
supplemented
women who gave
birth to male infants.
Birth weight was significantly
greater (95 g; P  .05) among
male infants born to
supplemented compared to
nonsupplemented women;
there was no significant effect






456 pregnant women were recruited
for the study; women in the
supplemented group (n  226) were
given a total of 230 g of dry skim
milk, enriched bread, vegetable oil,
and vitamin mineral supplement
during the third trimester; controls
(n  230) were not supplemented.
There was a 46% decrease in the
NMR and a 25% reduction in
the PMR. A 75% decrease was
detected in the stillbirth rate
among the infants of women
in the supplemented group
(on pooled sample of
stillbirths and neonatal deaths,
2 (1 df)  4.1; P  .05).
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settings and the relative size of the individual stud-
ies. Of the trials included in this review, only 4
reported preterm birth rates.97,101,105–107 Supplemen-
tation was not associated with an increase in mean
gestational age (mean difference: 0.1 week; CI:
0.2 to 0.1 week) or a significant reduction in
preterm birth (OR: 0.83; CI: 0.65–1.06). Supplemen-
tation generally resulted in increased birth weight
and/or a reduction in the LBW rate.104,105,108–115
Overall, however, balanced energy-protein supple-
mentation seems to have only a modest effect on
mean birth weight (weighted mean difference: 25 g;
CI: 4 to 55 g) but a more substantial effect on
reducing IUGR (OR: 0.68; CI: 0.57–0.80). No evidence
was found that these effects were greater in under-
nourished than in well-nourished women. However,
the magnitude of the birth weight increase was sub-
stantially larger (136 g) in the Gambian study,104 in
which the supplement provided an additional 3780
kJ per day, as compared with an 840- to 1050-kJ-per-
day increase in most of the other trials. Although a
trend toward increased weight gain of the supple-
mented mothers was observed in 2 studies, the dif-
ferences were nonsignificant.105,114 Moreover, other
studies showed no impact on maternal weight
gain.116,117 In the few studies that examined effects
on the stillbirth104,105 and perinatal mortality104,105,118
rates, reductions were seen. The largest of these
studies104 was undertaken in The Gambia, where, in
an RCT, chronically undernourished pregnant
women were provided a higher-energy supplement
(3780 kJ), largely toward the last trimester, with little
micronutrient content. Results from this Gambian
study104 reported significant reductions in rates of
stillbirths (53% reduction), early neonatal deaths
(46% reduction), and LBW (39% reduction).
In contrast to findings noted above regarding un-
balanced protein supplementation alone in pregnan-
cy,95 the impressive reduction in rates of stillbirths
and perinatal mortality from this large trial provided
strong evidence of the potential benefit of balanced
protein-energy supplementation during pregnancy.
conclusions. Although Kramer95 did not find a
differential effect of balanced protein-energy supple-
ments according to the degree of maternal malnutri-
tion, the weight of evidence is strong in favor of
improving perinatal mortality and birth weight
through balanced protein-energy supplementation
of malnourished pregnant women. Most of the evi-
dence, however, comes from strict efficacy trials con-
ducted under intense supervision, and the overall
results are largely driven by a single trial from The
Gambia. No effectiveness trials have been under-
taken to evaluate the benefit of balanced-energy pro-
tein supplementation at the community level nor of
using home-available diets to provide these supple-
ments. We believe that balanced protein-energy sup-
plementation merits additional field evaluation in
diverse geographic locations and may be cautiously
included in intervention programs in malnourished
populations. However, if such a program is insti-
tuted, data must be collected to evaluate the pro-
gram’s benefit and cost-effectiveness. Ideally, the
benefit of improved protein-energy intake in preg-
nancy may be achieved through dietary diversifica-
tion strategies as well as targeted supplementation
in at-risk populations, although the cost may be
substantial.
Iron Supplementation
background. Global estimates by the WHO indi-
cate that 55% of all pregnant women living in devel-
oping countries and 18% of those in developed
countries are anemic (hemoglobin [Hb] concentra-
tion 11 g/dL).119 It is also recognized that anemia
underlies some 8% to 15% of maternal deaths in
developing countries.120–122 Although the exact con-
tribution of maternal anemia to maternal mortality
TABLE 6. Continued
Source Location and Type
of Trial





Chronically malnourished women of 2
villages (n  405) received atole (a
high-protein/-calorie gruel), whereas
women of 2 villages were given
fresco (a low-calorie/no-protein cool
drink).
There was a significant
correlation between caloric
supplementation during
pregnancy and birth weight
(P  .01); the rate of LBW
births was approximately half
in the high-calorie/protein-
supplemented mothers
compared to the low-calorie/
protein-supplemented





3 groups of women (n  126) were
formed and followed from 20 wk
gestation to birth; women in group 1
(n  37) received an iron  folate
supplement, and group 2 (n  39)
received a dietary supplement high
in protein and calories, as well as
the iron  folate supplement; group
3 (n  50) received none of the
above and served as the control
group.
Women in group 2
gained an average of
1 kg more during
pregnancy than those
in group 1.
Infants born to women in group
1 were 0.27 kg heavier than
the infants born to women in
the control group; the infants
born to women in group 2
were 0.81 kg heavier than
those in the control group.
* Data are from the same trial.
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may be unclear,123,124 it is also widely recognized as
a major determinant of maternal morbidity in devel-
oping countries. The majority of such cases of anemia
are related to iron deficiency, although malaria and
hookworm infestation, as well as protein and other
micronutrient deficiencies, may play a role also.121
Iron-deficiency anemia is highly prevalent in de-
veloping countries, affecting an estimated 2 billion
people, including one fourth of the world’s women
and children.125,126 Thus, there has been much inter-
est in interventions geared toward improving iron
intake and status during pregnancy. Despite the ev-
idence that gastrointestinal iron absorption increases
during pregnancy, it is highly unlikely that sufficient
amounts can be absorbed from the diet during this
period to compensate for the increased requirement
of the body. Thus, supplementation with iron gener-
ally is required, especially where diets may be defi-
cient in iron and body stores of iron may be inade-
quate to meet requirements.127
Although it is widely accepted that iron-deficiency
anemia poses an increased risk of complications in
pregnancy and of maternal and perinatal mortali-
ty,128 there is surprisingly little evidence to support
this relationship. An association has been suggested
by some epidemiologic studies,129–131 but other stud-
ies, in fact, have failed to demonstrate a relationship
between iron-deficiency anemia and adverse preg-
nancy outcomes.132,133 Most of the evidence in the
literature has been largely derived from retrospec-
tive studies and has not been controlled for ancillary
factors such as overall nutrition, underlying health,
and health service delivery.123 Several review-
ers123,134–138 believe that anemia, which itself can be
due to a variety of factors, is just one of a multitude
of determinants of maternal and perinatal mortality
and that there is no conclusive evidence of a link
between maternal anemia and LBW or maternal or
perinatal mortality. Moreover, there is little docu-
mentation that health status can be improved by
treating anemia alone. There are no iron-supplemen-
tation trials with maternal mortality as a measured
outcome, and all intervention trials that used perina-
tal mortality as the outcome involved nonanemic
women,139 were poorly designed,140,141 or were too
small to be conclusive about iron effects.142 How-
ever, despite the fragmentary nature of the data on
the association between maternal anemia and mor-
tality, one can infer that there is a steep rise in ma-
ternal mortality with increasing severity of anemia,
especially Hb levels 5 g/dL.143 Nevertheless, the
association may not be causal.128 There also seems to
be a U-shaped relationship between maternal anemia
and birth weight, because both low and high mater-
nal Hb values are associated with an increased risk of
LBW.135,144,145 Again, although no causal evidence
has been established overall to support or refute the
relationship between iron-deficiency anemia and
LBW, the evidence from developing countries, in
which iron-deficiency anemia is common, shows that
maternal iron deficiency is positively associated with
LBW and poor obstetric outcome.136 There is also
evidence suggesting that a relationship exists be-
tween maternal anemia in early pregnancy and in-
creased risk of preterm birth.146–149
Meta-analyses of iron-supplementation trials, con-
ducted under the auspices of the Cochrane collabo-
ration,150–152 concluded that although iron supple-
mentation significantly reduced the prevalence of
low Hb concentration (105 g/L), it had no detect-
able effect on any other substantive measures of
maternal or perinatal outcomes. Although iron re-
duces maternal anemia, there is no evidence that iron
supplements administered alone or with folate have
any effect on birth weight or fetal survival in devel-
oped countries. There are insufficient data from de-
veloping countries to draw conclusions; the few
RCTs are inconclusive because of small sample size,
problems with compliance, and large losses to fol-
low-up. Small trials in The Gambia, Nigeria, and
India showed no significant effects on birth
weight,140,153–155 although 1 large trial in Niger
showed a significant increase in birth length and
Apgar scores and a reduction in PMR.156
There are several other reports of iron therapy in
pregnancy from developing countries that are rela-
tively less stringent in their inclusion and exclusion
criteria.157–163 However, most of these studies were
based in health facilities within developing countries
and varied considerably in design. The overall effects
of iron therapy in these studies were largely mixed
and did not suggest a particular effect. A review of 9
RCTs of iron supplementation from health facilities
in developing countries showed that the increment
in Hb level for given amounts of supplementation
was not greatest among those with the lowest Hb
levels, suggesting that factors other than iron defi-
ciency alone were operative.164
community-based evidence. Few community-
based iron-supplementation trials have resulted in
improvement in either iron stores or measures of
maternal and perinatal health.164–166 Among iron-
supplementation trials conducted to date, 5 were in
developing countries: 1 in a periurban setting and
the other 4 in rural settings (Table 7). All 5 studies
demonstrated a convincing effect of iron supple-
mentation on reducing rates of maternal
anemia.141,154–156,167,168
Several studies have evaluated the benefit of com-
bining iron with other micronutrients in an effort to
address multiple deficiencies. In a randomized, pla-
cebo-controlled trial (RPCT) in Indonesia, Suharno et
al168 found a synergistic effect of vitamin A and iron
supplementation in reducing rates of maternal ane-
mia, with two thirds of the response attributable to
vitamin A. Another study in India141 demonstrated a
reduction in LBW rates and an increase in birth
weight of infants born to women who were supple-
mented with both iron and folate. Increased birth
weight, however, was seen only in offspring of
women who began supplementation from 16 to 20
weeks’ gestation but not in those supplemented after
week 20 of gestation. Christian et al169 indicated that
both iron-folate supplements and multiple micronu-
trients reduced the prevalence of LBW comparably
among pregnant women in rural Nepal (16% vs
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14%). A different study167 found a synergistic effect
of antihelminthics with iron supplementation. How-
ever, this particular study also indicated that women
who were supplemented for 17 weeks did not
show any benefits, and there was no overall effect of
supplementation on birth weight. One study154
showed an increase in birth weight but only in the
offspring of women who had taken the iron supple-
ment for a period of 80 days.
It must be pointed out also that there is evidence
that administration of parenteral iron to iron-defi-
cient women during pregnancy in malaria-endemic
areas may be associated with an increase in the inci-
dence of malarial infections and clinical episodes of
disease.170,171 Thus, care must be exercised in admin-
istering iron supplements alone (without chemopro-
phylaxis) in malaria-endemic areas.
conclusions. Oral iron supplementation may im-
prove maternal anemia, but there is no clear effect of
iron supplementation on maternal and perinatal or
neonatal outcomes. However, the evidence for im-
pact of iron supplementation on health outcomes is
inconclusive, primarily due to a paucity of ade-
quately designed and robust trials of iron supple-
mentation in developing countries rather than a
demonstrated lack of effect.123,136 In any case, it
seems that initiation of therapy early in gestation is
important.
Pending the results of well-designed trials that
might more definitely delineate the role and mode of
iron supplementation in deficient populations, and
given the apparent importance of anemia, especially
severe anemia, as a risk factor for maternal mortality
and morbidity,128 it would seem prudent (pending
additional research, including meta-analyses) to con-
tinue with iron supplementation, concomitant with
folate administration (see “Folate Supplementa-
tion”), during pregnancy and in at-risk populations
of women of reproductive age. In malaria-endemic
areas, routine iron supplementation during preg-
nancy must be accompanied by malaria chemo-
prophylaxis (see “Malaria Chemoprophylaxis or
Intermittent Therapy”). Current WHO/UNICEF
guidelines recommend universal iron-folate pro-
phylactic supplementation of young children and
pregnant women in areas where anemia is highly
prevalent.172
Folate Supplementation
background. Folate is critical for DNA synthesis,
and folate deficiency is associated with dysfunction
in rapidly dividing cells. Observational studies have
suggested that lower maternal serum folate levels are
associated with LBW and prematurity.173,174 A large
US study suggests an association between higher
maternal serum folate at 30 weeks’ gestation and
lower risk of IUGR, higher birth weight, and higher
Apgar scores,175 although these results have not been
corroborated by data from South America.176,177
There is a large body of literature, mainly from
developed countries, reporting observational studies
and RCTs of folic acid in pregnancy. These have been
reviewed by Ramakrishnan et al,145 de Onis et al,86
and Mahomed.151,152 Some observational studies178
have shown positive associations between maternal
folate status and birth weight, but the evidence is
inconsistent. Twenty-one trials of folate supplemen-
tation were included in the Cochrane review,151
which concluded that, despite a significant reduction
in maternal anemia, there was only a small and
nonsignificant effect on the incidence of LBW (OR:
0.73; CI: 0.47–1.13). de Onis et al86 included 4 folate
trials in their review of nutritional interventions to
prevent IUGR and found a significant reduction in
LBW, but they commented on the poor quality of
much of the data. Although 2 studies from India179
and South Africa180 showed significant increases in
birth weight of offspring of malnourished women,
this result has not been confirmed in subsequent
studies.
Folate deficiency in early pregnancy is an impor-
tant factor underlying the occurrence of neural tube
defects (NTDs) such as spina bifida, encephalocele,
and anencephaly. Worldwide, NTDs (particularly
the 2 major types, anencephaly and spina bifida) and
encephalocele are estimated to affect 300 000 in-
fants each year.181,182 A trial of periconceptional fo-
late supplementation (400 g of folic acid per day
before and during the first 28 days after conception),
conducted by the Medical Research Council183 in 33
centers among developed countries, showed a reduc-
tion of NTDs by 50% to 70%. Similar data were
reported by Berry et al.184 Universal folic acid forti-
fication of flour at 240 g/100 g in consumed food
products has been shown to significantly reduce
NTD-affected conceptions and births.185 Currently,
the benefits of periconceptional folate supplementa-
tion in terms of reducing the incidence of NTDs are
well established, and this intervention should be
made universally available.
Although there is little evidence of widespread
folate deficiency, folic acid is commonly adminis-
tered along with iron supplements during preg-
nancy. The benefit of periconceptional folate admin-
istration has been convincingly demonstrated in a
large cohort (n  23 491) in the United States.186
Prevalence ratio estimates of NTDs among women
who took multivitamins containing folic acid during
the first 6 weeks of pregnancy were 0.27 and 0.29,
respectively, depending on whether they had a fam-
ily history of an NTD.
Two meta-analyses undertaken by the Cochrane
collaboration evaluated the impact of folate supple-
mentation during either pregnancy151 or the pericon-
ceptional period.187 In the former review of 21 stud-
ies, folate supplementation during pregnancy was
associated with a reduction in the proportion of
women with low Hb levels in late pregnancy (OR:
0.61; CI: 0.52–0.71). Apart from the small, nonsig-
nificant reduction in the incidence of LBW noted
above (OR: 0.73; CI: 0.47–1.13), folate supplementa-
tion seemed to have no measurable effect on any
other substantive measure of pregnancy outcome
such as pregnancy-induced hypertension, placental
abruption, or preterm delivery. Although folate ad-
ministration significantly improved maternal Hb lev-
els and folate status, there was insufficient evidence
to evaluate whether folate supplementation during
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pregnancy had any effect, either beneficial or harm-
ful, on clinical outcomes for mother and infant.
The second meta-analysis of periconceptional fo-
late supplementation trials187 principally included 4
trials with 6425 women and concluded that pericon-
ceptional folate supplementation significantly re-
duced the incidence of NTDs (OR: 0.28; CI: 0.15–
0.53). Of the 4 trials, 3 also evaluated different
multivitamin combinations, including various micro-
nutrients. Multivitamins or micronutrients alone
were not associated with prevention of NTDs and
did not produce any additive benefits when given
with folate. There was no effect on rates of miscar-
riage (OR: 1.12; CI: 0.98–1.29) or stillbirth (OR: 0.78;
CI: 0.34–1.78). There was some evidence that folate
supplements increase the risk of multiple births (OR:
1.40; CI: 0.93–2.11); although not statistically signifi-
cant, this was a consistent finding in 3 studies. None
of these studies reported birth weight as an outcome.
A trial of periconceptional and first trimester folic
acid and multivitamins conducted by the Indian
Council of Medical Research showed no effect on
abortions or stillbirths and a nonsignificant effect on
LBW (12.5% [folic acid] vs 15.6% [placebo]).188
We identified an additional 10 studies in devel-
oped countries that also evaluated the potential ben-
efits of periconceptional folate administration; only 1
of these studies189 presented data on neonatal out-
comes other than congenital malformations. This
large study from Denmark189 showed a decrease in
preterm, small-for-gestational-age (SGA), and LBW
rates in neonates born to mothers who were supple-
mented with folate. Women who benefited were
those supplemented with folate in the periconcep-
tional period, compared with women who either
were not supplemented or were supplemented dur-
ing some other time of pregnancy. There was no
difference in the effect of a 1-mg daily dose com-
pared with a 2.5-mg daily dose of folate. Other stud-
ies revealed a significant reduction in the incidence
of primary and recurrent cases of NTDs among ne-
onates born tomothers supplementedwith folate.190,191
Furthermore, these studies showed a decrease in the
incidence of other congenital malformations (eg, limb
defects, cardiovascular problems, urinary tract anoma-
lies, orofacial abnormalities).191–195
Given the recent interest in the prevalence of ma-
ternal hyperhomocysteinemia among folate and B12-
deficient populations and the potential relationship
with adverse pregnancy outcomes,196,197 there is re-
newed emphasis on ensuring adequate maternal fo-
late and B12 status during pregnancy. The serum
concentrations of these nutrients have been shown to
correlate with maternal pre-eclampsia,198 perinatal
outcomes,199 and newborn measurements.200
community-based evidence. Two studies from
developing countries provide evidence for efficacy of
folate supplementation (Table 8). In South Africa,
there was a significant decrease in the incidence of
LBW births among native African women supple-
mented with folic acid during pregnancy.180 In
China, a large-scale intervention with optional folic
acid supplementation given to women premaritally
revealed a significant reduction in the incidence of
NTDs in infants born to women who had received
the folic acid supplements.184
conclusions. Based on the demonstrated impact
of folic acid supplements given along with iron in
improving Hb levels in iron-deficient populations,
folate merits inclusion in antenatal supplementation
programs in developing countries. Overall, the evi-
dence also strongly supports the use of periconcep-
tional folate supplementation to reduce NTDs, al-
though the impact of folate supplementation on
other pregnancy outcomes such as LBW and preterm
births is not clear.
Several other aspects of folate use in pregnancy
remain unanswered, such as the optimal dosage, the
role of genetic polymorphisms at a population level,
and the considerable logistic difficulties in providing
folic acid to susceptible women periconception-
ally.201 Our review of the evidence on folate supple-
mentation suggests that this intervention is impor-
tant in areas of maternal malnutrition and endemic
micronutrient deficiencies, and it already is used
TABLE 8. Antenatal Folate Supplementation





247 831 pregnant women were studied
(31 960 from the northern provinces
having high rates of NTDs and
215 871 from the southern region of
China with lower rates of NTDs); of
the 31 960 women in the northern
region, 18 591 women used folic
acid, whereas 13 369 did not; in the
southern region, 111 551 used folic
acid, whereas 104 320 did not.
Among the women who did not take any
folic acid, the rates of NTDs among
offspring were 6.5 of 1000 pregnancies
of at least 20 wk of gestation in the
northern region and 0.8 of 1000
pregnancies of at least 20 wk of
gestation in the southern region;
among the fetuses or infants of the
women who used any folic acid, the
respective rates were 1.3 of 1000 (79%
reduction; OR: 0.21; CI: 0.13–0.32) and
0.7 of 1000 (16% reduction; OR: 0.84;




South Africa; tertiary hospital;
RCT
Women (n  354) were randomized to
1 of 2 groups; group 1 received 200
mg of iron daily, group 2 received 5
mg of folic acid daily  iron, and
group 3 received 50 g of vitamin
B12  iron and folate.
19 babies born to native African women
in group 1 had a birth weight 2270 g,
compared with only 4 such babies
among native African women in
group 2.
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routinely in maternal health programs. Better target-
ing of this intervention, by ensuring that young
women receive folic acid along with iron, may re-
duce rates of NTDs and other congenital malforma-
tions and improve pregnancy outcomes.
Iodine Supplementation
background. Iodine-dependent thyroid hor-
mones play a critical role in brain cell proliferation,
synapse formation and microtubular assembly. The
beneficial effect of iodine supplementation on en-
demic cretinism and goiter has been well established,
and deficiency disorders are now understood to
manifest across a spectrum ranging from subclinical
iodine deficiency to overt hypothyroidism and goi-
ter. The global importance of endemic iodine defi-
ciency in many developing countries is well recog-
nized.202 It is typically associated with mountainous
areas but may pose a problem anywhere that iodine
is leached from the soil by heavy rainfall or flooding.
It is estimated that approximately 1 billion people
live in high-risk areas, particularly China, India,
Eastern Europe, and parts of Africa. Clinical effects
of iodine deficiency are particularly serious during
pregnancy, and can result in miscarriages, early in-
fant death, LBW, and cognitive deficiencies.
Three trials involving 1551 women were included
in the Cochrane review of data on the impact of
maternal iodine supplementation on pregnancy out-
comes, including cretinism and mortality of off-
spring.203 In these trials,204–207 which were con-
ducted in areas of endemic iodine deficiency, the use
of injectable iodized oil resulted in a significant re-
duction in mortality in infancy and childhood (OR:
0.71; CI: 0.56–0.90) and reduced risk of endemic
cretinism by the age of 4 years (OR: 0.27; CI: 0.12–
0.60). The trial from Zaire further revealed that ad-
ministration of iodized-oil injections was effective in
reducing infant mortality and improving neurologic
outcome even when given in midpregnancy.207–209
community-based evidence. Apart from the data
from Zaire and Papua New Guinea, our search iden-
tified 1 additional community-based trial of iodine
supplementation (Table 9). In rural China, adminis-
tration of iodine in drinking water resulted in a
significant (65%) reduction in neonatal mortality (see
ref 715). However, no data on neurologic develop-
ment or cognitive function were available from this
intervention trial.
conclusions. Although limited data on the im-
pact of iodine supplementation on pregnancy out-
comes are available from developing-country com-
munities, the potential benefits (ie, reduced neonatal
mortality and neurologic deficits) are substantial.
Moreover, these findings are in accord with a vast
body of literature from developed countries that also
establishes the crucial role of iodine in cognitive
development. The evidence indicates the enormous
potential of public health approaches to this prob-
lem, especially in countries with endemic iodine de-
ficiency. Therefore, administration of adequate
amounts of iodine during pregnancy to expectant
mothers should be an important component of
health care interventions during pregnancy. Al-
though universal salt iodization is a well-established
intervention to control endemic iodine deficiency,
there is still a need to develop innovative means of
providing iodine supplements to deficient populations.
Antenatal Vitamin A Supplementation
background. Although there is conclusive evi-
dence for reduction of childhood mortality after
vitamin A supplementation,210 the corresponding
evidence for impact of vitamin A supplementation in
pregnancy on outcomes in the perinatal/neonatal
period is less well established. In Nepalese women,
night blindness in the third trimester was associated
with a significantly increased risk of anemia, infec-
tions, and pre-eclampsia as well as maternal mortal-
ity.211 Similarly, maternal night blindness was asso-
ciated with increased risk of mortality in early
infancy.212 Although there is evidence of an asso-
ciation between serum vitamin A or carotenoids
and birth weight,213,214 it has not been found
consistently.173,175,215–217
community-based evidence. Five trials per-
formed in rural settings in developing countries pro-
vided information on vitamin A supplementation
relevant to this review (Table 10). None of the trials
reported birth weight as an outcome. In an RPCT in
Indonesia in which women were supplemented with
vitamin A, iron, or both, Suharno et al168 found that
women given both supplements had maximal Hb
increases and one third of this response was attrib-
utable to vitamin A supplementation, suggesting
that vitamin A may help reduce rates of maternal
anemia and subsequent adverse birth outcomes.
In Nepal, a recent series of double-blind, cluster-
randomized trials examined the impact of low-dose
vitamin A or -carotene supplementation on a num-
ber of associated maternal and neonatal health out-
comes. Daily supplementation of married women
(n  44 646) with vitamin A or -carotene provided
preconceptionally, during pregnancy, and during
lactation resulted in a highly significant (44%) reduc-
tion in maternal mortality and reduced the maternal
mortality ratio by 40%.218 There was no impact, how-
ever, on perinatal or neonatal mortality, nor was
there any impact on rates of fetal loss (miscarriage,
stillbirth, loss due to maternal death), preterm births,
or early infant survival.219 However, the risk of early
infant mortality was reduced among night-blind
women supplemented with vitamin A.212 These
trials in Nepal showed no broadly observed effect of
vitamin A supplementation on neonatal mortality or
mortality in the first 6 months,219 although subanaly-
sis suggests that there may have been a trend toward
an effect.212
Some of the most important data on the potential
benefits of high-dose antenatal vitamin A supple-
mentation are from studies in HIV-infected women.
Trials among HIV-positive mothers in Tanzania220
and South Africa221,222 showed no effect of vitamin A
alone on fetal growth or fetal loss. In an RCT, HIV-
positive pregnant women supplemented with 5000
units of vitamin A and 30 mg of -carotene during
the third trimester and 200 000 units of vitamin A at
birth had a reduced incidence of preterm births of
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11%, compared with 17% among unsupplemented
women.222 In Malawi, administration of 10 000 units
of vitamin A in HIV-positive women lowered the
incidence of LBW compared with placebo-treated
control women.223,224
conclusions. Data on the impact of antenatal vi-
tamin A supplementation are limited, and the bio-
logical plausibility of the intervention has been ques-
tioned.88 The impact seems to be robust for maternal
mortality, but evidence of benefit for perinatal or
neonatal outcomes is lacking. There is an urgent
need to undertake additional studies of antenatal
vitamin A supplementation in areas of endemic or
subclinical vitamin A deficiency. These trials must be
designed with sufficient power to determine impact
on maternal mortality, pregnancy outcomes, and
mortality in infancy. Similarly, the strong evidence
for efficacy of -carotene in reducing maternal mor-
tality suggests that other forms of supplementation
also merit consideration. However, all such trials
must be designed as effectiveness trials, with suffi-
cient information regarding appropriate process in-
dicators to inform programs.
Notwithstanding the above, the data on reduction
of maternal mortality are compelling. Thus, it makes
sense to ensure that pregnant women in areas of
endemic subclinical vitamin A deficiency and night
blindness receive at least the recommended dietary
allowance (RDA) of vitamin A during pregnancy
from both dietary sources and supplements.
Zinc Supplementation
background. Because zinc is a critical nutrient
involved in immunocompetence, growth, and devel-
opment, there has been much interest in its role in
pregnancy. King225 and Keen et al226 reviewed the
evidence for an association between zinc deficiency
and adverse outcomes in pregnancy. They concluded
that, although evidence for the critical nature of zinc
in pregnancy is based largely on animal studies,
there were data to suggest that zinc was indeed an
important nutrient in human pregnancy. A review of
17 studies published from 1977 to 1994 also indicated
an association between maternal indicators of zinc
status and birth weight of offspring, although several
others were inconclusive.175 A further in-depth re-
view of 10 zinc-supplementation trials conducted up
to 1996 revealed that birth weight increased after
zinc supplementation in 4 of the 10 trials.145 How-
ever, the Cochrane review on maternal zinc supple-
mentation227 revealed no significant differences in
maternal or neonatal outcomes after zinc supplemen-
tation, although there was a small effect of supple-
mentation on reduction of preterm delivery rates. It
TABLE 9. Antenatal Iodine Supplementation
Source Location and
Type of Trial





Potassium iodate was added
to the rivers that were the
main source of water for
the entire population of
intervention villages;
control villages used
water from rivers without
any potassium iodate.
Neonatal mortality was reduced
by 65% in the population
supplemented with iodine







(16 000 individuals in 27
villages) was given
injectable iodized oil




Definite cretinism was reduced
by 100% in the neonates born
to the intervention group
(0 of 274 in the intervention
group vs 14 of 248 in the
control group; 2 (3 df) 
33.87; P  .001); the 15-y




greater than the survival of





Pregnant women (n  109)
around 28 wk of gestation
attending antenatal clinics
in a severely iodine
deficient area in Zaire
were allocated to either a
treatment or control
group; the treatment
group received 1 iodized
oil injection at the time of
the first antenatal clinic
visit, and the control
group received an
injection of iodine-free
vitamins; there were 118
newborns born to these
women during the
intervention period.
Correlation between infant thyroid
function and maternal thyroid
function was noticed; treatment
with iodized oil significantly
improved mean thyroxine
serum concentration (15.7 0.7
vs 11.5  0.7 g/dL in
untreated versus treated
mothers; P  .001) and lowered
mean thyroid-stimulating
hormone (5.4  0.5 vs 8.7  1.2
U/mL; P  .001).
Birth weight increased by a
mean 101 g (13.5 to
215.5 g); there was also a
trend toward reduced infant
mortality (RR: 0.66; CI:
0.44–1.03).
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was concluded, however, that there was insufficient
evidence to fully evaluate the effect of zinc supple-
mentation during pregnancy. Moreover, it is impor-
tant to point out that most of the studies in the
Cochrane review were from developed countries
with relatively few malnourished women, and there
have been a number of more recent studies from
developing countries that may shed more light on
this subject (reviewed below). On the other hand,
other reviewers94,228 have also concluded that it is
unlikely that zinc supplementation alone will influ-
ence birth weight or improve pregnancy outcomes in
developing countries. Recent studies have focused
also on combinations of zinc with other nutrients
such as vitamin A. However, the results have been
inconsistent. In 1 instance, although a positive im-
pact of either zinc or vitamin A supplementation on
maternal iron status during pregnancy was ob-
served, the combination of the 2 failed to improve
serum ferritin or Hb concentrations.229
community-based evidence. Our search identi-
fied 6 studies for additional review, only 1 of which
took place in a rural setting (Table 11). The majority
of the studies were undertaken in urban slums and
were comprised of subjects who had low zinc intake
and were considered to be at high risk of zinc defi-
ciency during pregnancy.
The additional studies of zinc supplementation in
pregnancy reviewed here also produced mixed re-
sults. Only 1 study from Chile230 showed a decrease
in prematurity rates in the supplemented group,
along with a reduction in rate of LBW; the latter
result was also seen in a study from the United
States.231 Overall, the majority of the studies failed to
show a significant impact of zinc supplementation
on birth weight, preterm delivery rate, and either
neonatal or perinatal mortality. A study from the
urban slums of Bangladesh,232,233 however, showed a
significant impact of zinc supplementation on rates
of infectious disease morbidity (eg, diarrhea, dysen-
tery, and impetigo) during the first 6 months of life
among LBW infants born to zinc-supplemented
mothers.
There are also ancillary studies that have evalu-
ated the effect of zinc supplementation on maternal
and infant outcomes that may be of value. Sazawal et
al234 showed a significant (68%) reduction in mortal-
ity during the first 9.5 months of life among SGA
infants born to zinc-supplemented women in urban
India. Thus, although it is unlikely that isolated zinc
supplementation among malnourished women will
impact LBW rates, it is possible that zinc supplemen-
tation may improve infectious disease morbidity and
boost immunity beyond the neonatal period. Recent
data on combined vitamin A and zinc supplementa-
tion of pregnant women in central Java indicate that
this combination supplement may significantly re-
duce anemia and rates of puerperal sepsis,229 high-
lighting the need to address multiple micronutrient
deficiencies in at-risk populations. Moreover, data
from Bangladesh showed that offspring of women
supplemented with zinc from 4 months’ gestation to
delivery had lower scores on mental and psychomo-
tor development indices at 13 months of age.235,236
These findings suggest the need for caution in ad-
dressing micronutrient deficiencies in malnourished
populations with single-nutrient solutions.
conclusions. It is highly unlikely that isolated
zinc deficiency exists in at-risk populations; signifi-
cant iron deficiency, among other nutrient defi-
ciencies, frequently coexists with subclinical zinc
deficiency. Evidence for benefit of isolated zinc sup-
plementation on pregnancy outcome is relatively
weak, and at present we cannot recommend isolated
zinc supplementation in pregnancy. However, all
attempts should be made to replenish zinc stores or
provide at least the RDA of zinc in malnourished
populations. Whenever possible, this must be done
through formulations that address other key micro-
nutrient deficiencies that coexist with zinc defi-
ciency, such as iron and vitamin A deficiencies, and
implemented through multiple program pathways.237
Multiple-Micronutrient Supplementation
background. With the emerging evidence of mul-
tiple micronutrient deficiencies in pregnancy, espe-
cially in HIV-endemic areas,238,239 there has been
much interest recently in interventions employing
multiple micronutrient supplements in pregnancy by
using the standard UNICEF multiple-micronutrient
supplements. Randomized trials of multiple micro-
nutrient interventions in pregnancy are currently un-
derway in a number of developing countries with
malnourished populations, such as Nepal, Pakistan,
Guinea Bissau, Bangladesh, and Indonesia.
The 10-year observational Camden Study on the
impact of multivitamin supplementation on preg-
nancy and perinatal outcomes was conducted in a
poor US urban setting240 and included 1430 pregnant
women in various stages of pregnancy. Risk of LBW
was reduced approximately twofold with supple-
ment use during the first (OR: 0.63; CI: 0.39–1.0)
and/or second (OR: 0.57; CI: 0.38–0.86) trimester.
The use of prenatal supplements during the first and
second trimester was also associated with an approx-
imately twofold reduction in risk of preterm delivery
(ORs: 0.53 and 0.71; CIs: 0.35–0.81 and 0.5–1.01; for
first and second trimester use, respectively). Thus, it
seemed that the decrease in rates of LBW or VLBW
was not due to a decrease in rates of IUGR but rather
to a decrease in the rates of preterm infants. In an-
other large trial in the United States reported in 1989,
use of multivitamins lacking in folic acid content had
no impact on prevalence of NTDs.186
In contrast to the above-mentioned studies, which
focused on micronutrient supplementation, there are
a large number of studies that have used combina-
tions of food and energy supplements and micronu-
trients. Most of these data are derived from pro-
grams and interventions in developed countries. The
US government’s Women, Infants, and Children
Supplemental Nutrition Program (WIC) provides
low-income mothers with vouchers for milk, eggs,
cheese, fruit juice, cereals, legumes, and peanut but-
ter.241 Although this intervention has not been as-
sessed prospectively in a randomized trial, it has
been estimated retrospectively242 that participation
544 COMMUNITY-BASED INTERVENTIONS FOR IMPROVING HEALTH OUTCOMES
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in the WIC program was associated with reduced
preterm delivery and fetal death and small but sig-
nificant increases in mean birth weight (22.7 g) and
head circumference. Retrospective analyses of moth-
ers with poor diets who had received supplemental
milk, eggs, and oranges revealed a higher mean birth
weight compared with siblings (107 g).243 These
effects were relatively greater in thinner mothers. In
a large Hungarian trial of micronutrient supplemen-
tation,192 there was no impact on birth weight.
Data from developing countries are limited and
relate to disparate programs of varying sizes. In
some cases, the trial design does not allow for clear
conclusions to be drawn regarding the contribution
of multiple micronutrients to the impact of the inter-
vention. Two large trials in Guatemala115 and Tai-
wan108 evaluated the benefit to pregnant women of
increased energy intake as well as multiple mineral
and vitamin supplements. The trial in Guatemala
administered 2 supplements, 1 caloric and 1 protein-
caloric, to malnourished pregnant women during
pregnancy to examine effects of supplementation on
birth weight. Both supplements were fortified with
comparable amounts of micronutrients including vi-
tamin C (4 mg), calcium (0.0–0.4 g), phosphorus
(0.0–0.3 g), thiamine (1.1 mg), riboflavin (1.5 mg),
vitamin A (18.5 mg), iron (5 mg), and fluoride
(0.2 mg). There was no difference in birth weight
between the 2 intervention groups, but infants born
to the subgroup of mothers who had consumed
83 750 J of either supplement during pregnancy
had a correspondingly greater increment in birth
weight. In contrast, the increment in birth weight
was comparable in Taiwan, where the supplements
were given to well-nourished women and were not
significantly fortified with micronutrients.108 Al-
though the results from the Guatemala trial have
been attributed to increased energy intake, there may
also have been an effect of the micronutrients present
in both supplements. However, because of the open
study design, it is difficult to measure the attribut-
able effects of micronutrient supplementation on
birth weight in this trial.
A small trial in a poor rural population of Thailand
studied the effect on birth weight of improving the
mothers’ dietary quality.110 Mothers (n  43) were
randomized into 3 groups to receive either extra food
(preprepared cooked food containing legumes, ses-
ame, peanuts, and sugar; or rice, oil, peanuts,
shrimp, and sugar) or no extra food. Newborn in-
fants born to mothers who had received the food-
based interventions were250 g heavier than infants
born to controls. In the Narangwal Study from In-
dian Punjab,244 villages were assigned to 1 of 4
groups, receiving (1) nutrition care, (2) health care,
(3) both, or (4) neither. In nutrition villages, pregnant
mothers received bulgar wheat porridge, sugar, milk
powder, and oil. Although birth weight was not
recorded, stillbirths were reduced by 40% compared
with control villages.
community-based evidence. As indicated above,
several community trials of multiple micronutrients
are currently underway. Preliminary results from a
community-based cluster-randomized trial of multi-
ple micronutrient supplements in Pakistan suggest a
significant impact on birth weight (Z.A.B., unpub-
lished observations, 2004).
The major published data available on efficacy of
multiple micronutrient supplementation in develop-
ing countries currently derive from a study in HIV-
infected women in Tanzania220 and another trial in
The Gambia of high-energy biscuits that also con-
tained extra micronutrients, calcium and iron104
(see Tables 6 and 12). The results of the Gambian
study have been presented already (see “Balanced
Protein-Energy Supplementation”). In Tanzania, af-
ter micronutrient supplementation, the mean birth
weight was higher among HIV-negative infants
(100 g; P  .01), and there were significant reduc-
tions in rates of LBW (44%), preterm births before
34 weeks’ gestation (39%), and IUGR (10% vs 18%;
P  .002). Moreover, use of multiple micronutrients
and multivitamins resulted in significantly fewer fe-
tal deaths (5.9% vs 9.6%; P  .02). Recent unpub-
lished data from the same group indicate that mul-
tiple RDAs of multivitamins and micronutrients may
be required in HIV-infected pregnant women (W.
Fawzi, MD, DrPH, verbal communication, 2002).
In a trial in Chile,100 mothers received either pow-
dered milk or milk fortified with vitamins and min-
erals. Mean birth weight was higher in the fortifica-
tion group (73 g; P  .05), and the percentage of
IUGR infants was lower (32% vs 44%; P  .05). In
Bogota´, Colombia, birth weight was greater (95 g)
in urban slum families who were randomly allocated
to receive extra food (milk, fortified bread, and veg-
etable oil).245 Similarly, infants born to women in
South Africa who received a supplement of maize
porridge and skim milk fortified with vitamins A, B1,
B2, and calcium were an average of 300 g heavier
than infants born to unsupplemented women.246
However, in Mexico, other studies of multiple-micro-
nutrient supplementation during pregnancy have
failed to demonstrate any benefit regarding in-
creased birth weight250 or maternal hematologic
parameters.251
conclusions. Although benefit from supplement-
ing pregnant women with multiple vitamins and
micronutrients seems plausible, particularly due to
increased nutritional requirements during preg-
nancy and lactation,94 there has been concern that
multiple-micronutrient–supplement formulations de-
signed for developed countries may be inappropriate
for women in developing countries with significantly
different staple diets.247 It is thus very important that
these studies be undertaken with full attention to
potential adverse outcomes. Recent data from Nepal
on the use of multiple micronutrients suggest that
multiple micronutrients may confer no additional
advantage over iron-folate supplements but rather
may alter the distribution of birth weight, leading
to higher PMR and NMR due to obstructed la-
bor.169,248,249 Current field trials of multiple micronu-
trient supplementation in pregnancy will provide
useful data on efficacy, impact on LBW and other
perinatal outcomes, and potential interactions of mi-
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cronutrients. Pending these data, however, the wide-
spread use of these multiple micronutrients cannot
be recommended.
Infection Control and Prevention
Interventions in Malaria-Endemic Areas
Malaria continues to be a major health problem in
endemic countries and a matter of concern within the
global community. Globally, malaria affects almost
10% of the world’s population, and of the nearly 500
million cases, 1 million may die annually.252 In areas
of high malarial transmission, chronic and repeated
malaria infections greatly increase the risk of mater-
nal anemia.253–257 In areas of low malarial transmis-
sion, immunity is low, and malaria in pregnancy can
rapidly progress to complications such as severe ane-
TABLE 12. Antenatal Multiple-Micronutrient Supplementation
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Fawzi et al220 Tanzania; urban
setting; DBRCT
Women (n  1075) were
randomized into 4 groups.
Group 1 (n  269) received a
daily dose of vitamin A, group
2 (n  269) was given
multivitamins excluding
vitamin A, group 3 (n  270)
received multivitamins
including vitamin A, and
group 4 (the control group, n
 267) was given placebo.
The multivitamin had a
beneficial effect on
Hb levels and CD4
cell counts.
A 40% decrease in fetal deaths was
seen in groups 2 and 3,
(multivitamin-supplemented
groups) (RR: 0.61; CI: 0.39–0.94; P
 .02). There was also a 43%
decrease in the rate of SGA births
in these groups (OR: 0.57; CI:
0.39–0.82; P  .002). Multivitamins
significantly decreased the
incidence of LBW by 44% (OR:
0.56; CI: 0.38–0.82; P  .003), and
the risk of VLBW by 58%.
Although the risk of extremely
preterm births was reduced by
39% in group 2, the overall effect
of multivitamins on preterm
births was not significant.
Mora et al245 See Table 6






Pregnant women attending 9
prenatal clinics were given
powdered milk, powdered








better in the fortified
group than in the
powdered-milk
group or the control
group.
Mean birth weight was higher
(mean weight difference 73 g;
P  0.05) in the multiple-
micronutrient–fortified group
than in the group given
powdered milk and even higher
when compared to controls
(mean weight difference 335 g;
P  0.05).




women 20 wk gestation (n 
171) were randomized to 1 of
4 groups receiving (1) a
micronutrient-fortified high-
bulk supplement (high in
niacin and iron); (2) a
micronutrient-fortified low-
bulk supplement (high in
vitamin A, calcium, thiamine,
and riboflavin; (3) a zinc
supplement; or (4) placebo.
Mean birth weight was 9.5% greater
in the low-bulk fortified-
supplement group compared
with the high-bulk supplement
group and 6.5% greater in the
low-bulk fortified-supplement
group than the placebo group.






Pregnant women (n  420) were
randomized to receive iron-
only supplements (Fe) or
multiple-micronutrient
supplements containing iron
(MM) to assess the effect on
maternal iron status.
Mean Hb (g/L) was
lower for the MM
group (104.2; 95% CI:
102.5, 106.0)
compared to the Fe








Pregnant women (n  873) were
recruited before 13 wk
gestation and received
supplements 6 d/wk at home,
as well as routine antenatal
care, until delivery. Both
supplements contained 60 mg
of Fe, but the MM group also




Mean birth weight and birth length
did not significantly differ
between the 2 groups.
* Data are from the same trial.
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mia, cerebral malaria, and death.258–262 Primigravi-
dae also tend to have a much higher prevalence and
density of parasitemia than both nonpregnant
women and multigravidae.256,263 Where malaria is
endemic, women become more susceptible to infec-
tion during pregnancy, but this susceptibility de-
creases with successive pregnancies.256,264 Given the
propensity of parasitized red blood cells to sequester
in the placenta, malaria is associated with maternal
anemia, increased risk of preterm birth, LBW, and
neonatal mortality.265–268 The estimated population
attributable risk of LBW among primigravidae with
malaria is 10% to 40%.269 Recent data also suggest
that HIV infection may impair the ability to acquire
pregnancy-specific immunity, thus increasing the
likelihood of complications of malaria among HIV-
positive multigravidae in endemic areas.258–262,270
Malaria Chemoprophylaxis or IPT
background. Although malaria chemoprophy-
laxis with chloroquine (CQ) has been the main strat-
egy for management of malaria in endemic areas,
there is uncertainty about its efficacy in comparison
with IPT. A review of 15 trials by the Cochrane
collaboration271 revealed that women who were
given regular, routine antimalarial drugs had less
risk of developing severe anemia and had fewer
episodes of fever antenatally than those who did not
receive prophylactic therapy. Newborn infants of
these women also had higher birth weight compared
with those born to women who did not receive pro-
phylaxis; this effect was principally seen among pri-
migravidae. However, there was no overall benefit of
antimalarial chemoprophylaxis on perinatal and
neonatal mortality.
Several studies indicated that IPT can be given
under directly observed therapy in antenatal clinic
programs and achieve high program effectiveness.272
Additional support for the effectiveness of IPT was
given in a meta-analysis by Newman et al,273 which
found that the 7 most promising drug regimens for
malaria prevention in terms of program effectiveness
and efficacy, were all IPT as opposed to chemopro-
phylaxis because of their ease of delivery and lower
cost. IPT with sulfadoxine-pyrimethamine (SP) in
areas without SP-resistant strains was ranked highest
in terms of effectiveness due to the low cost, wide
availability, easy deliverability, and acceptability of
SP.
community-based evidence. A variety of antena-
tal antimalarial chemotherapy drugs (eg, SP, CQ,
proguanil [PROG], and Maloprim [pyrimethamine-
dapsone]) given for prophylaxis have been evaluated
in developing countries (Table 13). Decreases in rates
of stillbirths and perinatal, neonatal, and/or infant
mortality were observed in some instances,274–277 but
overall, the impact on these outcomes was not sig-
nificant. The preterm birth rate also was not im-
pacted. An increase in birth weight, however, was
observed in nearly all studies155,258–262,275,277–284;
thus, the evidence for a beneficial effect of chemo-
prophylaxis on birth weight in endemic areas is
strong. Chemoprophylaxis also had a uniformly sig-
nificant effect in reducing maternal anemia, para-
sitemia, and/or placental parasite load.
Studies comparing various drug regimens re-
vealed that mefloquine was of particular benefit in
clearance of parasitemia and in some neonatal health
outcomes (eg, reduction in LBW rate) in areas with
high rates of CQ resistance.258–262,285 Another study
by van Eijk286 in Kenya found IPT (at least 1 dose of
SP) during pregnancy was associated with a signifi-
cant reduction in the LBW rate (OR: 0.65; CI:
0.45–0.95).
A growing body of research evaluates the cost-
effectiveness of different drug prophylaxis/IPT reg-
imens. In Malawi, Schultz et al287 found that 2
doses of trimethroprim/sulfamethoxazole during
pregnancy were equally effective as 1 dose. Another
study evaluated the cost-effectiveness of 3 ap-
proaches to malaria chemoprophylaxis compared
with case management of malarial disease in areas
with variable HIV prevalence and high malaria en-
demicity.283 In malaria-endemic areas with high HIV
prevalence (10%), administering 1 dose of SP pro-
phylaxis per month was more cost-effective, whereas
in malaria-endemic areas with low HIV prevalence
(10%), administering 2 doses of SP prophylaxis
during pregnancy was more cost-effective. In any
setting, the monthly and the 2-dose strategies were
more cost-effective than the case management
approach.
conclusions. Malaria prophylaxis during preg-
nancy is an important intervention in community
settings in malaria-endemic areas, because it serves
to reduce maternal anemia and parasitemia and im-
prove birth weight. In general, however, little im-
provement in survival of offspring (eg, stillbirths,
PMRs, and NMRs) has been demonstrated, although
most studies lacked sufficient power to evaluate
mortality outcomes. Case management strategies
alone are less effective than continuous or intermit-
tent prophylaxis, and in areas with high rates of CQ
resistance, alternative agents such as mefloquine are
superior.
There is a real need to undertake concerted re-
search in this area by means of large-scale effective-
ness trials of various prophylaxis strategies for ma-
laria, particularly IPT. Pending evidence to the
contrary or for alternative strategies, the current pol-
icies of antimalarial prophylaxis in high-risk popu-
lations must continue.
Malaria Prevention Using ITNs
background. Consistent use of bed nets impreg-
nated with permethrin, an insecticide, reduces the
frequency of bites from infected mosquitoes and can
consequently reduce rates of malarial infection and
parasitemia. A meta-analysis of RCTs evaluating
ITNs showed that when ITNs were compared with
untreated nets or no nets at all, the efficacy for pre-
vention of moderate to severe malarial infection was
17%, and child mortality was reduced 23%.271 On
average, 6 lives were saved annually for every 1000
children protected with ITNs. ITNs also reduced the
incidence of mild malarial episodes by 48% and 34%
SUPPLEMENT 551
 by guest on October 27, 2017http://pediatrics.aappublications.org/Downloaded from 
compared with no net and untreated bed net (NIB)
controls, respectively.
There is some evidence that the widespread use of
ITNs, particularly in high-transmission, malaria-en-
demic areas, may reduce rates of maternal anemia
and placental infection, consequently reducing the
risk of adverse birth outcomes such as stillbirth and
LBW due to prematurity and IUGR.288 There are
also significant data showing that ITNs can reduce
child morbidity and mortality, particularly in infants.
In a high-transmission area of western Kenya, an
RCT by Hawley et al289 reported that ITNs reduced
all-cause postneonatal mortality (deaths of infants
between 1 and 11 months old) by 23%. However, no
single research study has had sufficient size to ob-
serve a specific significant impact of ITNs on neona-
tal mortality; benefits of ITNs on neonatal mortality
have been largely inferred from pregnancy outcome
data.290
community-based evidence. Table 14 summa-
rizes the major studies evaluating efficacy of ITN use
among pregnant women in malaria-endemic areas.
Overall, use of bed nets was effective,272,291 although
not uniformly so,292 in reducing rates of maternal
anemia. In Kenya, the incidence of severe maternal
TABLE 14. Antenatal Malaria Prevention Using ITNs
Source Location and Type
of Trial
Intervention Maternal Outcome Perinatal/Neonatal
Outcome
Shulman290 Kenya; rural setting;
RCT
503 pregnant women and their
households participated in
the study. In the
intervention households,
nets measuring 190  180 
150 cm were impregnated
with permethrin to achieve
a target dose of 0.5 g
permethrin per m2 of
netting.
No significant effect of the
impregnated net
intervention was
observed in maternal Hb
levels or rates of anemia
or placental infection.
No significant effect of
the intervention was
seen on stillbirth rate
(RR: 0.67; CI: 0.19–
2.32; P  .51). No
significant effect on






651 primigravidae lived in





women lived in control
villages without bed nets.
The prevalence of severe
anemia was significantly
lower (73% reduction) in
villages with treated bed
nets compared with
control villages, but this




the 2 village groups
were seen for PMR or
birth weight. The





season (OR: 0.28; CI:
0.08–0.97; P  0.02).
Dolan et al291 Thailand; rural
setting; DBRCT
348 pregnant women were
randomly assigned to 1 of 4
groups: 1) 111 women to the
permethrin-impregnated
(500 mg/m2) bed net (PIB)
group, 2) 112 women to the
NIB group, 3) 30 women to
the no bed net group, and 4)
88 women in the family-size
nonimpregnated bed net
(FNIB) (These 88 women
were originally assigned to
the no bed net group, but
obtained family-size bed
nets and were reclassified.)
Women who used their
own FNIB or a PIB had
fewer episodes of malaria
than the combined NIB
and no-net groups (PIB
33%, P  .04; FNIB
group 32%, P  .07).
Thus, the risk of at least
1 attack of malaria was
1.67 (CI: 1.07–2.61) times
higher in the NIB and
no-net group than in the
pooled PIB and FNIB
group (P  .03 allowing
for parity). Use of PIBs
was associated with a
reduction in anemia in
all camps and in women
of all gravidae,
independent of the effect
on parasitemic malaria.
No significant effect of
the nets was observed
on IMR, birth weight






All households in 40 of 79
villages were randomized to
receive ITNs. Women were
followed monthly through
pregnancy to monitor health
and birth outcomes.
No significant effect of
the ITNs was found
on preterm birth rates.
LBW was lower
among ITN users than
controls (protective
efficacy: 28%; CI: 2–
47%). Adjusted mean
birth weight was 77.6
g higher during first 4
pregnancies of women
in ITN villages (P 
.0008).
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anemia (Hb 8 g/dL) was slightly lower in the
bed-net group (15% vs 20%), but the overall inci-
dence of anemia was the same (92% in the bed-net
group and 91% in the control group).292
The impact of ITNs on pregnancy outcomes was
unclear, but overall, the results were not significant.
The ITN intervention showed a trend toward re-
duced stillbirth rates and PMRs in Kenya,292 whereas
a study in The Gambia failed to show an impact on
perinatal mortality.272 This latter study, however,
revealed a decrease in premature birth rate and a
corresponding increase in birth weight, although
only among primigravid women.272 Another study
in Thailand showed no impact of ITN use on gesta-
tional age at birth,291 and overall, no study showed a
significant impact on birth weight.272,291,292 The im-
pact of the intervention on IMR also was mixed.291,293
conclusions. There is strong evidence for the ef-
ficacy of ITNs in reducing childhood mortality and
morbidity from malaria. There is encouraging evi-
dence for improved pregnancy outcomes and re-
duced perinatal or neonatal mortality from represen-
tative settings in developing countries. Some of the
variability in data may be a result of the considerable
heterogeneity in the treatment groups. Although the
overall effect of this intervention shows promising
trends, particularly in reducing rates of maternal
anemia, the number of well-designed studies with
the requisite power to assess outcomes of interest is
limited. Cost-effectiveness studies and operations re-
search are needed to help make this intervention
more feasible at scale. Currently, we are able to rec-
ommend both chemoprophylaxis and PIB use in
pregnancy in malaria-endemic areas, which, coupled
with the recommendation for use in childhood,
makes the case for family-centered approaches.10
Deworming
background. A conservative estimate by the
WHO suggests that at any given time, nearly 44
million pregnant women globally may be infected
with hookworms.294 In endemic areas, hookworm
infestation is known to be a major contributing factor
in development of anemia in women of reproductive
age.295
Although the current recommendation during
pregnancy is to use a single-dose regimen of either
mebendazole or albendazole for treating hookworm
infestation,296 in combination with iron-folate sup-
plements, there have been almost no systematic stud-
ies of the impact of this intervention on pregnancy
outcomes.
community-based evidence. Our review re-
vealed little community-based information on the
impact of maternal deworming. A recent
intervention trial in rural India297 used a combina-
tion strategy with iron supplementation, de-
worming, and nutrition education using specially
developed information, education, and communica-
tion materials (Table 15). Significant decreases in the
prevalence of maternal iron-deficiency anemia and
increases in mean Hb levels were seen and were
greater the earlier the intervention was introduced in
pregnancy.
Despite the lack of community-based data, there
were a few smaller studies on the impact of deworm-
ing in developing-country settings. In a nonrandom-
ized study in Sri Lanka167 women who received de-
worming along with iron folate as part of their
antenatal care had better Hb and higher birth weight
infants than women who did not. In Bangladesh, a
randomized trial using a 2 2 factorial design tested
the effects of iron and antihelminthic treatment on
Hb and wormload in female tea-plantation work-
ers.298 The group receiving both iron supplements
and antihelminthics had the largest increments in Hb
concentration compared with the controls. Preva-
lence and intensity of Ascaris, Trichuris trichiura, and
hookworm infestation declined in the 2 groups that
received antihelminthic treatment.
The only studies of the impact of deworming on
neonates undertaken in developing countries were
in Nepal and Sri Lanka299 (Table 15). This retro-
spective observational study in an urban hospital
setting in Sri Lanka found that antihelminthic ther-
apy (mebendazole) was associated with significantly
lower stillbirth rates and PMRs (OR: 0.55; CI: 0.4–
0.77). Taking medication was also associated with a
decrease in the proportion of women delivering a
VLBW infant (1.1% vs 2.3%). Women who took me-
bendazole during the first trimester, however, had a
higher proportion of congenital malformations com-
pared with the untreated women. In Nepal, another
study found that 2 doses of albendazole during preg-
nancy was associated with a 46% decrease in neona-
tal mortality (RR: 0.54; CI: 0.37–0.78).300
conclusions. These data suggest that deworming
in areas of high endemicity may reduce rates of
maternal anemia and lead to improved pregnancy
outcomes (eg, stillbirth, PMR, and LBW rates). How-
ever, there is a need to formally evaluate the benefits
and potential complications of antihelminthic ther-
apy in community-based effectiveness trials in di-
verse programmatic settings and locations.
UTIs and Reproductive Tract Infections
Ascending bacterial infections of the genitourinary
tract can be a significant underlying factor in many
late fetal deaths301 as well as spontaneous onset of
preterm labor.302 Although colonization of the lower
genital tract by fecal flora can occur commonly with-
out adverse consequences,303,304 infection of the am-
niotic fluid, the interior of the placenta, and/or the
fetus is associated with serious complications.301
Chorioamnionitis or amniotic fluid infection has
been identified as an important cause of fetal death
in several studies from developing countries.305–309
The following section will review the evidence of
interventions pertaining to common genitourinary
infections in pregnancy.
Syphilis Screening and Treatment
background. Although syphilis is widely recog-
nized as an important cause of morbidity among
the adult population, there are few reliable esti-
mates of the exact contribution of syphilis to the
burden of perinatal and neonatal mortality in devel-
oping countries. Congenital syphilis continues to
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be a major public health problem in developing
countries.310
Untreated syphilis was found to cause fetal death
in 22% of pregnancies among infected African
mothers; the risks for antepartum and intrapartum
stillbirths among infected women were 18-fold and
8-fold higher, respectively.311 In Malawi, a longitu-
dinal population-based study revealed a population-
attributable risk for syphilis of 26% among all fetal
deaths and 38% for antepartum fetal deaths.312 Syph-
ilis was the attributed cause of 10% of 315 late fetal
deaths in a case-control study (CCS) in Port Moresby,
Papua New Guinea.79 Syphilis is particularly com-
mon in Africa, with prevalence estimates around
10%.313–315 Syphilis is also recognized as a major
contributor to perinatal and infant mortality in the
African region.311,315–317 In Ethiopia, 6% of perina-
tal mortality was due to syphilis.318 In Zambia, al-
most 9% of infants seen at the University Teaching
Hospital were found to have congenital syphilis,319
and in the Central Hospital of Maputo, Mozambique,
1% of neonates had congenital syphilis.320 The re-
ported seroprevalence of syphilis among women at-
tending antenatal clinics in African, Asian, and Latin
American countries ranges from 4% to 19%.321–324
Some reports also indicate that the incidence of con-
genital syphilis may be increasing in many develop-
ing countries; to illustrate, a 10-fold increase in con-
genital syphilis was reported in the Brazilian Federal
District from 1980 (0.17 cases per 100 000 inhabitants)
to 1984 (1.7 per 1000).325 Early diagnosis and treat-
ment sharply reduce the risk of fetal death due to
syphilis.326
The potential benefits of large-scale population-
based intervention strategies for the prevention, de-
tection, and treatment of congenital syphilis is
strengthened by the experience in developed coun-
tries. To illustrate, the prevalence of congenital syph-
ilis was reduced by as much as 70% by a large screen-
ing and intervention program in Milwaukee.327
TABLE 15. Antenatal Deworming
Source Location and
Type of Trial




India; rural setting; PCS Iron supplementation and
deworming were provided
to all pregnant women in
the intervention area
(n  458) from the fourth
month of pregnancy. An
intensive information,
education, and communi-
cation effort was carried
out that provided facts on
anemia and diet
modification to each
pregnant woman, using a
1-to-1 approach in the
community, and a group
method in the mobile
clinics. This was carried
out for a period of 18 mo.
Pregnant controls in a
neighboring village
(n  387) received only
the previously available
standard of care.
A significant decrease in the
prevalence of anemia was
found, from 56% to 25%
(P  .001), 73% to 49%
(P  .001) and 69% to
57% (P  .01) among
women treated from the
first, second and third
trimesters, respectively, in
the intervention area.
Significant (P  .001)
increases of 0.85 g/dL in
mean Hb level (CI: 0.79–
0.91), 0.59 g/dL (CI: 0.57–
0.61) and 0.36 g/dL
(CI: 0.32–0.40) were also
observed in treated













that pregnancy. 5275 had
taken mebendazole and
1737 had not taken
antihelminthics and were
in the control group.
The stillbirth, PMRs and
VLBW rates were 45%,
45% (P  .004) and
53% (P  .003) lower,
respectively, among








Nepal; rural setting; PCS Pregnant women received








to women who did not
receive albendazole.
NMR of infants born to
women treated with
albendazole compared
to those born to
controls declined by
46% (RR: 0.54; CI:
0.37–0.78).
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community-based evidence. We identified 5 in-
tervention trials in developing countries that ad-
dressed the issue of antenatal screening and treat-
ment of syphilis and evaluated the impact on
pregnancy outcomes (Table 16). Of these, only one316
was rural-based, and one was in a periurban/subur-
ban setting328,329; the rest were urban hospital-based
studies. We included these hospital-based studies in
the current review because they were conducted in
developing countries and represented typical catch-
ment populations.
The data reviewed suggested that serologic and
clinical testing for syphilis did not have sufficient
sensitivity for case detection, especially when con-
ducted by paramedical or nursing staff.316,330 One
study reported sensitivity of 50% and specificity of
91% for on-site rapid plasma reagin (RPR) testing
done by nurses.330 Universal screening, preferably
on site, is the appropriate option,331 because it en-
sures immediate treatment. High-risk patients, how-
ever, should be rescreened in the third trimester.
The studies reviewed demonstrated a significant re-
duction in the incidence of congenital syphilis among
cases identified and treated antenatally.316,328,329 Still-
births and perinatal mortality328,329,332 were reduced
in offspring of mothers diagnosed and subsequently
treated for syphilis during pregnancy. An observa-
tional study also demonstrated that women who were
diagnosed and treated for syphilis during pregnancy
had lower risk (OR: 0.25; P .0001) of giving birth to an
LBW infant.332 Screening for and treatment of syphilis
is thus a cost-effective means of reducing fetal
deaths.332
conclusions. Case identification and treatment of
maternal syphilis have significant benefits in im-
proving perinatal and neonatal outcomes, particu-
larly in endemic areas such as sub-Saharan Africa.
There are major challenges, however, in implement-
ing diagnostic testing and treatment in programs
while assuring quality and access. Additional oper-
ational research is needed on how to make accurate
testing and effective treatment feasible and available
at scale.
Antibiotics for Asymptomatic Bacteriuria
background. Although treatment for symptom-
atic UTIs in pregnancy is standard-of-care in devel-
oped countries, and the role of specific antimicrobial
TABLE 16. Antenatal Syphilis Screening and Treatment
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Patel et al330 South Africa; urban
hospital setting;
QT
5 nurses were trained by a
laboratory technician to
perform and read the RPR
card test. The result of on-
site RPR testing (n  513
women) was compared with
RPR test results reported by
the laboratory.
Sensitivity for the onsite test
was 50%, specificity was
91%, positive predictive








Before the intervention, nurses
referred patients (n  918)
to an STD doctor. The
intervention trained the
nurses to be autonomous in
diagnosis and treatment of
syphilis with benzathine
penicillin.
Perinatal mortality was significantly
higher in the control group (P 
.03; 98.7% of the neonates were
alive on the seventh day of life in
the intervention group, vs 95.8%






Of the 22 466 neonates born to
women giving birth in the
hospital, 12 414 were tested
for syphilis. Cases were
defined as mothers whose




rate of adverse outcome
significantly from 26% to
15%.
Women who were seropositive and
untreated were 4 times more
likely to have adverse pregnancy
outcomes, including a stillbirth
(OR: 3.34, P  .03) or LBW baby
(OR: 4.01, P  .0001).
Hira et al328 Zambia; periurban
setting; QT
Staff was trained in methods





patients was 3005. Prior to
the intervention, the study
center had 491 patients and
the control center had 434.
Post-intervention, the study
center had 806 patients and
the control center had 1274.
Adverse pregnancy outcomes
(abortion, stillbirth, preterm birth,
LBW and congenital syphilis)
were evaluated as a combined
entity. Adverse outcomes were
significantly lower in the study
area (28%) compared to the





Nurses performed the RPR
test for 283 deliveries and
the women who were
positive were treated in this
community-based screening
and treatment protocol.
Screening averted 35% of congenital
syphilis but missed the remaining
65%.
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therapy in pregnancy is well established,333 there are
no community-based studies of treatment for asymp-
tomatic bacteriuria during pregnancy and its impact
on pregnancy outcomes. Most available data are
from facility-based cases and from developed coun-
tries. In a meta-analysis of the available evidence on
benefits of antimicrobial therapy for asymptomatic
bacteriuria in pregnancy, mostly from developed
countries but also including poor populations,
Smaill334 convincingly established a reduction in
rates of pyelonephritis (OR: 0.25; CI: 0.19–0.32) and a
pooled relative risk (RR) of 0.64 (CI: 0.50–0.82) for
the composite outcome of preterm delivery or LBW
based on 10 controlled clinical trials.
community-based evidence. No studies were
identified that reported data from developing-coun-
try community settings on the impact of antimicro-
bial therapy on asymptomatic bacteriuria in preg-
nancy. There is considerable evidence, however, that
bacteriuria and occult UTIs are widespread in devel-
oping countries.335–337
conclusions. Although there are no valid studies
of screening and treatment strategies for maternal
asymptomatic bacteriuria from community-based
settings in developing countries, there is little reason
to doubt the association of occult and overt UTIs in
developing countries with increased risk of preterm/
LBW births and neonatal infections, given the
strength of the relationship in developed coun-
tries.338,339 Moreover, although the choice of antibi-
otics may vary, there is little reason to suggest that
the findings of the main Cochrane review334 would
not be applicable in diverse settings.340 Given the
available evidence and biological plausibility, all
clinically symptomatic UTIs must be appropriately
treated, and attempts must be made to collect evi-
dence from representative developing-country set-
tings regarding the importance of treating asymp-
tomatic bacteriuria. However, the logistics, technical
requirements, and frequency of screening necessary
for diagnosis of asymptomatic bacteriuria in devel-
oping-country settings are formidable barriers to
wide-scale implementation of this intervention.
Thus, pending additional evidence as to the feasibil-
ity and cost-effectiveness of this strategy, and require
additional operational and cost-effectiveness research.
Antibiotics for Bacterial Vaginosis
background. Although reliable estimates of the
global burden of bacterial vaginosis are unavailable,
the disorder is known to affect a large proportion of
women in developed countries (16%) and is asso-
ciated with adverse pregnancy outcomes including
increased risk of preterm (40%) or LBW birth and
premature rupture of membranes (PROM).326,341–344
Some studies have found high rates of bacterial vagi-
nosis in developing countries,345 but data are lacking
on the attributable risk of bacterial vaginosis for
LBW.
Despite strong epidemiologic evidence of an asso-
ciation between bacterial vaginosis and preterm
birth, randomized trials of topical clindamycin, as
well as systemic antibiotic treatments using any of a
variety of agents (eg, erythromycin, amoxicillin, or
metronidazole), have not shown clear evidence of
benefit.302 This may be explained partly by hetero-
geneity in the patient populations studied. In the
only published trial among low-risk (ie, no history of
prior preterm birth) asymptomatic women, screen-
ing and treatment with oral clindamycin resulted in
nearly a 50% reduction in the rate of preterm birth or
PROM.346 It has been suggested, however, that data
showing benefit from a prospective double-blind,
placebo-controlled trial are needed before such an
approach is undertaken routinely in low-risk preg-
nant women.347
Antibiotic treatment of bacterial vaginosis among
high-risk pregnant women in developed countries
who previously had a preterm delivery has signifi-
cantly reduced the risk of subsequent preterm
birth.348–351 Although Duff et al348 used oral amoxi-
cillin for therapy, Hauth et al350 used a combination
of metronidazole and erythromycin for 7 days, and
others349,351 used a short course of metronidazole
alone. However, in a recent large trial from the NIH
Maternal-Fetal Medicine Network,352 a 2-dose regi-
men of oral metronidazole had no effect on rates of
fetal and neonatal deaths, LBW, or VLBW. Moreover,
a slightly increased risk of preterm birth was found
for women with a prior history of preterm birth.
Another recent publication from the same NIH net-
work also reported an increased risk of preterm birth
after treatment of women with asymptomatic tricho-
moniasis with metronidazole.353 Similarly, a com-
bined intravenous (IV)-oral regimen of ampicillin/
amoxicillin plus erythromycin had no impact on fetal
or infant death rates.354 In the latter trial, however,
treatment resulted in reduced incidence of neonatal
necrotizing enterocolitis, intraventricular hemor-
rhage (IVH), respiratory distress, and early-onset
sepsis. A single trial of treatment for reproductive
tract infection due to chlamydia failed to reduce the
risk of preterm birth.355 In a recent review of the
impact of treatments for bacterial vaginosis, Joesoef
et al347 concluded that women with symptomatic
disease, whether pregnant or not, should be treated
with metronidazole (500 mg, twice daily, for 7 days),
clindamycin vaginal cream (2%, once daily as a noc-
turnal intravaginal application, for 7 days), or met-
ronidazole vaginal gel (0.75%, twice daily, for 4
days), because these regimens have produced equiv-
alent cure rates. For pregnant women with high risk
of an adverse pregnancy outcome (ie, those with a
prior preterm birth) but asymptomatic disease, intra-
vaginal clindamycin is not recommended, because it
has failed to reduce rates of preterm births. If screen-
ing of high-risk women is undertaken, it is best per-
formed early in the second trimester, and treatment
doses should be limited to 250 mg of metronidazole
orally 3 times daily for 4 days to minimize any po-
tential teratogenic effects of treatment.
community-based evidence. Diagnostic methods
for bacterial vaginosis in developing-country set-
tings have not been standardized, and relatively few
studies have explored the impact of potential inter-
ventions to screen and treat bacterial vaginosis on
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pregnancy outcomes (Table 17). A double-blind, ran-
domized, placebo-controlled trial at 7 maternity clin-
ics in Indonesia reported an 85.5% cure rate among
women with bacterial vaginosis treated with 2% clin-
damycin vaginal cream, but rates of preterm delivery
or LBW were not affected.344 It was suggested that
systemic treatment may be needed to eradicate up-
per reproductive tract disease and to reduce preterm
births. Treatment of women in South Africa in early
preterm labor for 4 days with metronidazole and
ampicillin (agents effective against, but not specifi-
cally targeted toward, bacterial vaginosis in this trial)
increased pregnancy duration, but preterm birth
rates were not reported, and no reduction was ob-
served in either neonatal deaths or length of hospital
stay.356
Broad-spectrum treatment for reproductive tract
infections in rural Uganda with single doses of
azithromycin, cefixime, and metronidazole resulted
in a significant decrease in preterm birth rates
(23%) and early NMRs (17%).345 In Kenya, a sin-
gle oral dose of cefetamet-pivoxil given to women at
28–32 weeks of pregnancy with a prior history of
stillbirth or an LBW infant resulted in significant
reductions in the LBW rate (probably due largely to
preterm birth) and postnatal endometritis and an
increased birth weight.357 No effect was observed on
stillbirths or preterm birth rates. Large losses to fol-
low-up, however, suggest the need for cautious in-
terpretation of these results. Finally, a recently pub-
lished trial in pregnant women living in the Rakai
district of Uganda revealed that those randomized to
receive a single presumptive treatment dose of
azithromycin, cefixime, and metronidazole had
borderline significant reductions in risk of preterm
birth (OR: 0.72; CI: 0.56–1.05) and early neonatal
death (OR: 0.83; CI: 0.71–0.97).358 Each of these treat-
ment regimens broadly decreased rates of maternal
reproductive tract infections including bacterial
vaginosis.
conclusions. Available data suggest that antibi-
otic therapy effective for treatment of bacterial vagi-
nosis may be beneficial in decreasing rates of LBW
and, possibly, prematurity and neonatal mortality.345
Treatments that are effective against bacterial vagi-
nosis may also decrease rates of other reproductive
tract infections such as those due to chlamydia and
gonorrhea. However, results have been mixed, with
some studies showing increased risk for preterm
births. Moreover, there are still major problems with
operationalizing these interventions into programs,
because simple, affordable diagnostic methods and
additional large-scale effectiveness studies of simple
treatment regimens, particularly in asymptomatic
pregnant women, are needed. It is also unclear if the
prevention of preterm births between 34 and 37
weeks’ gestation will substantially improve perinatal
and newborn survival in public health programs.359
These interventions merit additional exploration be-
TABLE 17. Antibiotics for UTIs and STDs
Source Location and Type of
Trial
Intervention Maternal Outcome Perinatal/Neonatal
Outcome
Wawer et al345 Uganda; rural setting;
RCT
Intervention clusters(n  12 733,
of whom 6609 were HIV-
negative) were given broad-
spectrum treatment for STDs
that consisted of
azithromycin (1000 mg single
dose), cefixime (400 mg single
dose) and metronidazole (2 g
single dose). The control
group (n  6124) was
untreated.








There was a 17% reduction
in early neonatal death
and a 23% reduction in
the risk of preterm
delivery in the
intervention group.
Gichangi et al357 Kenya; urban hospital
setting; DBRCT
Pregnant women (n  320)
were randomized into an
intervention group (n  160)
and placebo (n  160). The
intervention group received a




group there were 65%
fewer Neisseria
gonorrheae cervical
infections (P  .04).
The intervention had no
effect on the rate of
stillbirth. However,
infants born to mothers
in the intervention
group were heavier
(mean difference 155 g)
than those in the placebo
group (P  .04). The
intervention reduced
LBW by 44% (18.7% vs
32.8%) but had no effect
on gestational age
(P  .01).
Joesoef et al344 Indonesia; multicenter
trial, urban hospital
setting; RCT
Women seeking prenatal care at
14–26 wk of gestational age
and who had bacterial
vaginosis (n  681) were
given either 2% clindamycin
vaginal cream (n  340) or a
placebo cream (n  341).





The rate of preterm
delivery (37 wk) was
15% for clindamycin
patients and 13.5% for
placebo patients (OR:
1.1; CI: 0.7–1.7). The rate
of LBW was 9% for
clindamycin patients and
6.8% for placebo patients
(OR: 1.3; CI: 0.8–2.4).
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fore their inclusion in routine antenatal care
strategies.
Antibiotics for Preterm Labor
background. Amajor proportion of the burden of
global perinatal mortality relates to preterm births.
The WHO estimates that prematurity is responsible
for nearly one fourth of neonatal deaths.29 Of 13
million annual preterm births globally,360 one third
may be related to spontaneous preterm delivery,361
and in 30% to 40% of preterm births, labor may
follow spontaneous rupture of membranes.362
Several studies have identified an association of
subclinical chorioamnionitis (ie, intact membranes)
with spontaneous preterm labor.363–365 Pathogens
were identified from the amniotic fluid in 10% to
15% of cases presenting with preterm labor.366 A
meta-analysis by the Cochrane collaboration of
available RCTs of antibiotic therapy in preterm labor
with intact membranes367 identified that antibiotic
treatment in this situation prolonged pregnancy
(weighted mean difference: 5.4 days; CI: 0.9–9.8
days). There was no effect on reduction of preterm
births or on respiratory distress syndrome or neona-
tal sepsis, but a significant reduction in neonatal
necrotizing enterocolitis (OR: 0.33; CI: 0.13–0.88) was
noted. The meta-analysis also revealed, however, an
increase in mortality related to preterm birth or its
sequelae (OR: 2.43; CI: 0.92–6.43) and an increase in
perinatal mortality in the group receiving antibiotics
(OR: 3.36; CI: 1.21–9.32). With regard to maternal
effects, antibiotic treatment significantly reduced
maternal infection (chorioamnionitis/endometritis)
(OR: 0.68; CI: 0.48–0.98). Still, overall evidence for
the benefit of antibiotic therapy in preterm labor with
intact membranes is lacking.
This large meta-analysis has been supplemented
by the large multicenter ORACLE II trial in several
developed countries, including almost 6300 pregnant
women randomized into 1 of 4 groups to receive
(1) erythromycin, (2) amoxicillin/clavulanic acid,
(3) both, or (4) placebo.368 The primary outcome mea-
sure was a composite of neonatal death, chronic lung
disease, or major cerebral abnormality on ultra-
sonography before discharge from hospital. There
was no evidence that any of the antibiotic regimens
improved maternal or neonatal outcomes; length of
pregnancy, length of maternal hospital stay, mode of
delivery, birth weight, proportion of infants admit-
ted to intensive care or ventilated, proportion of
infants with a positive blood culture, or composite
neonatal outcome were not different among the
treatment groups.
community-based evidence. Most of the trials of
antibiotic therapy for preterm labor have been con-
ducted in developed countries; none have been re-
ported from community settings. Table 18 illustrates
the 2 studies of antibiotic therapy for preterm labor
in developing-country settings.356,369 The overall
conclusions from these studies were consistent with
the results of the Cochrane meta-analysis367 and the
ORACLE II study.368
conclusions. No clear overall benefit for routine
antibiotic therapy for preterm labor with intact mem-
branes has been demonstrated in trials in urban set-
tings in developed or developing countries. Thus,
this intervention cannot be recommended routinely.
Evidence indicates that antibiotic administration in
preterm labor should be considered only when there
are clear indications of associated infection, or, as
indicated in the next section, in the presence of other
risk factors.
Antibiotics for PPROM
background. The most common antecedent of
preterm labor is PPROM.362 The culture positivity
rate of amniotic fluid for microbial organisms in such
cases ranges from 32% to 35%.366 The mechanisms
underlying PPROM may include local subclinical
infection and inflammation leading to weakening of
the amniotic membranes.370
A Cochrane meta-analysis of the benefits of anti-
biotic therapy in cases of PPROM concluded that
maternal antibiotic therapy in this situation is effec-
tive in prolonging pregnancy and reducing maternal
and neonatal infection-related morbidities.371 A sub-
sequent large (n  4826) multicenter RCT (ORACLE
I)372 in urban centers in multiple developed and de-
veloping countries (eg, Argentina, Brazil, Lithuania,
Malaysia, South Africa, Sri Lanka) corroborated the
findings of the meta-analysis and suggested that
administration of erythromycin to women with
PPROM was associated with significant health ben-
efits for the newborn. Fewer infants (P  .08) tended
to have the primary composite outcome (ie, death,
chronic lung disease, or major abnormality on cere-
bral ultrasonography) in the erythromycin group
(151 of 1190 [12.7%]) than in the placebo group (186
of 1225 [15.2%]). Among the 2260 singletons in this
comparison, significantly fewer had the composite
primary outcome in the erythromycin group (125 of
1111 [11.2%] vs 166 of 1149 [14.4%]; P  .02). Use of
erythromycin was also associated with prolongation
of pregnancy beyond 48 hours of presentation (P 
.004), reduction in neonatal treatment with surfactant
(P  .05), reduced requirement for supplemental
oxygen (P  .02), and fewer positive blood cultures
(P  .02). An important additional finding among
singletons was a lower rate of neonatal cranial ultra-
sonographic abnormalities at discharge (P .04) and
a probable reduction in childhood disability. Al-
though co-amoxiclav only and co-amoxiclav plus
erythromycin were associated with prolongation of
pregnancy, they were also associated with a signifi-
cantly higher rate of neonatal necrotizing enterocoli-
tis (4-fold higher with co-amoxiclav alone versus
placebo, 2.5-fold higher with any co-amoxiclav than
with none).
community-based evidence. The findings of 3
other studies373–375 conducted in developing coun-
tries largely corroborated findings from studies in
developed countries, although data are very limited
(Table 19). No trials of antibiotic therapy for PPROM,
however, have been conducted solely in community
settings in developing countries.
conclusions. Although there are few systematic
studies of antibiotic therapy for PPROM in develop-
ing countries and none in community settings, the
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evidence in support of the efficacy of this interven-
tion in diverse settings is strong, and the practice is
routine under certain circumstances (eg, early gesta-
tion). Thus, it is prudent to incorporate antibiotic
therapy of PPROM in intervention programs wher-
ever feasible, such as at referral-level health facilities.
A domiciliary cadre of trained birth attendants po-
tentially can be trained to recognize PPROM and
provide referral and, possibly, initial antimicrobial
therapy. However, this application of the interven-
tion requires additional assessment and may be dif-
ficult in community settings.
TT Immunization and Clean Delivery
background. Despite major advances in under-
standing of the pathogenesis and risk factors for neo-
natal tetanus, it is still prevalent in many developing
countries. A UNICEF/WHO/United Nations Popula-
tion Fund survey in June 2000 indicated that 57 coun-
tries globally had not achieved elimination of neonatal
TABLE 18. Antibiotics for Preterm Labor
Source Location and
Type of Trial






Women in labor between 22–36
wk gestation (n  173) were
given either amoxicillin and
erythromycin for 6–7 d, plus
tocolytic therapy (n  83) or
placebo (n  90).
No significant differences between
the groups were found for
maternal outcomes, including
duration of randomization-to-
delivery interval and frequency
of clinical chorioamnionitis and
endometritis. Rate of cesarean
section was significantly higher
in the placebo group (28% vs
12%).

















The study recruited 81 pregnant
women. The study group
(n  43) received ampicillin
and metronidazole for 5 d. The
control group (n  38)
received no antibiotics. In all
women, contractions were
suppressed with hexoprenaline
and indomethacin for 24 hours,
and betamethasone was given
for fetal lung maturity.
In those receiving ampicillin and
metronidazole, pregnancy was
significantly prolonged (median
15 d vs 2.5 d, P  .04) with
significantly more women still
pregnant after 7 d (63% vs 37%,
P  .03, OR: 0.34; CI: 0.13–0.94).
Significantly fewer infants in
the treatment group
developed necrotizing
enterocolitis than in the










6241 women in suspected or
confirmed preterm labor (37
wk gestation) were
randomized to receive 1 of 4
possible treatments: 1) co-
amoxiclav (325 mg) plus
erythromycin (250 mg); 2) co-
amoxiclav plus erythromycin
placebo; 3) erythromycin plus





Antibiotic use did not prolong
pregnancy, as most women did
not deliver within 48 h (89.9%) or
7 d (84.6%).
The only significant differ-
ence between the antibiotic
and placebo groups was
that the rate of oxygen
dependence at 36 wk post-
conception was higher
with erythromycin use
than with no erythromycin
(P  .04). Importantly, the
other measure of chronic
lung disease (oxygen
dependence at 28 d of
age) did not show this
difference. There were no
significant differences
between the babies with
respect to birth weight or
need for intensive or
special care. Co-amoxiclav
was associated with a
(non-significant) doubling
of risk for suspected or
proven necrotizing
enterocolitis. In the
subgroup of infants born
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tetanus (defined as 1 case of neonatal tetanus per
1000 live births in every district).376 Globally, only
about half of women of reproductive age are ade-
quately immunized, and it has been estimated that
neonatal tetanus accounts for as much as 7% of neona-
tal deaths globally.29 Others point out that maternal
tetanus may account for at least 5% of all maternal
deaths.377 An additional 90 000 mothers die annually
from puerperal infections caused by unclean delivery
practices, and sepsis accounts for 14% of all obstetrical
deaths.378 Thus, it is imperative that preventive strate-
gies such as clean delivery and maternal tetanus
immunization form a cornerstone of maternal care in
any setting and that they go hand-in-hand.
Given the scientific basis for the importance of
tetanus prevention and basic hygiene, it would now
be unethical to conduct RPCTs assessing such ap-
proaches. Hence, much of the evidence for benefit of
TABLE 19. Antibiotics for PPROM
Source Location and
Type of Trial







4826 women with PPROM were
randomly assigned to receive
250 mg erythromycin (n 
1197), 325 mg co-amoxiclav
(250 mg amoxicillin plus 125
mg clavulanic acid; n  1212),
both (n  1192), or placebo
(n  1225), 4 times daily for
10 d or until delivery.
Significant prolongation of gestation
(40.7% females delivered within 48
hours in the placebo group, vs
34.8% in the erythromycin-only
group, P  .004)was seen in
mothers treated with any
erythromycin combination but no
differences were seen in rates of
maternal infection or the need for
additional antibiotics.
The primary outcome measure
was a composite of neonatal
death, chronic lung disease, or
major cerebral abnormality on
ultrasonography before
discharge from hospital. Fewer
infants (P  .08) had the
primary composite outcome in
the erythromycin group (151
of 1190 (12.7%)) than in the
placebo group (86 of 1225
(15.2%)). Among the 2260
singletons in this comparison,
significantly fewer had the
composite primary outcome in
the erythromycin group (125
of 1111 (11.2%) vs 166 of 1149






171 women with PPROM
between 26 and 36 wk
gestation were randomized to
a course of prophylactic
Augmentin or no prophylactic
antibiotic treatment at all. The
calculated sample size was 72
women per group.
Although there was a trend towards
higher maternal febrile morbidity
rate in the group that did not
receive any treatment, no statistical
significance was achieved. The
women in the treatment group had
a significant prolongation of
gestation, with 37.8% of the
mothers in the this group
delivering within 48 hours of
membrane rupture compared to
58.1% in the group that received no
treatment (P  .01247). More
mothers in the treatment group
(43.9%) delivered between 48 hours
and 7 d after membrane rupture in
comparison to the group that did
not receive treatment (34.9%). 18%
of the mothers in the treatment
group delivered after 7 d, as
opposed to only 7% of the mothers
in the group that received no
treatment. (P  0.01247).
The neonatal outcome measures
in the 2 groups (birth weight,
Apgar scores, neonatal death
due to sepsis, neonatal sepsis)
were not significantly different.
Ovalle-Sallas
et al374




79 women with PPROM were
randomized to receive IV
clindamycin plus gentamicin
for 7 d (n  39) or to the
control group (n  40).
Overall, incidence of premature
births (37 wk and 34 wk
gestation) was not reduced. In
women with infections who
received antibiotics, incidence of
premature birth (34 wk) was
significantly lower than those
patients who received placebo
(44.4% vs 88.9%, respectively, P 
.05).
Neonatal outcomes were unclear
as the trial was stopped after
the treatment group showed







106 third trimester pregnant
women with PPROM were
randomized to either oral
amoxicillin (0.75 g, 3 times
daily) (n  50) or placebo
(n  56) in a blinded fashion.
The patients were hospitalized




interval was 68.4 hours in the
placebo group and 91.7 hours in
the amoxicillin group (P  .28).
Hospital stay (3.0 vs 4.3 d, P  .03)
was prolonged by 43% in the
amoxicillin group. Rates of
hemorrhage and postnatal
endometritis-myometritis did not
differ significantly in the 2 groups.
Birth weight and stillbirth rate
did not differ significantly in
the 2 groups. There was a
trend towards longer duration
of hospital stay among
newborns in the amoxicillin
group suffering neonatal death
(1.6 vs 6.5 d, P  .06).
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clean delivery practices and TT immunization comes
from observational studies.
community-based evidence. In addition to a host
of descriptive studies, our search identified 8 trials
conducted in rural settings in developing countries that
provided pertinent information on perinatal and/or
neonatal outcomes after various interventions to pre-
vent tetanus and provide clean delivery (Table 20).
These studies variably involved maternal TT immuni-
zation and/or preparation for clean delivery by equip-
ping mothers and/or birth attendants with delivery
kits and promoting hand-washing for delivery and
newborn care. Thus, in general, it was not possible to
determine the impact of individual interventions on
outcomes.
Significant reductions in rates of neonatal tetanus,
as well as associated case fatality and NMRs, were
observed in newborns of mothers immunized for
tetanus during pregnancy.379–385 Even partial immu-
nization was found to be effective in decreasing mor-
tality and tetanus morbidity.379,382 Hand-washing
and use of clean instruments for cord cutting were
TABLE 20. Antenatal TT Immunization and Clean Delivery
Source Location and Type
of Trial
Intervention Perinatal/Neonatal Outcome
Meegan et al389 Kenya and Tanzania;
rural setting; QT
During the project period, there were 29 689
births in the intervention areas and 88 471
births in the control areas. In the
intervention area, TBAs carried out
antenatal, intrapartum and postnatal care.
They were supplied with delivery kits and
taught clean delivery. No immunization was
performed.
The neonatal tetanus rate decreased by
99% in the intervention area compared
to the control area (0.75/1000 live births
in intervention areas, range  0–3, vs
82/1000 live births in control areas,
range  74–93).
Tsu393 Nepal; rural setting;
PCS
Women from 3 districts who had delivered a
live infant (defined as a baby that survived
at least 24 hours after birth and was born at
home between 7 and 28 d prior to the
interview) were enrolled in 1 of 4 possible
cohorts: 1) kit user with trained attendant
(n  420), 2) kit user with untrained or no
attendant (n  398), 3) kit non-user with
trained attendant (n  404), and 4) kit non-
user with untrained or no attendant
(n  438). The data were then collected by
interviews with the mothers of the
newborns, members of the mother’s
household who were present for the
delivery or were caretakers of the newborn
along with some trained TBAs who had
participated in some eligible deliveries. Field
interviewers also directly observed the
newborn’s abdomen and cord area, and
consulted with medical records if available.
The cohorts in which kits were used had
less than half the infection rate (0.45;
CI: 0.25–0.81) of kit non-users who did
not use a new or boiled blade and clean
cutting surface (after adjusting for
confounders), but there was no
significant difference between kit users
and any other group of kit non-users,
suggesting that clean cord-cutting is one
of the most important practices in
preventing infection.
Gupta et al379 India; rural setting;
PCS
TT vaccination was given IM to pregnant
women (n  1760) as a single booster dose
to those who had received 2 doses in the
preceding 3 y (n  762), and TT vaccine was
given in 2 doses at 1-month intervals to
those who had no previous history of TT
immunization (n  696) or who were
previously only partially immunized
(n  230).
Neonatal tetanus prevention attributable
to TT vaccine was 88% for complete
immunization and 59% for partial
immunization compared to
nonimmunized. The risk of neonatal
tetanus among children born to women
who received any dose of TT was one-
fifth that of children born to non-






An education program for TBAs (n  214)
consisting of general midwifery and cord-
care training was carried out in 2 provinces
with a total population of 500 000, and mass
TT immunization was carried out in just 1
of the provinces. Pre- and post-intervention
surveys were carried out with randomly
selected groups of 210 respondents; the
project also interviewed 112 TBAs.
The incidence of neonatal tetanus in both
provinces declined sharply, suggesting
that reinforcement of routine services
and hygienic practices was of primary
importance. The NNT death rate was
0.2–0.4/1000 at the end of the
intervention, reduced 8- to 10-fold.
Kapoor et al380 India; rural setting;
QT
TT immunization of pregnant women was
initiated in 28 villages in 1970. The second
strategy adopted in this area after 1982 was
to distribute to every registered pregnant
women a sterilized delivery kit containing
gauze pieces, half a razor blade and thread.
There was a gradual and sustained
reduction in the neonatal mortality rate
from 42.3/1000 live births in 1972 to
17.9/1000 in 1987. During this period,
neonatal deaths due to tetanus
disappeared (14.6/1000 live births in
1972, 0/1000 in 1987). A 22% reduction
in NMR occurred after the introduction
of birth kits; there is a mixed impact of
birth kits and TT.
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associated with reduced neonatal tetanus inci-
dence,381,386–389 neonatal mortality,380,384 and sep-
sis.271,384 Training TBAs in clean delivery and mak-
ing clean delivery kits available were seen as
important factors in infection control.380,385,390–392 In
rural Nepal, failure to wash hands before cutting the
cord or use of dirty cloths on the umbilical cord were
associated with 60% and 70% increased risk of cord
infection, respectively.393 Moreover, failure to use a
boiled blade among nonusers of clean delivery kits
led to a 2.3-fold increase in risk of cord infections
above that of clean delivery kit users. However, use
of a clean home-delivery kit did not affect cord in-
fection rates, provided that a new or boiled blade
was used to cut the cord.
Thus, tetanus immunization of pregnant women in
combination with promotion of hand-washing and
clean delivery, including clean umbilical cord care,
was protective against neonatal tetanus and resulted
in reduced neonatal mortality and morbidity.
Among these interventions, the most persuasive data
on efficacy are in support of tetanus vaccination
strategies. In Sri Lanka, the introduction of the Ex-
panded Programme on Immunization (EPI) vaccina-
tion strategy in 1978 led to a dramatic reduction in
neonatal tetanus infection rates, which declined from
2.16 to 0.06 cases per 1000 live births.394 Similar data
were reported from Burma,384 showing that neonatal
tetanus mortality rates in non-EPI areas were three-
fold higher than in EPI areas (9 vs 3 per 1000 live
births). Similarly, in Bangladesh, national TT-immu-
nization programs reduced the incidence of deaths
from neonatal tetanus by 90% (from 41 to 4 deaths
per 1000 live births) over a decade.29 One study (in 2
sites) compared the efficacy of 3 intervention strate-
gies for reducing neonatal tetanus: maternal TT ad-
ministration, hospital-based delivery (to promote
clean delivery), and home delivery by a trained birth
attendant.395,396 Overall, maternal tetanus vaccina-
tion is most effective and seems to offer the single
best option for reducing neonatal tetanus in devel-
oping countries (Table 21).
conclusions. Evidence for the benefits of mater-
nal tetanus immunization on neonatal outcomes is
incontrovertible. Maternal TT immunization must be
an essential part of antenatal care packages as well as
mass-vaccination programs. Similarly, the impor-
tance of clean delivery practices, including clean um-
bilical cord care, must be underscored. Available
community-based data suggest that the best gains
may be obtained from implementation of a combina-
tion of maternal immunization and clean delivery
and cord-cutting practices. On the other hand, there
is no evidence that as a single intervention, use of a
clean delivery kit is necessarily the most appropriate
way of ensuring that caregivers and birth attendants
pay sufficient attention to antisepsis, nor is there
evidence that kit use impacts umbilical cord infection
or NMRs. To the contrary, behavior-change commu-
nications strategies to promote clean delivery prac-
tices, including clean cord cutting, should be im-










Burma395 91.4% 84.6% 32.8%
Egypt721 87% 77% 49%
TABLE 20. Continued
Source Location and Type
of Trial
Intervention Perinatal/Neonatal Outcome
Rahman et al383 Bangladesh; rural
setting; PCS to
evaluate an RCT
Neonatal mortality was compared between
offspring born from 1978–1979 to women
who had received TT prior to pregnancy
(n  956), offspring born to women given
TT while pregnant from 1978–1979 (n 
934), offspring born to partially
immunized women (n  729), and
offspring born to non-immunized mothers
(n  7237). Women given TT were given 2
doses if immunized in 1974 (non-
pregnant), 3 doses of TT if immunized in
1978 (pregnant) and 2 doses if immunized
in 1979.
Decreases in the stillbirth rate (44%,
P  .05) and neonatal mortality rate
(49%, P  .01) were observed in the
women who were fully immunized in
pregnancy compared to those who
were not.
Rahman 384 Bangladesh; rural
setting; RCT
In 3 unions, TBAs were trained in better
maternal nutrition and hygienic newborn
care practices; in 3 unions TT was given;
and 3 unions were kept as controls. 1760
pregnant women were cared for by these
TBAs.
NMR decreased 72% and 54% in the
TBA training areas and the TT areas,
respectively. The NMR was 38.9/1000
in TT unions compared to 85.2/1000
in control unions. Tetanus neonatorum
decreased by 94.6% in the TT area.
Black et al382 Bangladesh; rural
setting; DBRCT
Volunteer non-pregnant women (n  46 443)
received 0.5 mL of cholera toxin or
aluminum phosphate-adsorbed TT by IM
injection. 13 220 women received 1 TT
injection, while 33 175 received 2 TT
injections. Neonatal mortality in infants
born 9–32 mo after immunization were
compared.
In the first cohort of offspring, neonatal
mortality was significantly lower
(33%, P  .01) among those born after
9–32 mo of mass tetanus vaccination
in women (68.4/1000 in controls vs
44.1/1000 in TT area). 75% of the
reduction in mortality was attributable
to the reduction in neonatal mortality
between 4–14 d of age (P  .001).
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plemented in tandem with introduction of clean
delivery kits.
We would underscore the need to undertake an
evaluation of the most appropriate, cost-effective,
and sustainable clean delivery strategies in commu-
nity and rural settings in developing countries. If
clean delivery kits are promoted, it should be done in
the context of broader behavior-change communica-
tions regarding clean delivery practices.
Maternal Pneumococcal Immunization
background. The high incidence of infectious dis-
eases in young infants in developing countries sug-
gests that, in many cases, maternally derived anti-
bodies fail to provide adequate protection. For
example, infection with Streptococcus pneumoniae ac-
counts for 10% of deaths (220 000 deaths per year)
globally in infants 90 days old.397 Although live
vaccines are contraindicated in pregnancy, killed or
toxoid-based vaccines can be administered safely to
pregnant women. These strategies may be particu-
larly useful in circumstances in which background
rates of routine vaccinations in childhood and ado-
lescence are low or available vaccines are contrain-
dicated or ineffective in young infants. Thus, al-
though the benefits of maternal immunization
against tetanus are well established, there is very
little information about the impact of other vaccines
administered during pregnancy on pregnancy
outcomes.
community-based evidence. One study of mater-
nal pneumococcal vaccination has been reported
(Table 22).398 Although the study took place in an
urban hospital setting, we included it in our evalua-
tion because it was based in a developing country
and evaluated neonatal outcomes. Infants born to
mothers who had been immunized had higher blood
levels of antibodies sufficiently protective against
pneumococcal antigens. However, the newborn an-
tibody levels depended primarily on the duration
between immunization and delivery. Although the
level of antibodies decreased at 22 weeks of age
postnatally, levels were still higher than those found
among control infants. Additional data on clinical
outcomes and long-term protection were not
available.
conclusions. Although limited and preliminary,
these data provide intriguing information on the
possibility of maternal immunization as a strategy
for addressing early neonatal pneumococcal infec-
tions. Development of maternal immunizations
against group B streptococcus and Haemophilus influ-
enzae is similarly of great interest and under active
investigation.
Promotion of Smoking Cessation During Pregnancy
background. Inhalation of smoke by pregnant
women may occur through several modes of expo-
sure and has been consistently associated with IUGR
and LBW in offspring. It is widely recognized that
smoking increases the risk of LBW births almost
twofold399 and significantly increases perinatal
mortality.400
Infants born to women who smoke during preg-
nancy weigh, on average, 200 g less than infants
born to comparable women who do not smoke.399
Smoking has been shown to double the risk of LBW
births among those mothers who smoke, compared
with those who do not. In addition to LBW, in-
creased risk of spontaneous abortion, as well as in-
creased risk of perinatal and neonatal mortality, have
also been associated with maternal smoking.401 Re-
cently, new evidence has shown an association of
indoor air pollutants with LBW and increased infant
and perinatal mortality.402,403 One study reported
an association of LBW with use of wood as cooking
fuel.401,402 The study by Boy et al,402 using a retro-
spective cohort design, evaluated the association be-
tween LBW and exposure to wood smoke by asking
women at the time of delivery about the type of
cooking fuel they used. The study results were po-
tentially confounded, however, failing to control for
differences in nutritional and socioeconomic vari-
ables associated with different fuel types. The study
also included a combination of hospital and home
deliveries but excluded women living in remote ar-
eas due to inaccessibility.
Smoking and use of tobacco in other forms are
widespread in developing countries. Moreover, ex-
posure to outdoor air pollution, indoor air pollution,
and indoor smoke (either from cooking or secondary
inhalation of cigarette smoke) is widespread and
may impact the mother as well as the young infant,
leading to increased risk for asthma and respiratory
infections.404
A systematic review of RCTs evaluating the im-
pact of cessation of smoking during pregnancy405
found that there were significant reductions in the
incidence of LBW (OR: 0.8; CI: 0.67–0.95) and pre-
term births (OR: 0.83; CI: 0.69–0.99) and an increase
TABLE 22. Maternal Pneumococcal Immunization
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Shahid et al398 Bangladesh; urban
hospital setting;
DBRCT
Women 30–34 wk gestation
(n  70) were ran-
domized to receive 23-
valent pneumococcal
polysaccharide vaccine
(n  36) or meningo-
coccal vaccine containing
polysaccharide of groups
A, C, Y and W-135.
(n  37).
Among pneumococcal vaccine





correlation RS  0.66 for
type 6B and RS  0.77 for
type 19F, P  .0001).
Infant cord blood antibody titers
were highly correlated with
the maternal titers at delivery.
In the 22 wk postnatal
sample, 71% and 63% of the
infants of women who had
received pneumococcal
vaccine had antibody
0.15 g/ml for types 6B and
19F, respectively (P  .01).
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in mean birth weight of 28 g (CI: 9–49 g). However,
there was no difference in the incidence of VLBW
births or overall perinatal mortality, and the largest
cluster-randomized trial reviewed showed no evi-
dence of an impact of reduction in smoking on ad-
justed mean birth weight.406
community-based evidence. Measures to reduce
environmental exposure to smoke may improve
pregnancy outcomes, but this has not been system-
atically studied in developing countries. In light of
this lack of data, evidence available concerning the
impact of smoking cessation on pregnancy outcomes
is presented from developed countries in an attempt
to evaluate the impact of this potential intervention.
We identified 8 additional studies, the majority of
which were undertaken in the United States, pri-
marily in urban settings, that reported on the im-
pact of smoking cessation on pregnancy outcomes
(Table 23). No rural-based study could be identified.
The studies included several smoking-cessation
counseling methods ranging from individual coun-
seling by midwives to counseling by a trained pro-
fessional counselor, often supplemented with litera-
ture about the potential adverse effects of smoking
on the developing fetus. In all but 1 study,407 inter-
ventions to promote smoking cessation in pregnant
women were found to be significantly effective in
increasing smoking-cessation rates408–411 and reduc-
ing the number of cigarettes smoked by moth-
ers.410,412 In most studies, however, no impact was
seen on pregnancy outcomes, including birth
weight,407,408,410,413,414 rates of LBW or preterm de-
livery,407–410,413,414 or perinatal mortality.409,413,414
Some studies, however, demonstrated an increase in
birth weight and/or length in subgroups that
stopped smoking due to the intervention.409,411,412
conclusions. Overall, smoking-cessation pro-
grams have produced mixed results on pregnancy
outcomes such as preterm birth or LBW rates and
have failed to impact fetal, perinatal, or infant mor-
tality despite success in reducing smoking rates. Few
studies have evaluated the impact of environmental
smoke and indoor air pollution on pregnancy out-
comes in developing countries or interventions to
redress them. However, a recent review by the WHO
has highlighted the potential adverse health conse-
quences from indoor air pollution.403
Clearly, it is prudent to discourage maternal
smoking due to the general harm that smoking does
to health. It is important, however, that additional
studies on reducing exposure to tobacco and indoor
air pollution be conducted in developing countries
with direct assessment of pregnancy outcomes and
health of the young infant, because evidence for the
impact of interventions on health status of newborns
in developing countries is currently unavailable.
Presently, despite the paucity of studies from com-
munity settings in developing countries, there is
enough information from developed countries to de-
cry the use of any form of tobacco (smoked or
chewed) and addictive drugs such as alcohol, co-
caine, and narcotics in pregnancy.
Maternal Care Packages
background. The aforementioned studies and
interventions largely evaluated solitary maternal
interventions. In most programmatic settings, how-
ever, such interventions typically are provided in
combinations and as part of a package of care. Al-
though most such studies have examined maternal
outcomes, data also exist on the impact of pack-
ages of maternal interventions on perinatal
outcomes.
community-based evidence. Our review yielded
2 studies that provided maternal care packages in a
rural community-based setting and reported infor-
mation on perinatal outcomes (Table 24). These pro-
grams were directed toward identification of high-
risk patients and their early referral to a higher-level
facility and provided a multilayered series of mea-
sures including essential antenatal care, improved
referral systems, and facility-based care. The com-
munity-based maternal care programs showed sig-
nificant reductions in perinatal (34%) and neonatal
(43%) mortality.415 Recent data from a perinatal in-
tervention trial in Macedonia indicate that it may be
possible to reduce perinatal and neonatal mortality
at the national scale through a concerted perinatal
education and health worker–training program
within the health system setting.416 Similarly, the
introduction of a structured primary care program in
Bolivia,417 coupled with maternal care, led to a dra-
matic reduction in infant and young child mortality.
In 1992–1993, the annual rates of mortality of chil-
dren 5 years old were 205.5 per 1000 and 98.5 per
1000 in the comparison and intervention areas, re-
spectively. The absolute difference in mortality of
107.0 deaths per 1000 (CI: 72.7–141.3 per 1000) rep-
resented 52.1% (CI: 35.2–68.8%) lower mortality
among children 5 years old in the intervention
areas, compared with the control areas.
conclusions. Available evidence suggests that
much of the improvement in perinatal and neonatal
health in the West preceded the advent of neonatal
intensive care and is largely owed to better and
comprehensive maternal care and reproductive
health.418 In developing countries, the dependence of
infant survival on the survival and health of the
mother has been clearly demonstrated.14 Data on the
impact of maternal interventions on perinatal and
neonatal outcomes are scarce but robust. Investing in
improved maternal health must form the cornerstone
of strategies aimed at improving perinatal and neo-
natal outcomes.
Intrapartum Interventions
Maternal Vaginal and Newborn Skin Antisepsis
background. Maternal intrapartum and postpar-
tum infections are a major cause of maternal morbid-
ity and mortality in developing countries. A large
proportion of early-onset neonatal infections in de-
veloping countries may also be related to vertically
transmitted infections from the maternal genital
tract.21,25,419 Thus, there is interest in evaluating low-
cost strategies for preventing and reducing infectious
564 COMMUNITY-BASED INTERVENTIONS FOR IMPROVING HEALTH OUTCOMES
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complications of maternal infections, particularly for
settings in which antenatal care may be suboptimal.
A number of antiseptic solutions or preparations
may be used for cleansing the maternal genital tract.
However, the largest body of evidence and greatest
measure of support is available for chlorhexidine.
This agent has been used successfully in developed
countries for prophylaxis against newborn coloniza-
tion and infection with group B streptococcus.420–426
community-based evidence. A study of the im-
pact of chlorhexidine cleansing was undertaken in
Malawi at an urban hospital, at a cost of $0.10 for
each maternal-infant pair treated (Table 25).427,428
Cleansing of the maternal vaginal canal and the
newborn skin with a 0.25% chlorhexidine solution
resulted in significant reductions in serious postpar-
tum maternal infections (P  .02), neonatal admis-
sions (OR: 0.8; CI: 0.79–0.97), neonatal sepsis (OR:
0.5; CI: 0.32–0.76), overall neonatal mortality (28.6 vs
36.9 per 1000; P .05), and neonatal mortality due to
infections (OR: 0.5; CI: 0.29–0.88; 2.4 vs 7.3 per 1000;
P  .005).428 Among women with rupture of mem-
branes for 4 hours, the HIV transmission rate was
decreased by 40% (OR: 0.6; CI: 0.4–0.9). In another
study in Kenya comparing intrapartum vaginal la-
vage with 0.2% and 0.4% chlorhexidine, there was no
overall effect on transmission of HIV, but risk of
transmission was significantly reduced (OR: 0.1; CI:
0.0–0.9) in the subgroup that had not had rupture of
membranes before treatment.429
conclusions. Chlorhexidine cleansing of both the
maternal vaginal canal and the newborn skin has
TABLE 24. Maternal Care Packages
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Yan415 China; rural setting;
PCS
7 of 29 townships were randomly
selected. A 3-tiered (village,
township and county) Maternal
Child Health network was
developed in which MCH
workers at the community
level identified pregnant
women and gave them
antenatal care, with regular
higher-level supervision from
doctors. A ward for newborns
was available at the county
level for emergencies.
NMR declined by 34% (from
26.6/1000 to 17.5/1000 births).
Antia725 India; rural setting
(Mandwa Project);
QT
In collaboration with the elders
of the villages, VHWs were
trained to take care of pregnant
women. A small health center
with 10 beds (chiefly for
maternity care and tubectomy)
was established.
Increased case detection and
treatment of leprosy and
tuberculosis by VHWs
was recorded.
The IMR was lower in the
project area compared to the
national figures (74/1000 live
births vs 114 nationally for
that time period).
TABLE 25. Maternal Vaginal and Newborn Skin Antisepsis
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Taha et al428 Malawi; urban
hospital setting;
QT
3635 women giving birth to 3743
babies were enrolled in the
intervention phase and 3330
women giving birth to 3417
babies were enrolled in the
non-intervention phase.
Intervention consisted of
manual cleansing of the birth
canal and cleansing the baby
immediately after birth with a
0.25% chlorhexidine gluconate
solution.
The intervention resulted in
reductions in maternal
admissions related to
delivery (29.4 vs 40.2/





The intervention resulted in
a 22% reduction in NMR





(16.9% vs 19.3%; P  .01),
neonatal sepsis (7.8/1000
vs 17.9/1000; P  .0002),
overall neonatal mortality
(28.6/1000 vs 36.9/1000;
P  .06) and mortality due
to infections (2.4/1000 vs
7.3/1000; P  .005).
Biggar et al427 Malawi; urban
hospital setting;
RCT
The infection status of infants of
3327 control women (con-
ventional delivery procedures)
was compared with that of
3637 infants of intervention-
delivered women. Intervention
consisted of washing the
maternal birth canal and the
skin of the newborn with
0.25% chlorhexidine.
Among women with rupture
of membranes 4 h before
delivery, chlorhexidine
reduced HIV transmission
rate by 40% (OR: 0.6; CI:
0.4–0.9). No significant
effect for women with
rupture of membranes
4 h before delivery.
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significant potential for reducing maternal and neo-
natal postnatal infections and improving neonatal
(and perhaps maternal) survival. Additional efficacy
trials are needed to confirm these results in different
facility-based settings, to determine the relative con-
tribution of vaginal cleansing versus newborn skin
cleansing, and, thence, to evaluate potential applica-
tions and feasibility of the intervention within the
community. Evaluation of higher-concentration for-
mulations of chlorhexidine to prevent sepsis with
pathogens from the skin34 and to prevent maternal-
to-child transmission of HIV (1%) is also warranted.
Postnatal Interventions
Newborn Resuscitation
background. Intrapartum hypoxia and birth as-
phyxia are widely regarded as major causes of mor-
bidity and mortality in developing countries.18,430,431
“Birth asphyxia,” or failure to establish breathing at
birth, comprises just a portion of the burden of early
death from hypoxia. For every neonatal death from
asphyxia, there seems to be 1 additional fresh still-
birth that occurs due to intrapartum hypoxia,430,432
although the precise burden of stillbirths is not yet
well defined.24 Evidence for birth asphyxia as a ma-
jor cause of neonatal mortality is well established;
however, the contribution of intrapartum hypoxia
and birth asphyxia to cerebral palsy and the overall
burden of handicap in developing countries is un-
clear.433 Previously, it was estimated that for every
case of mortality due to asphyxia or intrapartum
hypoxia, another 4 newborns survived but suffered
sequelae.434 However, more recent data suggest that
this may be a gross overestimation of the burden of
handicap, because most newborns in developing
countries with severe asphyxia die.435
Approaches to improving birth asphyxia-related
outcomes may include prevention through improved
antenatal care such as birth preparedness; intrapar-
tum care such as the presence of a skilled birth
attendant and fetal monitoring (eg, use of a parto-
graph); or improved management (eg, resuscitation)
of newborns who do not breathe adequately at birth.
The effects of antenatal and intrapartum interven-
tions on birth asphyxia outcomes are thoroughly
covered in another recent review24 and are not in-
cluded here. The important role of neonatal resusci-
tation in immediate newborn care is well accepted
and forms a cornerstone of immediate newborn care
in developed countries,17 but there are particular
challenges to making this intervention feasible in
developing-country settings.24 Recent treatment mo-
dalities and interventions such as cerebral hypother-
mia436,437 therapy and the role of medications after
asphyxia are experimental and have been evaluated
only in controlled facility-based situations in devel-
oped countries. This latter group of interventions is
not evaluated further in this review.
community-based evidence. In addition to a host
of descriptive studies, we identified 13 studies from
developing countries that evaluated various aspects
of neonatal resuscitation, including the feasibility of
primary care staff undertaking the interventions
(Table 26, see also Table 39). The reported literature
suggests that TBAs who are trained and supervised
in newborn resuscitation are capable of learning
and properly using simple resuscitation tech-
niques431,438–442 and that resuscitation may be per-
formed successfully by trained health providers us-
ing relatively simple equipment (eg, mouth-to-mask
breathing)443,444 and room air.445,446 Training hospi-
tal staff in India447 and China448 in newborn resusci-
tation has been shown to reduce asphyxia-related
deaths.
It has been suggested that neonatal mortality may
be reduced after training of TBAs in resuscita-
tion,431,449 although little objective data have been
provided. Daga et al449 reported 41% and 62% reduc-
tions in NMR and PMR, respectively, over a 3-year
period after introduction of a TBA training program
that included mouth-to-mouth resuscitation of as-
phyxiated infants as a central component of the in-
tervention. Successful resuscitation was reported in
83% of cases of asphyxia. Kumar and Aggarwal431,442
reported a 70% reduction in asphyxia-specific mor-
tality (P  .05) among infants delivered by selected
TBAs in rural India trained in advanced resuscitation
using a mucus sucker and bag-and-mask compared
with TBAs trained in mouth-to-mouth resuscitation.
Newborns delivered by TBAs with advanced train-
ing also had a 19% lower PMR and a 20% lower
case-fatality rate, although neither outcome effect
was significant. A recent meta-analysis of the impact
of TBA training programs found that neonatal mor-
tality due to asphyxia was reduced 11% (CI: 2–21%).3
It was uncertain, however, which aspects of the
training programs were responsible for the impact.
Most programs did not describe neonatal resus-
citation as an important part of training; thus, the
impact seemed to be due to interventions other than
resuscitation.
In northern India, CHWs were trained in essential
newborn care (clean cord cutting, maintenance of
warmth, breastfeeding promotion); identification
and special care, including referral when indicated,
of at-risk infants; and mouth-to-mouth resuscitation
of asphyxiated infants.438 The NMR fell 25%, from
51.9 to 38.8 per 1000 live births, during the 2 years of
the study, with 18% of deaths attributed to asphyxia.
In another trial of home-based neonatal essential and
emergency care, including resuscitation of asphyxi-
ated newborns by trained CHWs, Bang et al439 re-
ported a 48% reduction in asphyxia-specific neonatal
mortality. Training of grassroots-level health provid-
ers in a Chinese province in methods of newborn
resuscitation resulted in a reduction in the case fatal-
ity rate from 7.1% to 0.45%.450
No data exist on the role of family members in
neonatal resuscitation.
conclusions. Our review suggests that, although
objective evidence for the impact of community-
based resuscitation efforts is sparse, there are prom-
ising approaches and techniques that seem effective
in preliminary trials. Trained TBAs or CHWs seem to
be capable of learning resuscitation skills and saving
newborn lives; however, the feasibility of scaling up
SUPPLEMENT 567
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this approach is unclear. Supervision and mainte-
nance of skills are critical to success, yet formidable
challenges exist at the community level. One of the
areas of greatest need is to define feasible and cost-
effective approaches by which community-level pro-
viders (eg, CHWs, community midwives) can pre-
vent fresh stillbirths and neonatal deaths due to
intrapartum hypoxia/birth asphyxia. There is evi-
dence that mouth-to-mask and bag-and-mask resus-
citation are comparable techniques with regards to
neonatal mortality and morbidity443; however, the
former was deemed more difficult for the providers.
Thus, where feasible, bag-and-mask ventilation has
become the preferred modality.439 The evidence that
room air could be satisfactorily used for neonatal
resuscitation suggests that staff training alone and
basic equipment may be sufficient for resuscitation
of asphyxiated newborns in developing-country
communities.
Additional large-scale effectiveness trials of such
intervention strategies with defined criteria and end-
points are clearly required. More precise definitions
of “birth asphyxia” at the community level and im-
proved verbal autopsy instruments for identification
of fresh stillbirths and neonatal deaths due to acute
intrapartum hypoxia are urgently needed. The cost-
effectiveness and sustainability of resuscitation using
various modalities and the impact of resuscitation on
disability rates have not been documented. The var-
ious components of resuscitation, such as the role of
pharyngeal suction, the need for oxygen therapy,
and the role of ventilation by bag-and-mask (as op-
posed to other modalities such as tube-and-mask,
mouth-to-mask, or mouth-to-mouth), also require
additional scientific scrutiny. Meanwhile, it is rea-
sonable to promote the basic elements of newborn
resuscitation (namely, drying, stimulation, and
warming) as a routine part of newborn care and to
further evaluate the potential role of trained TBAs
and CHWs in using equipment such as the bag-and-
mask to ventilate nonbreathing newborns. In addi-
tion, all skilled attendants should be trained to pro-
vide proper newborn stimulation and ventilation.
Delayed Umbilical Cord Clamping
background. There is little evidence as to
whether the current practice of umbilical cord clamp-
ing soon after birth, to prevent polycythemia on the
one hand or anemia on the other, is based on solid
scientific criteria. Some studies have demonstrated
that delayed cord clamping (after the cord stops
pulsating) may increase neonatal blood volume by
approximately one third.451,452 Thus, delayed cord
clamping may increase the newborn infant’s iron re-
serves and reduce the incidence of iron-deficiency ane-
mia in infancy, an issue of considerable public health
importance.453
community-based evidence. In the course of in-
troducing a program to reduce tetanus incidence in
Haiti, it was observed that nearly half of families
ceased cutting the cord at home after delivery and
instead bundled the infant, placenta, and cord and
sought cord care at the hospital.385 Despite delays in
cord cutting for up to several hours, neonatal mor-
tality declined dramatically and no adverse effects
on neonatal outcomes were noted.
We identified only 1 comparative trial from a devel-
oping country that evaluated this issue in an urban
hospital setting (Table 27). Delaying umbilical cord
clamping until the cord ceased pulsating was associ-
ated with an increase in red blood cell count in the
neonatal circulation regardless of whether the infant
was level with or below the level of the placenta.454
conclusions. Despite the potential importance of
the timing of cutting the cord, there are little data on
its relationship to neonatal health. No data are avail-
able from developing countries on whether the com-
mon practice of waiting until after the placenta has
been delivered to cut the cord has a beneficial or
adverse impact on neonatal circulation and health.
However, the scarce available evidence does indicate
that delayed cord clamping may be beneficial, be-
cause it may allow for greater transfer of placental
blood to the newborn’s circulation before cutting the
cord. Additional studies are needed to resolve this
issue, because it may have important implications for
prevention of anemia in infancy in susceptible pop-
ulations in developing countries.
Umbilical Cord Antisepsis
background. The importance of clean cord cut-
ting for the prevention of neonatal tetanus was con-
sidered in the section on tetanus prevention (see “TT





Grajeda et al454 Guatemala; urban hospital
setting; RCT
88 infants were enrolled, out of which
73 were followed up at 2 mo of
age. 69 blood samples were
available. In group 1 (n  29) the
cord was clamped immediately
after birth. Group 2 infants (n  30)
had the cord clamped after
pulsations stopped but with the
infants kept at the same level as the
mother’s heart. Group 3 infants
(n  29) had delayed cord
clamping at cessation of pulsations
but the infants were placed at a
lower level.
Infants in the groups with
delayed cord clamping
had significantly higher
hematocrit values 2 mo
after delivery compared
with the control group.
There were no differ-
ences between groups 2
and 3.
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Immunization and Clean Delivery” and Table 20).
Studies of the impact of topical applications of anti-
septics to the umbilical cord in the postnatal period
generally have shown reductions in bacterial coloni-
zation compared with no treatment.34 However, im-
pact has varied with the specific antimicrobial com-
pound, the mode or frequency of application, and
the degree of contamination in the environment. In
general, chlorhexidine seems to be the most favor-
able choice of antiseptic because of its broad spec-
trum of activity, residual effects on the skin, low
toxicity, and results showing overall reductions in
cord colonization after treatment.34,455
Evidence for the effect of topical antiseptic treat-
ment of the cord in reducing local cord or skin infec-
tions or sepsis is less clear because of conflicting
reports.34 Thus, several neonatal skin care reviews
have called for discontinuation of routine topical
antiseptic care of the cord based on conflicting evi-
dence regarding which topical agent most effectively
decreases colonization and the lack of a clear rela-
tionship between colonization and infection.456,457
However, in many cases, when antiseptic treatments
have been discontinued, increased rates of cord col-
onization and infection have been found.458,459 In
general, wide variation in trial design, small sample
sizes with insufficient power to assess impact on
infections, and inconsistent comparisons between
different regimens have contributed to the largely
conflicting literature on the impact of cord-care
regimens.
A Cochrane review on different methods of neo-
natal cord care, including the use of topical antimi-
crobials, suggested that the incidence of omphalitis
and skin infections within 6 weeks of observation
was not affected by use of antiseptics.460 There was a
trend toward reduced microbial colonization with
the use of antibiotics compared with no treatment.
Antiseptics such as chlorhexidine, however, pro-
longed the time to cord separation. It was concluded
that simply keeping the cord clean was probably as
effective as topical antibiotic use. However, this re-
view was based on 10 RCTs, all conducted in devel-
oped countries, none of which reported any systemic
infections or neonatal deaths.
In addition to the aforementioned Cochrane re-
view, the WHO461 also reviewed the evidence from
a host of descriptive and physiologic studies and
concluded that medical cord-care practice recom-
mendations are overwhelmingly based on research
from hospital nurseries in developed countries. It
was concluded that, compared with no treatment,
application of a topical antimicrobial to the cord
stump reduced umbilical colonization by harmful
bacteria in hospital nurseries. Chlorhexidine, tinc-
ture of iodine, povidone-iodine solutions, triple
dye and silver sulfadiazine were all found to be
effective in reducing microbial colonization, al-
though caution was issued regarding the need to
balance their use with the potential for emergence
of antimicrobial resistance. In general, dry cord care
was recommended along with the use of soap-and-
water solution to clean the cord when visibly soiled.
community-based evidence. There is a large
body of literature outlining the increased risk of um-
bilical infection, mainly due to Clostridium tetani col-
onization, after application of unclean substances
such as ash or mud to the cord of neonates in devel-
oping countries.462–464 Observational studies have
shown that application of antimicrobial agents to the
cord after cutting was protective against tetanus and
resulted in reduced neonatal mortality and morbid-
ity381,387,463 (Table 28). In a large CCS of tetanus
deaths in Pakistan, Bennett et al388 showed that in-
fants who received applications of antimicrobials
(type unspecified), both at birth and subsequently,
were at significantly less risk of death than those
who received dry cord care alone (OR: 0.2; CI: 0.06–
0.58), even after adjusting for use of unclean sub-
stances such as cow dung, ash, or ghee (clarified
butter) (OR: 0.4; CI: 0.21–0.77). In Papua New
Guinea, neonates who received daily application of
10% acriflavine in spirit to the umbilical cord were
9.4 (P .02) and 6.7 (P .01) times less likely to have
sepsis or fever, respectively, than those who did not
receive the antiseptic applications.463
conclusions. There is no definitive answer to the
question of what constitutes the best form of cord
care after birth, particularly in domiciliary settings.
More research is needed on this issue, especially in
situations of limited resources and high potential for
environmental contamination of the cord. Although
there is evidence to suggest that cord antisepsis may
be beneficial, there is insufficient evidence to recom-
mend the widespread use of topical antimicrobials
on the cord stump. Nevertheless, the decision to use
them may depend on local circumstances.
Rooming-in and keeping the infant with the
mother also significantly reduces the incidence of
colonization with pathogenic bacteria and cord infec-
tions.465,466 Thus, early colonization of the newborn
with commensal flora from the mother, facilitated by
early and prolonged contact as with KMC, may be
protective and may have contributed to the reduc-
tion in infections observed in cohorts who practiced
KMC (see “KMC” and Table 35). Similarly, for home
deliveries and for cord care after discharge from
hospital in developed countries, clean cord care
seems to be sufficient, and the application of antisep-
tics may not be required. However, for developing-
country communities in which the majority of new-
borns are delivered at home and may face severe
immunologic challenge from pathogenic bacteria in
the environment, the benefits of topical antiseptics
remain unknown. Provision of clean delivery kits
may increase compliance with clean cord cutting and
tying after birth, although this has not been demon-
strated (see “TT Immunization and Clean Delivery”
and Table 20). Topical antimicrobial applications
may be a useful strategy for other instances in which
potentially harmful practices such as cow dung ap-
plication on the cord stump are widely prevalent,
even if just for replacement of the harmful prac-
tices.388,461 If chosen, the antimicrobial should have a
broad spectrum of activity against Gram-positive
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and Gram-negative pathogens and should be inex-
pensive, culturally acceptable, and widely available.
Additional research is needed to define best cord-
care practices in developing-country communities.
Meanwhile, efforts must focus also on providing cul-
turally appropriate behavior-change communica-
tions to communities and caregivers on proven in-
terventions such as clean cord-care practices,
particularly hand-washing and use of a clean blade
to cut the cord.
Hypothermia Prevention and Management
background. Hypothermia in the newborn pe-
riod is widely regarded as a major contributory cause
of morbidity in developing countries,467 although it
has been poorly documented. Hypothermia has been
associated with increased risk of infection, coagula-
tion defects, acidosis, delayed fetal-to-newborn cir-
culatory adjustment, hyaline membrane disease, and
brain hemorrhage.468,469 At its extreme, hypothermia
may manifest as neonatal cold injury470,471 and be
associated with significant mortality.439 This risk is
particularly marked among LBW infants in develop-
ing countries and is seen commonly even in coun-
tries with tropical climates. Studies in Nepal using
continuous temperature monitoring have indicated
that thermal stress may be extremely common
among newborn infants; 80% of hospital-born infants
became hypothermic soon after birth.472 In another
maternity hospital study in Nepal, 85% of newborns
had a temperature 36°C within 2 hours of birth.473
Similarly, in facility-based studies in Ethiopia,474
Zambia,475 and Zimbabwe,476 one half to two thirds
of newborns had hypothermia.
Few studies have addressed practices during and
after birth, which can put the newborn at risk for
hypothermia. In a multicenter evaluation in Latin
America, Asia, and Africa, 65% and 73% of health
facility workers had adequate knowledge regarding
causes and prevention, respectively, of hypothermia,
yet interventions to prevent hypothermia were sel-
dom provided (eg, 0% warmed the delivery room,
11% dried and wrapped the infant, and 50% and 61%




Parashar et al381 Bangladesh; rural
setting; CCS
For each neonatal tetanus case identified
(n  359), 3 living infants matched for
gender, residence and date of birth
were selected as controls.
Application of antibiotics to the umbilical
stump at delivery decreased neonatal
tetanus by 79% (OR: 0.21; P  .019).
Hand-washing by the delivery
attendant and prior immunization with
TT were protective in multivariate
analyses, decreasing tetanus rates by
36% (OR: 0.64; P  0.005) and 50%
(OR: 0.50; P  .001), respectively.
Bennett et al388 Pakistan; rural
setting; CCS
Cases (n  211) were uncircumcised
infants diagnosed as having definite
or probable neonatal tetanus. 3
controls who survived the neonatal
period and whose mothers had not
received TT were selected per case
(n  633).
Reported hand-washing by the delivery
attendant was highly protective against
neonatal tetanus, decreasing rates by
56% (OR: 0.44; CI: 0.29–0.67; P 
.0002). Continuous use of antimicrobial
agents (antibiotics and antiseptics) on
the cord at delivery and during the
first few days after delivery was highly
protective in univariate testing
(matched OR: 0.2; CI: 0.11–0.64;
P  .003), and remained significantly
protective when other delivery and
cord-care practices were controlled for.
Garner et al463 Papua New Guinea;
rural setting; QT
Newborns (n  132) were divided into
3 groups. Infants in the control group
(n  64) were born to mothers
without birth kits. Infants born the
initial part of the intervention phase
(n  33) were born to mothers who
had been supplied with a new razor
blade and acriflavine 10% in spirit.
Infants born during the later part of
the intervention phase (n  34) were
born to mothers who had been
supplied with a razor blade,
acriflavine 10%, and plastic umbilical
cord clamps which the women had
been instructed how to use.
Of the 9 cases of neonatal sepsis, 8 were
in the control group and 1 was in the
intervention group (P  .02).
Traverso et al387 Pakistan; rural
setting; CCS
Tetanus cases (n  102) were identified
at an urban hospital and 3 controls
(n  306) were selected from the
village of each case.
Delivery conducted by formally trained
personnel was associated with a
decreased risk of neonatal tetanus
(OR: .28; CI: 0.08–1.0). Use of a topical
antibiotic was also associated with a
protective effect, decreasing neonatal
tetanus rates by 66% (OR: 0.34; CI:
0.18–0.65).
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provided special protection during transport or to
LBW infants, respectively).477 In 1 village-based
study in India, 11% of 189 neonates were found to be
hypothermic based on a single temperature reading
taken within the first 24 hours after birth. Only 58%
of newborns were wiped soon after delivery, the
head was covered in 59% in winter and 10.5% in
summer, no newborns were kept in skin-to-skin con-
tact, and the room temperature was 24°C in 41% of
households.442 Early bathing and removal of vernix
are also recognized but understudied risk factors for
hypothermia. However, based on expert opinion, the
WHO recommends that bathing be delayed for at
least 6 hours after birth to minimize the risk of cold
stress during the period of maximum physiologic
transition of the newborn.469
Although it has been demonstrated that physicians
and trained assistants in health facilities are capable
of perceiving newborn body temperature by touch
with reasonable accuracy,441,478,479 in a community-
based study in India, mothers using touch alone had
limited ability to detect hypothermia.480 Overall,
only one fourth (24.6%) of hypothermic infants were
correctly identified as such by the mothers. A tem-
perature-indicator device (ThermoSpot) placed on
the newborn’s skin has been shown to provide an
accurate indicator of the presence of hypothermia
and is acceptable to mothers in hospital set-
tings,476,481–484 but additional research on its utility
and use in resource-poor communities, especially by
mothers, is needed.
It is now well recognized that rapid rewarming of
hypothermic newborns in developed-country set-
tings may be entirely safe and result in lower mor-
tality compared with slower methods of rewarm-
ing.485,486 The WHO has recognized the importance
of thermal care of the newborn by including it as a
priority behavior in the Mother-Infant Package of
interventions in developing countries,14 and the Sav-
ing Newborn Lives initiative of Save the Children/
USA considers it an essential newborn care prac-
tice.17 Accepted ways to achieve optimal thermal
control of the newborn include warming of the room,
immediate drying and wrapping after birth, imme-
diate and frequent breastfeeding, delay in bathing
until the infant is physiologically stable, close contact
with the mother such as skin-to-skin contact, and
appropriate swaddling and dressing, including the
use of head cover. However, few studies have been
conducted to evaluate feasible strategies for the pre-
vention, recognition and management of hypother-
mia in developing countries. Recent emphasis has
been on the use of skin-to-skin contact or KMC in the
prevention of hypothermia, and this strategy will be
considered separately (see “KMC”). Other potential
interventions (eg, incubators, semipermeable plastic
sheeting) commonly used to reduce transepidermal
water loss (TEWL) and heat loss, particularly in pre-
term infants in developed countries,455 have not been
adequately evaluated in developing-country set-
tings, are largely impractical for community settings,
and will not be considered further here.
community-based evidence. Topical application
of products such as paraffin-based ointments or oils
aimed to modify skin-barrier function and reduce
transepidermal loss of water and heat455,487–490 has
been evaluated in 2 hospital-based studies in devel-
oping countries473,491 (Table 29). In India, topical
therapy of preterm infants with corn oil every 4
hours resulted in a significant reduction (P .001) in
need for an external source of heat to maintain nor-
mal body temperature.491 Another study in Nepal
found that traditional oil massage with mustard oil,
swaddling with a plastic swaddler, or KMC was
equally effective in preventing hypothermia during
the first 24 hours after birth.473
During neonatal transport, a simple Styropor box
showed promise for preventing hypothermia.492,493
Other trials have included elements of hypothermia
prevention in a package of postnatal interven-
tions,438,439,494,495 but the specific impact of the ther-
mal control interventions could not be determined.
conclusions. Despite the critical importance of
maintaining warmth for the newborn, there is a re-
markable paucity of studies evaluating and com-
menting on community-based prevention, recogni-
tion, and/or management of hypothermia. There is a
clear need for additional research on appropriate and
cost-effective strategies for prevention of hypother-
mia in health system settings, including transport
and care of high-risk LBW infants. Approaches such
as training TBAs, CHWs, and caregivers to recognize
and respond appropriately to warning signs of hy-
pothermia, for example, have not been reported. Al-
though heated cots have been scientifically evaluated
in institutional settings,485 these are too expensive for
use in most developing countries.494 The Styropor
box offers an excellent example of simple technology
that could be used as an alternative to transport
incubators in developing countries, but additional
evaluation is warranted to compare it with other
options. Preliminary studies suggest that topical ap-
plications of skin barrier–modifying products may
be beneficial for preservation of body heat.473,491
Nevertheless, most cases of hypothermia likely could
be prevented by a few simple behaviors such as
immediate drying and wrapping of the infant, in-
cluding the head; immediate breastfeeding; delay in
the initiation of bathing; close contact with the moth-
er; and keeping the room warm and the infant
properly clothed and/or wrapped. In addition, KMC
may be a highly cost-effective intervention for pre-
venting hypothermia, especially of LBW infants (see
“KMC”). Nevertheless, even when health workers
possess knowledge of how to prevent hypothermia,
this knowledge may not be translated into prac-
tice.477 Thus, there is a great need to develop and
evaluate the impact of culturally appropriate behav-
ior-change communications to promote these health-
ful domiciliary thermal control practices.
Hypoglycemia Prevention and Management
background. Hypoglycemia after birth is a major
cause of morbidity, particularly among intrauterine
growth-restricted and preterm infants. The risk of
hypoglycemia is significantly greater among preterm
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infants because of their reduced energy and glycogen
reserves and inability to mobilize alternative meta-
bolic fuels.496 Hypoglycemia is also relatively com-
mon among LBW infants and macrosomic infants of
diabetic mothers.497 Prevention and management of
neonatal hypoglycemia have been the subjects of a
major review by Williams.498
Little data on hypoglycemia incidence or impact
on newborn health are available from developing
countries, in part due to difficulties in detection,
which requires proper processing in a well-function-
ing laboratory. Studies in Nepal indicated that 38%
of term infants had hypoglycemic episodes after
birth.499,500
The most cost-effective strategy for preventing hy-
poglycemia is early feeding (continued every 2 to 3
hours on demand day and night) with breast milk,
which is superior to milk formula in that it can
promote relatively greater ketogenesis501 and has a
relatively lower insulinogenic effect.502 The benefits
of breast milk feeding are comparatively more
marked in preterm infants.503 Although nasogastric
feeding may be difficult in primary care settings,
there is evidence that cup and/or spoon feeding in
larger preterm infants may be entirely feasible.504,505
Although the cornerstone of prevention and man-
agement of neonatal hypoglycemia is early co-
lostrum and breast milk feeding, other options may
be needed for circumstances in which breast milk is
not available, insufficient, or contaminated with
HIV.
community-based evidence. We identified 2
studies from India for which alternative strategies
for prevention of hypoglycemia were used506,507
(Table 30). Both studies, conducted in urban hospital
settings, indicated that the addition of granulated
sugar to formula feeds in a sterile fashion was satis-
factory for prevention and treatment of hypoglyce-
mia. The osmolality of the sugar-fortified formula,
however, was significantly higher than standard
feeds. Thus, in the absence of follow-up information
on risk of enteric infections and diarrhea with such
an approach, sugar fortification of formula cannot be
recommended for widespread implementation in
programs.
conclusions. The use of artificial formulas forti-
fied with glucose polymers508 or lipids such as me-
dium-chain triglycerides,509,510 has been shown to be
effective in the prevention and management of hy-
poglycemia in developed-country studies. It is
highly unlikely, however, that these strategies would




Gosavi et al493 India; urban setting;
PCS
32 high-risk newborn infants of varying
disease severity were transported
using the Styropor box.
None developed hypothermia (all
had temperatures 36.5°C
before and after transport). No
other complications occurred
during the transportation.
Daga et al492 India; rural setting;
PCS
1 normal birth weight infant (2.6 kg)
and a LBW infant (1.8 kg) were
sequentially studied using KMC and
then a Styropor box.
The temperature of the 2 infants
was comparable using the 2
methods of care.
Johanson et al473 Nepal; rural setting;
RCT
A prospective observational study of
postnatal neonatal body temperature
was followed by a randomized
controlled intervention study using
KMC, traditional “oil massage” and a
“plastic swaddler.” There were 500
infants in the initial observation
study and 300 in the intervention
study. In the observation study, 85%
(420/495) of infants had temperatures
36°C at 2 h and nearly 50% (198/
405) had temperatures 36°C at 24 h
(14% were 35°C). Most of the
infants who were cold at 24 h had
initially become cold at the time of
delivery (only 7 infants had been
both well-dried and wrapped). In the
intervention study, all infants were
dried and wrapped before random
assignment to 1 of the 3 intervention
methods.
All 3 methods were found to be
equally effective. Overall, 38%
(114/298) and 18% (41/231) of
the infants had a temperature
36°C at 2 and 24 h,
respectively. None were
35°C.





Preterm babies (n  25) between 28
and 36 wk gestational age were
treated with corn oil applied every
4 h to the entire body. An equal
number of preterm infants (n  25)
were matched for weight and
gestational age and served as the
control group.
The study group required the use
of the warmer to maintain
rectal body temperature for
significantly less time (P 
.001) than the controls. Serum
triglyceride levels also rose
significantly (P  .01) in the
study group from baseline to
72 h after initiation of
treatment.
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find favor in developing countries with significantly
higher risk of infection. Although the data on use of
sugar-fortified milk supplements in India are inter-
esting,506,507 these studies did not evaluate the effi-
cacy of this intervention in comparison with co-
lostrum and breast milk feeding, nor would it have
been ethical to do so. These alternative strategies to
breast milk feeding cannot be recommended pres-
ently but merit careful controlled evaluation with
appropriate endpoints and outcomes as possible in-
terventions in settings in which breast milk feeding is
not possible or is inadvisable. Thus, consonant with
the recommendations of the WHO,498 the mainstay
of prevention and treatment of hypoglycemia in de-
veloping countries must clearly remain early and
exclusive breastfeeding and the use of expressed
breast milk in other circumstances.
Breastfeeding
background. Breastfeeding is a foundational
practice for appropriate care and feeding of newborn
infants. A wide variety of benefits of breastfeeding
have been well documented, including reduced risk
of hypothermia, hypoglycemia, necrotizing enteroco-
litis, omphalitis, acute respiratory infections (ARIs),
diarrhea, and septicemia.511 Benefits of breastfeeding
on infant and child health and development have
also been extensively reviewed recently.60,512 Several
studies have effectively demonstrated reduced rates
of morbidity and mortality in early infancy with
exclusive breastfeeding in community settings in de-
veloping countries.513–519 However, there are rela-
tively few studies that have principally evaluated the
impact of breastfeeding on neonatal outcomes. Huff-
man et al511 recently reviewed the evidence in this
regard and concluded that early and exclusive
breastfeeding played an important role in reducing
neonatal mortality, particularly after the first week of
life. There is also additional evidence linking lack of
exclusive breastfeeding with increased risk of early-
onset520 and late-onset neonatal sepsis.521
community-based evidence. Our review identi-
fied several studies that addressed the issue of im-
pact of breastfeeding practices on perinatal and neo-
natal outcomes in developing countries. These
studies were mostly from developing-country hospi-
tal-born cohorts220,505,522–525 (Table 31), although 2
other reports principally provided community-based
data.526,527 These studies consistently showed re-
duced rates of morbidity (eg, diarrhea, pneumonia)
and mortality associated with breastfeeding. The
largest systematic review available on the relation-
ship of breastfeeding to infectious disease outcomes
in developing countries is the WHO multicountry
pooled analysis.528 This study clearly indicated that
those infants 2 months old who were not breastfed
had significantly higher mortality (OR: 5.8; CI: 3.4–
9.8) due to infectious diseases than breastfed infants.
Although a number of barriers to effective breast-
feeding in the neonatal period have been identi-
fied,529–532 including reduced tendency to breastfeed
LBW infants,533 there is ample evidence that cultur-
ally appropriate behavior-change communications
strategies can increase immediate and exclusive
breastfeeding rates59,61,62,531,532,534–536 (Table 32). In
particular, recent data from India convincingly dem-
onstrate the benefit of community strategies for pro-
motion of breastfeeding in terms of reducing diar-
rhea morbidity and preventing growth faltering.537
conclusions. Despite the lack of RCTs evaluating
the impact of breastfeeding on neonatal outcomes,
there is overwhelming evidence in support of a va-
riety of perinatal and neonatal health benefits from
breastfeeding. All newborn infants in developing
countries, especially in domiciliary settings, must re-
ceive colostrum and exclusive breastfeeding, and
intervention programs must place substantial em-
TABLE 30. Hypoglycemia Prevention and Management
Source Location and Type
of Trial
Intervention Perinatal/Neonatal Outcome
Singhal et al507* India; urban hospital
setting; RCT
110 term SGA infants without complications
were enrolled in the study. Infants in the
intervention group (n  55) received
fortified feeds that were prepared by
adding 1 sachet containing 1.5 g of
powdered sugar to 30 mL of standard
milk formula. Infants in the control group
(n  55) received standard milk formula.
There was an 85% decrease in the
incidence of hypoglycemia
among newborn infants in the
intervention group compared
to controls (P  .01). No other
morbidity was reported.
Singhal et al506* India; urban hospital
setting; RCT
130 term large-for-gestational-age infants
without complications were enrolled in
the study. Infants in the intervention
group (n  65) received fortified feeds
that were prepared by adding 1 sachet
containing 1.5 g of powdered sugar to
30 mL of standard milk formula. Infants
in the control group (n  65) received
standard milk formula.
There was a 77% reduction in
rates of hypoglycemia among
intervention group infants
compared to controls. The
incidence of hypoglycemia was
reduced significantly (P  .05)
by the sugar-fortified feeds.
The mean blood sugar level in
babies receiving fortified feeds
was significantly (P  .001)
higher at all ages as compared
to those receiving standard
feeds. No other morbidity was
reported.
* Data are from the same trial.
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Studies from Brazil, The Gambia,
Ghana, Pakistan, The
Philippines and Senegal;




mixed or formula feeding and
providing data on outcomes in
infancy were combined in this
pooled analysis.
Pooled OR for mortality in nonbreastfed
individuals was 5.8 (CI: 3.4–9.8) for
infants 2 mo of age.
Coutsoudis et al724 South Africa; urban hospital
setting; PCS
549 women-infant pairs were
studied; 1 cohort of infants was
never breastfed (n  156), a
second cohort was exclusively
breastfed (n  103), and a third
cohort received mixed feeding
(n  288). Among 549 infants, 3
distinct groups were studied: (1)
those who were exclusively
breastfed, (2) those who were
given mixed feeds, and (3) those
who were never breastfed.
Breastfed and nonbreastfed infants had
comparable rates of HIV infection
(acquired from mothers who were HIV
positive). Exclusive breastfeeding to
3 mo or longer was associated with a
significantly lower risk of infection
(hazard ratio: 0.52; CI: 0.28–0.98,
P  .04). Never having breastfed also
carried a risk of infection similar to
mixed feeding (0.85, CI: 0.51–1.42,
P  0.53).
Kumar et al525 India; urban hospital setting; PCS 50 newborns were enrolled in the
study. group 1 (n  25) was
exclusively breastfed (EBF);
group 2 (n  25) was mixed fed
(MF).
Although birth weights in both groups
were comparable, group 1 infants had
significantly greater weight gain from
the second month of life onwards
(P  .01). EBF infants had 40 sickness
episodes per 100 child-mo as compared
to 69 per 100 child-mo in group 2.
Diarrheal episodes were 20 per 100
child-mo in group 2 as compared to 6
per 100 child-mo in group 1 (P  .01).
Cases of pneumonia, otitis media and
hospitalization were also more common
among MF infants than EBF infants (4 vs
3; 3 vs 1; and 5 vs 2, respectively),
although the sample size was too small
to measure significance.
Augustine et al524 India; hospital setting; RCS Mortality and morbidity statistics
using the records (n  169) of
all the infants (60 preterm and
109 term) admitted during the
first 7 d of life in a rural
pediatrics ward over 1 y were
analyzed.
Exclusive breastfeeding was associated
with the lowest rate of mortality (29%),
compared with infants not yet fed (64%)
or those receiving sugar water or cow’s
milk with or without breastfeeding
(43%).
Singh et al526 India, urban and rural settings;
Cross-sectional survey
Data from a cross-sectional survey
on the relationship between
colostrum and neonatal and
post-neonatal deaths, in which a
cohort of newborn infants
(n  826) were followed up,
was analyzed for mortality
patterns.
In the rural high socioeconomic group, no
neonatal deaths were found among the
subgroup that received colostrum, and
8.2% of neonates died in the subgroup
that did not receive colostrum. As a
general conclusion, 1.7% of urban
neonates and 2.6% of urban postneonates
who received colostrum died, compared
with 6.3% and 7.1%, respectively, who
did not receive colostrum. In rural areas,
comparable neonatal and postneonatal
death rates were 1.7% and 1.7%,
respectively, for infants who received
colostrum, and 7.4% and 3.5%,
respectively, for infants who did not
receive colostrum.
Victora et al523 Brazil; urban hospital setting;
CCS
Cases (n  357) in which young
infants had died of infections
were identified through
coroner’s records. 2 controls
were matched to each case for
age and socioeconomic status
(n  714).
Compared with infants who were
exclusively breastfed, those who were
mixed-fed (given formula or cow’s milk
in addition to breast milk) had 4.2 times
the risk of death from diarrhea (CI:
1.7–10.1), whereas those who were
completely weaned (not receiving any
breast milk) had a risk 14.2 times higher
(CI: 5.9–34.1). Compared with exclusively
breastfed infants, mixed-fed infants and
completely weaned infants had 1.6 times
(CI: 0.7–3.6), and 3.6 times (CI: 1.7–7.5)
the risk of death from respiratory
infections.
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phasis on this component. Several authors have dem-
onstrated that it is possible to improve breastfeeding
practices through culturally appropriate behavior-
change communications. There is a need, however,
for enhanced understanding of barriers to early, ex-
clusive breastfeeding in many settings, leading to
effective development and implementation of breast-
feeding promotion programs.
Prevention and Treatment of Ophthalmia Neonatorum
background. Ophthalmia neonatorum is caused
primarily by Neisseria gonorrhea or Chlamydia tracho-
matis. The prevalence of ophthalmia neonatorum in
developing countries is uncertain. Before the intro-
duction of preventive therapy, this condition was
recognized to affect between 1% and 15% of new-
born infants in Europe and 9% of newborn infants
in the United States.538 Transmission rates from
mothers with gonococcal cervicitis to their offspring
range from 30% to 50% in the absence of prophylactic
ocular treatment,14 whereas transmission ranges
from 18% to 61% for chlamydia.539 In developing
countries such as Kenya, where rates of maternal
STDs are high, rates of gonococcal ophthalmia range
from 15% to 34%.540,541
A variety of interventions have been evaluated for
prevention of ophthalmia neonatorum in developed
countries, mostly in hospital settings, and have
largely focused on the prevention of gonococcal in-
fections.542–545 These studies have suggested that sil-
ver-nitrate, tetracycline, or erythromycin ointments
given prophylactically are equivalent in effica-
cy.546,547 The WHO recommends 1% silver-nitrate
solution, 1% tetracycline ointment, or 2.5% povi-
done-iodine within 1 hour of delivery.14,16,548 The
American Academy of Pediatrics also considers
0.5% erythromycin ointment as standard therapy, in
addition to silver nitrate or tetracycline.549 In the
presence of proper prophylactic treatment, gonococ-
cal ophthalmia develops infrequently. However, sil-
ver nitrate is not effective if used after infection has
been established, which may help to explain the
higher risk of gonococcal eye infections observed in
association with PROM. For infants born to mothers





Habicht et al527 Malaysia; urban and rural
settings; RCS
Sample consisted of 5357 births
between 1940 and 1975, with
an average IMR of 47.8 infant
deaths per 1000 live births.
Sample was restricted to
babies who could have lived
until the end of the at-risk
period. 83% of infants were
fully breastfed.
The effects of breastfeeding on infant
mortality were reported for 3 sub-
periods of infancy: 8–28 d, 29 d-6 mo,
and 7–12 mo. Reductions in deaths per
1000 infants per added month of full
breastfeeding were 68.6 (CI: 41.1–96.1),
24.9 (CI: 13.4–36.4), and 3.4 (CI: 1.6–5.2)
for the periods 8–28 d, 29 d-6 mo, and
7–12 mo, respectively. Reductions in
deaths per 1000 infants per added
month of partial breastfeeding were
21.9 (CI: –7.9–51.7), 11.2 (CI: 0.2–22.2),
and 1.7 (CI: 0.4–3.0) for the 3 time
periods, respectively.
Narayanan et al505 India; urban hospital setting;
RCT
A total of 226 LBW infants were
randomly assigned to 1 of 4
intervention groups. Group 1
(n  57) was fed raw
expressed human milk only;
group 2 (n  56) was fed
human milk subjected to
holder pasteurization. Group 3
(n  56) was fed raw milk
from 9 am until 9 pm (5 feeds)
and formula for 3 feeds at
night. Group 4 (n  57) was
fed pasteurized human milk
from 9 am until 9 pm and
formula for the remaining 3
feeds.
There was a 68% reduction in neonatal
infection rates in group 1 (10.5%)
compared to group 4 (33%); however,
sample size was too small for statistical
significance.
Clavano522 Philippines; urban hospital
setting; PCS
9886 newborn infants were
followed up to assess the
relationship of neonatal
mortality and diarrhea to
feeding patterns.
Of the 138 infants with diarrhea, 90%
were formula fed, 6% were partially
breastfed, and 4% were exclusively
breastfed. Mode of infant feeding was
also significantly related to mortality.
Of the 67 infants who died, 96% were
formula fed, 1% was partially
breastfed, and 3% were exclusively
breastfed. After rooming-in and formal
breastfeeding policies were introduced,
the proportion of infants exclusively
breastfeeding increased by 135%, and
the incidence of death among clinically
infected newborns dropped by 95.3%.
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TABLE 32. Breastfeeding Promotion and Education
Source Location and
Type of Trial






1226 pregnant women who gave birth
to 1250 children were randomized to
1 of 2 groups. Mothers in the
intervention group (n  659) were
given individual health education
sessions at the local health center on
their routine visits (ie, first antenatal
visit, vaccination sessions in weeks 6,
10 and 14, and when the child
reached the age of 9 mo). Mothers in
the control group (n  591) were not
exposed to these messages.
Intervention messages encouraged
breastfeeding for 2 y, avoidance of
introducing weaning foods and
water for 4–5 mo, and continued
breastfeeding for ill children. Family-
planning information was also
included.
Significantly more mothers in
the intervention group had
had an intrauterine device
inserted (rate ratio  2.45
(CI: 1.27–4.70) compared
with the control group.
However, mothers who had
an intrauterine device
inserted did not breastfeed
longer compared with
mothers who reported not
to have had an intrauterine
device inserted.
Introduction of weaning foods was
significantly delayed in the
intervention group compared
with the control group (incidence
rate 1.22; CI: 1.05–1.42). More
children in the intervention group
(31.1%) compared to controls
(24.8%) were almost exclusively







130 pregnant women were randomized
to 1 of 3 groups. Group 1 (n  44)
received 6 visits by a peer counselor.
Group 2 (n  52) received 3 visits by
a peer counselor. Group 3 (n  34)
was the control group; women in
this group were referred to a
physician for lactation problems.
There were significantly more
females who were ex-
clusively breastfeeding their
infants in the intervention
groups than the control
group. Duration of any
breastfeeding (3 mo or
6 mo) was significantly
greater in the intervention
group than the control
groups (P  .024).
Control infants had a significantly
higher risk of diarrhea than those
in the intervention groups (OR:






442 women were enrolled in the study;
236 women delivered at the program
hospital and 206 delivered at the
control hospital. The intervention
hospital had an active breastfeeding
promotion program, characterized by
rooming-in, early initiation of
breastfeeding and breastfeeding
assistance and talks during
hospitalization. The control hospital
had no such programs.
The median duration of exclusive
breastfeeding was 75 d among
women in the program hospital
compared with 22 d in the control
hospital. At 1 mo, the probability
of exclusive breastfeeding was
0.64 in the program group











Study area covered 30 000 households;
a random sample of households with
infants ages 0–6 mo (n  1100) were
selected. Mothers were interviewed
at home. The WHO classification was
used to describe infant feeding
practices.
93% of mothers fed their infants
colostrum during the first 3 d of
life. However, only 8% fed
colostrum as the first food. 97%
claimed they had heard the term
“exclusive breastfeeding” and
understood it but 70% wrongly
perceived it to mean giving the
baby breast milk and water. 33%
and 5% of infants in their first








40 adjacent zones were randomized to
control or intervention groups.
Women were enrolled during the last
trimester of pregnancy. 15 house-
based counseling visits were
scheduled, with 2 visits in the last
trimester, 3 during the early
postnatal period (1 within 48 h, 1 on
day 5, and 1 between days 10 and
14), and every 2 wk until the infant
was 5 mo old. Peer counselors were
local mothers who received 10 d of
training.
363 women were enrolled in each
group. Peer counseling
significantly improved
breastfeeding practices. For the
primary outcome, the prevalence
of exclusive breastfeeding at 5 mo
was 202/228 (70%) for the
intervention group and 17/285
(6%) for the control group (mean
difference: 64%; CI: 57–71%; P 
.0001). For the secondary
outcomes, mothers in the
intervention group initiated
breastfeeding earlier than control
mothers and were less likely to
give prelacteal and postlacteal
foods.
* Data are from the same trial.
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ceftriaxone is recommended as first-line therapy by
the WHO548 and the American Academy of Pediat-
rics,549 although penicillin G can be considered if
resistant strains are unlikely. Silver nitrate has been
shown to be equivalent to tetracycline or erythromy-
cin ointments for prevention of chlamydia conjunc-
tivitis.539,545 Thus, systemic treatment with erythro-
mycin is also needed to prevent progression to
chlamydial pneumonia.
community-based evidence. Our search identi-
fied 2 studies from developing countries (see Table
33) on prevention and treatment of ophthalmia neo-
natorum. Both were undertaken in urban hospital
settings.541,550 In 1 study, povidone-iodine was supe-
rior to silver-nitrate drops and to costlier erythromy-
cin ointment.550 In another study, tetracycline oint-
ment was superior to silver-nitrate drops.541
conclusions. Evidence for the benefit of prophy-
laxis with silver-nitrate drops, tetracycline ointment,
or erythromycin ointment to prevent ophthalmia
neonatorum is well established, based largely on
developed-country studies. Scarce data from devel-
oping countries suggest that povidone-iodine is also
effective, and this agent is recognized by the Amer-
ican Academy of Pediatrics as a first-line prophylac-
tic therapy. Thus, choice of agent may be less im-
portant than wide-scale implementation of this
intervention, which must form part of primary neo-
natal management packages, particularly in areas
endemic for sexually transmitted diseases (STDs)
due to gonorrhea. In areas with low rates of gono-
coccal infections in pregnancy, the benefits of routine
prophylaxis relative to other newborn interventions
may be questionable. Although local gonococcal re-
sistance rates should be considered, local availability,
acceptability, and cost of the various agents gener-
ally will be primary determinants in choice of agent.
Overall, the evidence in support of prophylaxis for
chlamydial infections is less clear.
Vitamin K Prophylaxis
background. Vitamin K prophylaxis in neonates
for prevention of IVH is well established. Two
Cochrane reviews have addressed the role of vitamin
K prophylaxis in neonatal health. Puckett and Of-
fringa,551 in a Cochrane review of prophylactic vita-
min K for prevention of IVH, also concluded that a
single dose (1.0 mg) of intramuscular (IM) vitamin K
after birth is effective in the prevention of classic
hemorrhagic disease of the newborn (HDN), and IM
or oral (1.0 mg) vitamin K prophylaxis improves
biochemical indices of coagulation status at 1 to 7
days. However, neither IM nor oral vitamin K has
been tested in randomized trials with respect to the
effect on late HDN, and oral vitamin K, in either
single or multiple doses, has not been tested in ran-
domized trials for its effect on either classic or late
HDN. Crowther and Henderson-Smart,552 in a
Cochrane review of vitamin K administration to
pregnant women before preterm delivery, concluded
that antenatal vitamin K was associated with a non-
significant trend toward reducing all grades of
periventricular hemorrhage (RR: 0.82; 95% CI: 0.67–
1.00), particularly severe (grades 3–4) disease (RR:
0.75; CI: 0.45–1.25). This trend disappeared when
poorer-quality trials were excluded. It was con-
cluded that vitamin K administered to women before
very preterm birth has not been shown to signifi-
cantly prevent periventricular hemorrhage.
Although well established in developed countries,
the incidence and implications of vitamin K defi-




Isenberg et al550 Kenya; urban
setting; RCT
3117 newborns were enrolled and
randomized to 1 of 3 groups to
receive 2.5% povidone-iodine
solution (n  1076), 0.5%
erythromycin ophthalmic
ointment, (n  1112), or a drop
of 1% silver-nitrate ophthalmic
solution (n  929).
13% of the infants in the povidone-iodine
group, vs 17.5% of the infants in the
silver-nitrate group (P  .001), and
15.2% of the infants in the erythro-
mycin group (P  .01) had infectious
conjunctivitis. Povidone-iodine was
more effective against Chlamydia
trachomatis than was silver nitrate
(P  .001) or erythromycin (P  .008).
Noninfectious conjunctivitis was less
frequent among povidone-iodine-
treated infants (9.7%) than those
treated with silver-nitrate (13.9%,
P  .001) or erythromycin group
(13.3%, P  .004). Incidence of N
gonorrhoeae and Staphylococcus aureus
infections was similar in the 3 groups.
Laga et al541 Kenya; urban
setting; QT
2732 infants were enrolled in 1 of
2 groups to have either 1%
silver nitrate (n  1233) or 1%
tetracycline (n  1499) instilled
in their eyes. A historical
cohort of newborns who did
not receive eye prophylaxis
were included as controls.
Infection rates of gonococcal ophthalmia
neonatorum in newborns exposed to N
gonorrhoeae at birth were 7.0% in those
receiving silver nitrate and 3.0% in
those receiving tetracycline
(CI: 3.4 to 11.4%). As compared with
historical controls, the incidence of
gonococcal ophthalmia neonatorum
decreased 83% and 93% among infants
treated with silver nitrate and those
treated with tetracycline, respectively.
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ciency in developing countries has received little
attention. In a national hospital-based survey in
Thailand, the incidence of vitamin K deficiency was
found to be 35 cases per 100 000 births.553 In contrast,
a community hospital–based study in rural Thailand
found the incidence to be as high as 72 cases per
100 000 births.554 There are very few community-
based data on vitamin K deficiency or HDN from
either Africa or south Asia.
community-based evidence. Our review could
not identify any community-based vitamin K inter-
vention trials.
conclusions. Vitamin K prophylaxis is a well-
established intervention for prevention of IVH and
early HDN in newborns in developed countries. The
preferred route is IM administration, whereas the
efficacy of the oral route needs additional investiga-
tion. There is no definitive evidence that administer-
ing prenatal vitamin K to pregnant women entering
preterm labor can prevent IVH in the neonate, but
this intervention warrants additional investigation.
Moreover, studies are needed in developing-country
community settings to identify cost-effective meth-
ods of implementing vitamin K interventions.555
Hepatitis B Vaccination
background. Disease due to hepatitis B virus
(HBV) infection is one of the most prevalent public
health problems worldwide. An estimated 350 mil-
lion people are HBV carriers, and 1 million deaths
each year are attributed to the virus.556,557 The hep-
atitis B surface antigen (HBsAg) carrier rate in the
general population in Taiwan was reported to be
15% to 20%,558 whereas the prevalence of HBsAg
positivity in Bangladesh was highest in 5- to 9-year-
olds (8.5%), and simultaneous infection with hepati-
tis D virus was common (24.4%), particularly in older
age groups.559 Dusheiko et al560 reported a hepatitis
B carrier rate of 5.5% to 14% in the southern African
population.
Hepatitis B immunization prevents chronic HBV
carrier states and, subsequently, chronic liver disease
in adulthood. However, Wong et al561 found that the
incidence of preterm birth, PPROM, SGA births, neo-
natal jaundice, fetal distress, perinatal asphyxia, con-
genital abnormalities, gastrointestinal tract abnor-
malities, and perinatal mortality were similar among
pregnant women with and without serologic HBsAg
positivity. Thus, the benefits of hepatitis B vaccina-
tion are long-term and most evident well after the
neonatal period.
community-based evidence. Seven studies were
identified that discussed programs implementing
hepatitis B vaccination in developing-country com-
munities; the 2 main studies were conducted in Tai-
wan and The Gambia558,562–567 (Table 34). In general,
incorporation of hepatitis B immunization into the
EPI program of various countries was highly suc-
cessful and effective. Hepatitis B vaccination pro-
grams were not only effective in preventing perinatal
and early horizontal transmission of HBV but also
resulted in decreasing mortality due to fulminant
hepatitis and reduced development of childhood
hepatocellular carcinoma. One study in South Afri-
ca,568 however, determined that the intervention was
not effective. Some reasons for the lack of effective-
ness were given, and the authors proposed that the
problems they identified were likely to be faced by
other programs in developing nations. Importantly,
they found that program participants had difficulty
in complying with WHO recommendations that the
first dose of hepatitis B vaccine be given as soon as
possible after birth. Administering all 3 doses within
reasonable limits of the recommended vaccine
schedule is often difficult in rural areas, where dis-
tances to clinics are great and mobile outreach clinics
are impeded by poor road conditions. Moreover, the
birth dose may be particularly difficult given various
proscriptions against seeking care for newborns out-
side the home in the formal health sector, particu-
larly for early postnatal care.439,569–571 Providing ap-
propriate training to village health workers (VHWs)
in The Gambia to deliver heat-stable vaccines in a
Uniject device, however, was shown to be a cost-
effective and reliable method for hepatitis B vaccina-
tion in rural settings.572 This alternative means of
delivering the intervention may facilitate resolution
of the above-mentioned problems with traditional
hepatitis B vaccination and may be an effective way
to improve coverage and seroconversion rates.
conclusions. Hepatitis B vaccine is administered
universally at birth in developed countries. Consid-
ering the high risk of hepatitis B infection in many
developing countries and the efficacy of the hepatitis
B vaccine, policies regarding routine immunization
need to be developed and implemented urgently in
developing countries endemic for HBV infection. It is
important to recognize, however, that evaluating the
success of integrating hepatitis B vaccination into the
EPI is more complex than for many other diseases.
Because many infected children do not have any
recognizable signs of illness, serologic surveys,
rather than disease surveillance, will be needed to
monitor the success of immunization programs. The
appropriate field methodology for such surveys
must be developed and standardized. The true ben-
efit of such programs also requires measurement of
the reduction in long-term sequelae of infection.
The total financial burden derived from both the
direct and indirect costs of HBV detection and
vaccination must be weighed critically in light of
multiple health problems and competing agendas in
resource-poor countries. However, support from do-
nor agencies such as the Bill & Melinda Gates Foun-
dation and the Children’s Vaccine Program, which
has initiated aid for hepatitis B vaccination in a num-
ber of countries, could help to make immunization
against HBV, a proven intervention for benefit later
in life, a reality.
Neonatal Vitamin A Supplementation
background. The significant public health bene-
fits of vitamin A supplementation on child mortality
in developing countries210 are well established.
There is much interest in the potential benefit of
neonatal vitamin A supplementation on neonatal
and infant outcomes, given the widespread subclin-
ical vitamin A deficiency that exists among pregnant
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In July 1984, a nationwide vaccination program
was started. Preparatory work was done 1 y
before the program started. It included
education of doctors, allied health workers and
public laboratory facilities in testing HBsAg
and hepatitis B virus “e” antigen (HBeAg). A
confidential registration data bank was formed.
Infants born to HBsAg-positive mothers were
given the vaccine at ages 1, 5, and 9 wk and
then a booster at 12 mo. Infants born to mother
testing positive for both antigens received a
hepatitis B immunoglobulin within 24 hours
along with the vaccines.
87% of the children received at least 3 doses
of vaccine. The overall prevalence rate of
HBsAg decreased from 9.8% in 1984 to
1.3% in 1994 in children 10 y of age. A
statistically significant decrease was
observed in every age group between 1 and
10 y. The overall prevalence rate of HBeAg
was 26% in 1984, 15% in 1989 and 4% in
1994. The average annual incidence of
hepatocellular carcinoma in Taiwanese
children aged 6–14 y declined from 0.7 per
100 000 children in 1981–1986 to 0.36 per
100 000 in 1990–1994. The average mortality
associated with fulminant hepatitis in
infants from 1975–1984 was 5.36/100 000
infants (range: 2.9–6.7), which decreased to
1.71/100 000 (range: 0.3–4.6) for the period
1985–1998. Thus, the mortality rate














Children (n  60 000) were divided into 2
groups. 1 group received routine EPI
vaccination, and the other received routine EPI
vaccination plus the hepatitis B vaccine. This
continued from 1986–1990, after which all
children were given hepatitis B vaccine and it
became a part of the standard EPI. The first
dose was given at the same time as BCG
vaccine (ie, during the first month of life). The
second dose was given along with a first dose
of triple antigen at 2 mo of age or later. The
third dose was given with the third dose of
triple antigen at 4 mo of age or later. A
minimum interval between doses was fixed at
4 wk. A cohort of 1000 children was followed
long-term to measure immunogenicity.
The coverage survey showed that 98% of
children aged 12–18 mo had received the
first dose, 94% had received the second
dose and 74% had received the third. In
94% of children, immunization produced
protective levels of antibodies at 1 y of age.
As a result of the vaccination program,
protection against infection was 80% and






Immunization and preprimary health care
services were commenced for children (n 
327) in a rural community in Nigeria. Hepatitis
B vaccine was administered at birth and then
in a single injection with diphtheria-tetanus-
pertussis vaccine at 6 wk of age and another at
3 mo of age.
2 y after the program was started, the
immunization coverage rates were 94% for
BCG, 88% for diphtheria-tetanus-pertussis
vaccine (third dose) and 82% for measles.




Healthy Start Program in Indonesia involved a
visit by the village midwife between 1 and 7 d
after birth to provide Hepatitis B vaccination
and maternal care/education.
Hepatitis B vaccination rate increased from
0% in 1990 to 84% in 1996. IMR decreased
from 73/1000 to 55/1000 live births, due to






Hepatitis B vaccination has been an integral part
of the EPI since 1992. In each of 5
representative provinces, 400–488 healthy
immunocompetent infants ranging from 6 to
18 mo of age were evaluated by examining
their sera for viral hepatitis markers.
The coverage rate of hepatitis B vaccine was
71.2% to 94.3%. The number of individuals
undergoing complete course of hepatitis B
vaccination increased fourfold. Only 0.7%
of children born after the implementation





During the study, village midwives (n  110)
used Uniject devices, rather than the standard
disposable or reusable syringes. The midwives
were provided with these devices in an
outreach carrier box. After they picked up
these boxes the midwives were allowed to
keep them under ambient conditions (27°C
average, range of 2532°C) for 1 mo. Nurses
administered 10 000 sterile injections in home-
based settings during the trial.
Potency test of the Uniject compared to the
standard injection after 1 month showed
that the TT vaccine had lost 6% of its
potency, while the hepatitis B vaccine had
suffered a 1% drop in potency.
Seroconversion rates were identical in
children immunized using the Uniject vs
the standard vaccine method. Total cost per
child immunized using the Uniject device
was US $6.57 vs US $7.19 using a standard






All infants born in 1989 in a self-governing
region of the Transvaal were immunized
according to 2 schedules: (1) early schedule 
birth, 3 mo and 6 mo and (2) late schedule  3
mo, 4.5 mo and 6 mo. Those who were not
given vaccine according to any 1 of these
schedules were classified as unscheduled.
Only 6.6% of vaccine recipients were
vaccinated according to the schedules,
whereas 93.4% were given vaccines in an
unscheduled manner. There was no
difference in seroconversion to the surface
antigen between the 2 groups.
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women and lactating mothers in many developing-
country settings, the demonstrated positive impact
of antenatal vitamin A supplementation on maternal
mortality218 (see “Antenatal Vitamin A Supplemen-
tation”), and the demonstrated benefits of vitamin A
supplementation during infancy and childhood.94
Vitamin A supplementation has been investigated
in selected subsets of newborns in developed coun-
tries, such as in VLBW infants, to prevent chronic
lung disease.573–575 However, the benefit and cost-
effectiveness of such interventions in developing-
country settings, in which survival rates of VLBW
infants are low, remain unclear; few VLBW infants
survive to develop chronic lung disease.419
community-based evidence. We identified 3
studies that evaluated the impact of vitamin A sup-
plementation during the neonatal period on neonatal
and/or infant outcomes in developing countries in
both rural and urban settings (Table 35). No study
showed a reduction in mortality during the neonatal
period,576,577 and the 3 studies showed a mixed im-
pact on infant mortality.576–578 Results are forthcom-
ing from an additional large-scale trial of neonatal
vitamin A supplementation in Zimbabwe.
conclusions. Neonatal supplementation with vi-
tamin A holds some promise for reducing mortality
during or shortly after the neonatal period, and there
is some evidence of reduced mortality during infan-
cy.576 These results, coupled with emerging evidence
that antenatal vitamin A supplementation may re-
duce maternal mortality,218 indicate the need for ad-
ditional research in this area. A critical factor may be
the timing of vitamin A supplementation, with po-
tentially increased impact with early administra-
tion.577 The role of supplementation in populations
with relatively high rates of HIV infection also re-
quires investigation.
KMC
background. KMC refers to the technique of po-
sitioning and skin-to-skin care of LBW infants after
birth and was pioneered by Rey579 from Colombia.
After initial skepticism,580 the technique has now
found widespread acceptance and has been used
extensively in both developed and developing coun-
tries. Despite numerous intervention studies evalu-
ating the technique, however, very few have used
rigorous (eg, RCT) designs. A recent Cochrane re-
view of KMC581 identified 3 studies that met criteria
for inclusion in their analysis, but the analysis was
based largely on just 1 RCT.582 The review found that
neonates who were given KMC versus standard care
had lower risk of nosocomial infection (OR: 0.49; CI:
0.25–0.93), severe illness (OR: 0.3; CI: 0.14–0.67), and
lower respiratory tract disease (OR: 0.37; CI: 0.15–
0.89) at 6-month follow-up. In addition, the propor-
tion of infants who were not exclusively breastfeed-
ing at discharge was reduced (OR: 0.41; CI: 0.25–
0.68), as was the rate of maternal dissatisfaction with
method of care (OR: 0.41; CI: 0.22–0.75). Infants
given KMC also had gained more weight per day by
discharge (weighted mean difference: 3.6 g per day;
CI: 0.8–6.4). Despite these interesting data, because
the results were largely based on a solitary RCT, it
was concluded that there were insufficient data to
recommend its routine use in LBW infants.
Since the Cochrane review noted above, Charpak
et al583 reported another RCT of KMC impact in a
hospital setting. The intervention consisted of con-
tinuous skin-to-skin contact and nearly exclusive
breastfeeding, and infants were followed until 12
months’ corrected age. Risk of death tended to be
lower in the infants given KMC (OR: 0.57; CI: 0.17–
1.18) but was not significantly lower than the control
infants given routine incubator care. Infection rates









2067 newborn infants were allocated
to receive 1 oral dose of 52 mol
vitamin A plus 23 mol vitamin E
(n  1034) or placebo (0.1 mol
vitamin A plus 23 mol vitamin
E) (n  1033), on the first day of
life.
Supplementation had no effect on NMR.
The probability of survival during the
first year of life, however, was greater
in the vitamin A-supplemented than
the control infants (OR: 0.36; CI: 0.16–
0.87).
West et al578 Nepal, rural
setting;
DBRPCT
Newborns (n  11 918) were
randomized to either an inter-
vention group (n  6086) or a
placebo group (n  5832).
Newborns in the intervention
group received a single oral dose
of vitamin A (15 000 retinol
equivalent [RE] [3 drops of oil]);
newborns in the placebo group
received 75 RE (250 IU).
The cumulative OR of death after 4 mo
of the supplementation trial suggested
a modest protective effect for vitamin
A (OR: 0.9) but this pattern then
changed in the second year and the
OR returned to 1.11 (CI: 0.86–1.42)
after 24 mo; no impact overall on





Infants (n  11 619) were randomly
assigned to receive either 24 000
IU of vitamin A twice within a
24-h interval beginning within
48 h of birth, or to receive a
placebo.
Infants in the vitamin A group had a
22% reduction in total mortality (CI:
4–37%) compared with those in the
placebo group. Vitamin A had an
impact on mortality between 2 wk and
3 mo after treatment, with no
additional impact after 3 mo.
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were similar, although severity was judged to be
higher in the control infants, and there was no dif-
ference in disability rates. Total days in the hospital
were decreased in infants who weighed 1500 g at
birth and received KMC.
An earlier 2-cohort study by Charpak et al584 re-
ported a higher RR of mortality in infants given
KMC (RR: 1.9; CI: 0.6–5.8), although this risk re-
versed after adjusting for weight at birth and gesta-
tional age (RR: 0.5; CI: 0.2–1.2). Infants given KMC
grew less in the first 3 months and had a higher
proportion of developmental delay at 1 year. No
significant differences were found in overall mortal-
ity rates between the 2 groups. The cohorts in the
study, recruited from 2 different tertiary hospitals,
showed many social and economic differences.
A nonrandomized, controlled study conducted in
a remote Zimbabwe mission hospital without incu-
bator care reported that survival of infants born
weighing 1500 g improved from 10% to 50%,
whereas that of infants 1500 to 1999 g improved from
70% to 90%.585 Similar results were shown by an-
other nonrandomized study from a secondary hos-
pital in Mozambique. Of 32 infants weighing 1800
g, survival was 73% in 22 infants given KMC and
20% in 10 infants not given KMC (P .01). It also has
been suggested that infants given KMC discharged
during the cold season may be more vulnerable to
severe illness, especially lower respiratory tract in-
fections, than those discharged during the warm sea-
son.586 Another study on a small number of newborn
infants with mild respiratory distress suggested that
early introduction of KMC might have beneficial
effects.587
Ramanathan et al588 reported from their RCT in
Delhi, India, that KMC neonates demonstrated better
weight gain after the first week of life (15.9  4.5 vs
10.6 4.5 g/day in KMC and control groups, respec-
tively; P  .05) and earlier hospital discharge (27.2 
7 vs 34.6  7 days in KMC and control groups,
respectively; P  .05). The number of mothers exclu-
sively breastfeeding at 6-week follow-up in the KMC
group was double that of the control group (12 of 14
[86%] vs 6 of 14 [43%]; P  .05).
community-based evidence. There are no data
on the impact of KMC from community-based set-
tings in developing countries. All studies reported
from developing countries were conducted among
medically stable LBW infants (typically 2000 g) in
urban hospital settings (Table 36).
Two reports describe adaptation of the technique
for use in the community.589 In a pilot study in
Bangladesh, CHWs were trained in community-
based application of KMC (CKMC) and subse-
quently taught expectant and new mothers how to
give KMC. Women were interviewed 1 month post-
partum to evaluate their experience with CKMC. In
all, 77% of mothers initiated skin-to-skin care, and
85% with LBW infants did so (37% were LBW).
CKMC was adopted quickly and popularly in this
community. Similarly, in Uttar Pradesh, India, pro-
motion of CKMC through a community mobilization
and behavior change communication program re-
sulted in adoption of skin-to-skin care of newborns
by 70% of families.590
conclusions. Studies to date have suggested that
KMC had a variety of beneficial effects on the health
of LBW infants, including increased weight gain and
exclusive breastfeeding rates and lower risk of nos-
ocomial infection and severe illness. The literature
also suggests that KMC promotes mother-infant
bonding, improves newborn thermal control, short-
ens duration of hospital stay, results in earlier stabi-
lization of physiologic and behavioral functioning,
and may improve survival. This last claim is un-
proven and may be unrealistic, given that studies
have all included medically stable infants.
Limited experience with adaptation of skin-to-skin
care for use in the community in developing coun-
tries has been encouraging. There is an urgent need,
however, to adapt the approach for various cultural
settings and to further evaluate its acceptability,
safety, and efficacy in developing-country commu-
nity settings.26,591 We feel that KMC must be viewed
in its wider application to include even culturally
appropriate variants such as co-bedding with the
mother and skin-to-skin practice by caregivers other
than the mother herself, particularly the father, be-
cause fathers, too, can provide effective thermal con-
trol in newborn infants to reduce the risk of hypo-
thermia.592 Given the paucity of resources and risk of
hypothermia in domiciliary settings in developing
countries, this intervention (or mode of newborn
care) may be suitable for essential care of all new-
borns in the community as well as for high-risk
situations such as the care of preterm, VLBW infants,
and transport of sick newborns.
Topical Emollient Therapy
background. The skin barrier of preterm infants
is compromised for a variety of reasons including
developmental immaturity455 and lack of vernix,
which is produced near term during gestation and
serves as a naturally protective cutaneous biofilm.593
In addition, the skin barrier of preterm infants is
easily injured,594 and particularly in developing-
country situations, the skin barrier of even term in-
fants may be compromised as a result of intrauterine
malnutrition.595 Thus, the skin may serve as an im-
portant portal of entry for serious bacterial infec-
tions.596 However, evidence from laboratory studies
in animals and clinical trials in humans suggests that
it may be possible to enhance skin-barrier function
through application of topical emollients or oils,
thereby improving health outcomes.
In experimental conditions, compromised epider-
mal barrier function and dermatitis in essential fatty
acid (EFA)-deficient rodents was reversed by topical
application of either purified EFAs or EFA-rich veg-
etable oils, particularly sunflower-seed oil.597,598 Cu-
taneous absorption and metabolism of linoleic acid
seemed largely responsible for the beneficial effects
of sunflower-seed oil.490,598–600 Topical therapy with
sunflower-seed oil has also been found to correct
cutaneous signs of EFA deficiency (ie, normalization
of TEWL, resolution of dermatitis) in humans, in-
cluding premature infants.598,601,602 It has been ad-
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vanced that these beneficial effects may be due to
increased metabolism of lipids in the epidermis, in-
cluding active fatty-acid transport by keratinocytes,
which makes it possible for even the immature epi-
dermis of preterm infants to metabolize lipids de-
rived from topically applied emollients and to utilize
them as nutritional building blocks for the formation













149 LBW neonates were
randomly assigned to KMC
(almost exclusive skin-to-skin
care after stabilization), and
136 LBW neonates to con-
ventional methods of care
(warm room or incubator
care).
Overall scores on mother’s sense
of competence were better in
the KMC than in the control
group (weighted mean
difference: 0.31; CI: 0.13–0.50)
On the other hand, overall
scores on mother’s perception
of social support during the
infant’s stay in the NICU were
worse in the KMC group than
in the control group (weighted
mean difference 0.18; CI:
0.35 to 0.01).
Lower rates of not exclusively
breastfeeding were recorded at






In an urban tertiary hospital,
746 newborns were ran-
domized to receive either
KMC (n  382) or traditional
care (n  364).
Significantly lower rates of nosocomial
infection (OR: 0.49; CI: 0.25–0.93) and
severe illness at 6 mo follow-up were
found in the KMC group. The risk of
dying was similar in both groups
(RR  0.59; CI: .22–1.6), and no
differences were found in growth
indices. Hospital stay after eligibility
was shorter in the KMC group,






300 newborns were randomized
to KMC (n  140) or
incubator/thermal cot care
(n  160).
Trial was stopped early because of a
significantly lower rate of severe
morbidity in the KMC group






A group of 746 newborns were
randomized when eligible for
minimum care, into KMC (n
 382) and “traditional” care
(n  364). Information on
vital status was available for
93% of infants at 12 mo of
corrected age. KMC consisted
of skin-to-skin contact on
mother’s chest 24 h/d, nearly
exclusive breastfeeding, and
early discharge, with close
ambulatory monitoring.
Controls remained in
incubators until the usual
discharge criteria were met.
There was a “trend” toward lower risk
of death among the KMC group,
although the result was not
significant (KMC: 11 [3.1%] of 339
infants died; control: 19 [5.5%] of 324
infants died; RR: 0.57; CI: 0.17–1.1).
Growth index of head circumference
was significantly greater in the KMC
group, but the developmental indices
of both groups were similar. Infants
weighing 1500 g at birth and given
KMC spent less time in the hospital
then the group given standard care.
There were similar numbers of
infections in both groups, but








28 neonates with birth weights
1500 g were randomized
into 2 groups, 1 receiving
KMC and 1 receiving
incubator care. The KMC
group (n  14) received KMC
for 4 h per day in not more
than 3 sittings. Infants
received KMC after shifting
from NICU and at home.
Control infants received
standard care. A Likert scale
was used to assess mothers’/
nurses’ attitudes towards
KMC.
The number of mothers exclu-
sively breastfeeding at 6-wk
follow-up was double in the
KMC as compared to the
control group (12/14 [86%] vs
6/14 [43%], respectively;
P  .05).
KMC neonates demonstrated better
weight gain after the first week of life
(15.9 4.5 g/d vs 10.6 4.5 g/d in
the KMC and control groups,
respectively; P  .05) and earlier
hospital discharge (27.2 7 vs
34.6 7 d in KMC and control






74 infants (37 in each of 2
groups) were consecutively
allocated to receive either
KMC or incubator care.
KMC infants gained twice as much
weight per day (20.8 vs 10.2 g;
P  .0001); had shorter stays in the
hospital (16.6 vs 20.7 d; P  .0457);
and had a better survival rate (0% vs
9% deaths; sample size too small for
significance).
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Darmstadt et al490 used a hairless-mouse model to
demonstrate that the impact of topical therapy varies
markedly with the product applied. A single appli-
cation of sunflower-seed oil significantly improved
skin-barrier function within 1 hour, and the effect
was sustained 5 hours after application. In contrast,
other vegetable oils tested (mustard, olive, and soy-
bean oils) significantly worsened skin-barrier func-
tion (ie, increased TEWL) 1 and 5 hours after appli-
cation and delayed recovery of a compromised skin
barrier compared with control- or Aquaphor-treated
skin. Moreover, a single application of mustard oil
resulted in a variety of adverse ultrastructural
changes in the epidermis under transmission elec-
tron microscopy, suggestive of toxicity.490,605 Thus,










2 cohorts of LBW (2000 g) infants
(n  246) were enrolled. The first
cohort (n  149) was selected
during the cold season and a
second cohort (n  122) was
enrolled in the hot season. The
intervention encouraged KMC at
home. In 64%, routine follow-up
exams after discharge were
performed until infants reached a
weight of 2500 g.
No seasonal differences in weight gain
or the risk of complications were
found in infants treated with KMC
in the hospital. Risk of serious
complications, including death (RR:
1.96; P  .02) and readmission (RR:
2.77; P  .04), was higher after dis-
charge in the colder season because
of mother’s incomplete compliance






KMC was introduced as the
exclusive means of treating LBW
infants (n  126), without
incubators and standard
equipment for care of LBW
neonates. Survival with KMC
were compared to hospital
survival data prior to the
intervention, from 1983 to 1987.
The survival of babies born 1500 g
improved from 10% to 50%,
whereas that of infants 1500–1999 g
improved from 70% to 90%. Overall









admission weight of 1500 g
admitted in the NICU were
randomly assigned treatment
with skin-to-skin (STS) care by
the mother (n  41) or in an
incubator (n  39).
At 240 min, 90% of babies in STS
group reached normal temperature
(37.1–37.2°C), compared with 60% in







KMC for LBW infants (n  32) was
introduced with limited
resources and without an
intensive care unit. Care included
post-discharge follow-up visits to
all infants 1800 g. Mothers of
infants in the intervention group
(n  22) were taught skin-to-skin
care and asked to observe other
mothers to facilitate compliance.
Control infants (n  10) were
given standard non-KMC care in
the maternity ward.
Out of 32 LBW infants (1800 g)
admitted in 3 mo, survival was 73%
in KMC and 20% in non-KMC











332 newborns weighing 2000 g
and eligible for care in the
minimal care unit were enrolled
in either of 2 groups: 1 receiving
KMC (n  162), and 1 control
group (n  170). KMC infants
eligible for MCU were
discharged regardless of
gestational age or weight, were
kept 24 h/d in an upright
position, attached to the mother’s
chest and receiving skin-to-skin
contact until KMC was not
tolerated anymore. Control
babies from another facility were
kept in incubators until they
were discharged. Both groups
were followed periodically up to
the age of 1 y.
RR of death was found to be higher in
KMC infants (RR: 1.9), though the
reverse was found after adjusting
for weight at birth and gestational
age (RR: 0.5). There were no
significant differences in overall
mortality rates among the 2 groups.
KMC infants grew less in first 3 mo
and had a higher proportion of
developmental delay at 1 y.
* Data are from the same trial.
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of newborns, as documented in south Asia,488,606 it
seems that millions of newborns each year are being
treated with potentially toxic applications to the
skin.488,490
In clinical trials in developed countries, topical
applications of epidermal barrier-enhancing emol-
lients have been shown to decrease TEWL, improve
skin condition, and minimize skin injury in ex-
tremely preterm infants.490,594,607–609 However, topi-
cal therapy has had a variable impact on risk of
infection. A pilot study at Stanford University (Stan-
ford, CA) showed that twice-daily application of the
ointment Aquaphor for the first 2 weeks of life to
premature infants 33 weeks’ gestational age re-
sulted in improved skin condition and a reduction in
episodes of culture-proven sepsis due to coagulase-
negative staphylococci.608 In another trial, Aquaphor
therapy in neonates weighing 1500 g decreased the
nosocomial bloodstream infection rate to 5.4 per 1000
patient-days, compared with 12.7 per 1000 patient-
days during the preceding 16 months.610 In contrast,
a small CCS suggested that extremely preterm in-
fants weighing 1000 g who were treated with top-
ical petrolatum ointment were at increased risk for
Candida infections,611 and another report suggested
that topical applications of Aquaphor might serve as
a source for nosocomial infections with coagulase-
negative staphylococci and Gram-negative organ-
isms.612 A recently completed multicenter US-based
trial showed that Aquaphor therapy increased risk
of sepsis with coagulase-negative staphylococci
among neonates weighing 501 to 750 g (OR: 1.60; CI:
1.07–2.39); no effects were seen in neonates weighing
751 to 1000 g.613 A Cochrane review of studies in
developed countries concluded that prophylactic
topical-ointment therapy increases the risk of coag-
ulase-negative staphylococcal infection and any nos-
ocomial infection.614
community-based evidence. Oil massage of neo-
nates is a nearly universal practice in south Asia.488,606
The typical timing (from the first days of life), fre-
quency (typically 1–3 times daily), pattern (total body),
and duration (throughout infancy and early childhood)
of use suggest that the practice is an important event in
daily child care, that significant time and resources are
devoted to it, and that exposure of the infant’s skin to
the oil is significant. The most commonly used oil for
infant massage is mustard oil, which, as noted above, is
potentially toxic490 and, when tainted with seeds of the
weed Argemone mexicana, may cause the neurologic
syndrome coined “epidemic dropsy.”615,616
In India, topical therapy with corn oil improved
thermoregulation (see also “Hypothermia Preven-
tion and Management”) of 5- to 7-week-old infants in
the community,491 and growth of hospitalized pre-
term infants was improved with sesame-seed oil
therapy.617 In Nepal, it was found that traditional oil
massage with mustard oil, swaddling with a plastic
swaddler, or KMC was equally effective in pre-
venting hypothermia during the first 24 hours after
birth (see Table 29).473
No community-based data are available on the
effect of topical therapy on neonatal infections or
mortality. Hospital-based studies have been con-
cluded in Egypt and Bangladesh, and data have been
reported from Egypt (Table 37). In Egypt, topical
application of sunflower-seed oil 3 times daily to
preterm infants 34 weeks gestational age (n  51)
at the Kasr El-Aini neonatal intensive care unit at
Cairo University significantly improved skin condi-
tion (P  .037) and reduced the incidence of nosoco-
mial infections (incidence rate ratio: 0.46; CI: 0.26–
0.81; P  .007; adjusted for weight on admission,
gestational age, and gender) compared with infants
not receiving topical prophylaxis (n  52) (see ref
732). In Bangladesh, preliminary data analysis sug-
gested that emollient therapy of preterm infants 33
weeks gestational age 3 times daily with sunflower-
seed oil or Aquaphor reduced the odds of neonatal
mortality (OR: 0.75; C:I 0.57–0.98). Among infants
weighing 1250 g, emollient therapy reduced the
odds of mortality by 35% (OR: 0.63; CI: 0.46–0.87).618
conclusions. Emollient therapy is a promising
intervention, particularly for LBW infants in devel-








In a Special Care Nursery, neonates
(n  385) were randomized to
topical application of sunflower oil
or Aquaphor 3 times a day, or to
the control group, which received
standard nursery care.
Treated infants (sunflower-seed oil
and Aquaphor-treated infants
combined) had a significantly
reduced risk of neonatal
mortality (25%) (OR: 0.75;
CI: 0.57–0.98). Among infants
weighing 1250 g, emollient
therapy reduced the odds of
mortality by 37% (OR: 0.63; CI:
0.46–0.87).
Darmstadt et al732 Egypt; urban
hospital setting;
RCT
Neonates were randomized to 3 times
daily topical application of
sunflower oil (n  51) or to usual
nursery practice (control group)
(n  52).
Treatment with sunflower-seed oil
resulted in a significant improve-
ment in skin condition (P 
.037) and a highly significant
reduction in the incidence of
nosocomial infections (adjusted
incidence ratio: 0.46; CI: 0.26–
0.81; P  .007) compared with
infants not receiving topical
prophylaxis (n  52).
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oping countries, although data to date are hospital-
based. Data thus far are also restricted to LBW in-
fants 33 to 34 weeks’ gestational age, in whom the
skin barrier is likely to be most highly compromised.
Additional research is needed on the impact of this
therapy in the community and among all newborns
(without restriction based on birth weight).
Emollient therapy is inexpensive ( $0.20 [US dol-
lars] for a course of therapy in a preterm infant
weighing 1.5 kg)490 and technologically simple and
can be delivered readily by health care workers and
caregivers. Research suggests that the practice of oil
massage is nearly universal in south Asia, and care-
givers indicate a willingness to modify their behavior
and apply an alternative oil that has skin barrier–
enhancing properties.488,606 Behavior-change com-
munications may be an effective way to introduce
the intervention more broadly by modifying what is
already a well-entrenched traditional practice. Fur-
thermore, in many communities, cadres of workers
such as the domin or nau´n in India (and similarly, in
Nepal) are designated to apply oil massage in the
community to newborns, and working with them
could enhance the feasibility and scalability of the
intervention.606
Choice of emollient is important. Emollients con-
taining a physiologic balance of epidermal lipids
(3:1:1:1 molar ratio of cholesterol/ceramide/palmi-
tate/linoleate) are optimal for barrier repair,604,619
and tests of impact on neonatal outcomes are war-
ranted using topical products with optimized effects
on skin-barrier function. However, natural vegetable
oils are readily available worldwide and may pro-
vide a simpler, inexpensive alternative that also war-
rants additional investigation as a more readily scal-
able and affordable intervention, particularly for use
in the community.
Hyperbilirubinemia Screening
background. Hyperbilirubinemia is widespread
among newborns. Almost 97% of all healthy new-
born infants have biochemical hyperbilirubinemia
(ie, serum bilirubin 17.1 mol/L), and almost 65%
may be overtly jaundiced. Jaundice tends to occur
in term infants with serum bilirubin levels above
85 mol/L.620 Although hyperbilirubinemia may
not be a major direct cause of mortality in developing
countries, delayed detection and therapy may pre-
dispose infants to bilirubin encephalopathy and ker-
nicterus,621,622 both of which are common causes of
handicaps in developing countries.419,623
It is not the purpose of this review to discuss the
numerous options for management of hyperbiliru-
binemia but rather to evaluate strategies for its early
recognition in community settings. Management of
this condition has been reviewed extensively, and
interventions such as phototherapy and medical
therapy (eg, phenobarbital, exchange transfusion,
and management of underlying conditions such as
sepsis, hemoglobinopathies, and blood-group in-
compatibilities) largely pertain to hospital set-
tings.624 Nevertheless, of the known risk factors for
jaundice and bilirubin encephalopathy, prematurity
and past history of hemolytic disease of the newborn
are important. Frequent and exclusive breastfeeding
must be encouraged, because it has been shown to
reduce the propensity for hyperbilirubinemia, due at
least in part to improved hydration status.625,626
Early detection of jaundice in developing countries
would be significantly facilitated if first-line health
workers at peripheral health facilities were able to
accurately identify young infants with clinically sig-
nificant jaundice who needed care at a referral-level
facility. Several studies, mostly from developed
countries, have found that bilirubin levels deter-
mined with a simple hand-held icterometer corre-
lated to varying degrees with measures made by
using more expensive and sophisticated instruments
and standard techniques (ie, serum bilirubin mea-
surement).627–632 However, there has been consider-
able debate, even in developed countries, about
whether the presence of jaundice can be determined
reliably by using visual assessment and what cadres
of individuals can perform visual assessments reli-
ably. Although some investigators have found that
clinical estimation of jaundice in newborns by neo-
natologists633 or physicians or nurses631,634,635 was
highly correlated with serum bilirubin levels, others
have questioned the ability of health care providers,
including physicians and nurses, to diagnose clinical
jaundice by visual estimation.628,636
community-based evidence. Our review identi-
fied 5 studies from developing countries that evalu-
ated strategies for the early detection of neonatal
hyperbilirubinemia (Table 38); however, none of
these studies were in a rural setting (all were con-
ducted in urban hospitals). Only 1 of these studies
tested the accuracy of visual estimation of jaundice;
Riskin et al633 reported that neonatologists’ visual
estimates were highly correlated to measurements
using a spectrophotometer (r: 0.682; P  .001).
All the other studies tested the accuracy of nonin-
vasive techniques (eg, use of a hand-held icterometer
or bilirubinometer) relative to laboratory serum bil-
irubin measurement. Bilgen et al632 and Kumar et
al627 compared transcutaneous bilirubin readings by
using a bilirubinometer to serum bilirubin, and both
reported strong evidence of a linear correlation (r 
0.83 and 0.91, respectively). Two studies, 1 in Turkey
and 1 in India, also found a significant positive cor-
relation between icterometer measurement and se-
rum bilirubin levels.630,632 However, in Pakistan,
Bhutta and Yusuf629 found that transcutaneous bil-
irubinometry was much less effective than standard
biochemical testing in accurately identifying hyper-
bilirubinemia, particularly among dark-skinned
infants.
conclusions. Simple methods including visual
assessment of degree of jaundice by health workers
and use of simple, hand-held icterometers hold
promise for use at the community and primary care
levels in developing countries, but additional studies
are warranted. The role of visual inspection in the
home by caregivers, particularly in areas with a rel-
atively high prevalence of hyperbilirubinemia, has
never been evaluated.
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TBA/CHW Training
background. Although there is consensus that in-
creased access to skilled health care, including a
skilled birth attendant during delivery, is widely
desired and likely to improve pregnancy out-
comes,16,24 approximately half of women and new-
borns lack access to skilled care.18 Moreover, nearly
two thirds of births worldwide take place in the
home, and a large percentage of births in developing
countries take place in the hands of untrained or
trained TBAs. Given the projected absence of ade-
quate cadres of skilled birth attendants in many
countries for years to come and a potential role for
TBAs and/or CHWs in health service delivery for
newborn care, we evaluated the available evidence
for the impact of TBA and CHW training on perina-
tal outcomes. CHWs typically differ from TBAs in
education (higher) and age (younger) and are per-
ceived by many as being more amenable to train-
ing.24 However, we considered them together for the
purposes of this review.
community-based evidence. A number of studies
have assessed changes in knowledge and attitudes
after the training of TBAs.440,637–642 An observational
study showed that trained TBAs were more likely
than untrained TBAs to give advice on breastfeeding
as well as on immunizations and oral rehydration
therapy.643 Trained TBAs also had better skills in
neonatal resuscitation relative to untrained TBAs but
did not have any impact on maternal behaviors.
Kumar et al640 stressed that continued training of
TBAs was important in sustaining improved mater-
nal and newborn care practices.
Table 39 (see also Tables 26, 41, and 42) summa-
rizes the evidence from studies that examined the
effect of TBA and CHW training on perinatal and
neonatal health status outcomes in community set-
tings. The CHWs were community based in all set-
tings and had varying levels of training and linkage
to the health system. Their relationship to the health
system ranged from close association that facilitated
referral of high-risk infants and/or those with com-
plications to settings in which care was entirely home
based.439
The 1 randomized trial in The Gambia644 showed a
reduction in neonatal mortality of 61% in the villages
to which primary health care was introduced and
TBAs were trained. However, neonatal mortality
also fell by 35% in the control villages, rendering the
26% comparative fall in neonatal mortality nonsig-
nificant. There was a significant increase in the num-
ber of women receiving antenatal visits and tetanus
immunization during pregnancy, although the num-
ber of women whose births were conducted by a





Bilgen et al632 Turkey; urban
hospital setting;
QT
Transcutaneous measurements were obtained
from newborns (n  96) with a Minolta
AirShield bilirubinometer and an Ingram
icterometer and compared to serum
bilirubin measures.
A linear correlation existed between
serum bilirubin values and the
readings on both the Minolta
bilirubinometer (r  0.83) and the
Ingram icterometer (r  0.78).
Riskin et al633 Israel; urban
urban hospital
setting; PCS
4 neonatologists were asked to estimate
visually the level of bilirubin in a group of
term clinically jaundiced infants (n  283)
before discharge from the nursery on the
third day of life. Their clinical estimation
was compared with actual measurement of
serum total bilirubin from samples drawn
simultaneously.
Clinical visual estimation of serum
total bilirubin had a high
correlation to actual serum
bilirubin levels as measured by
spectrophotometer (r  0.682;
P  .001).
Kumar et al627 India; urban
hospital setting;
RCT
Term babies (n  100) were randomly
selected for estimation of transcutaneous
bilirubin (by Minolta AirShield
bilirubinometer 101) and serum bilirubin
levels by conventional diazo method.
Babies needing phototherapy (n  40)
were randomized into 2 groups: (1) those
having their transcutaneous bilirubin level
measured from a covered area on the
forehead, and (2) those who did not have a
covered area on the forehead.
There was a linear correlation (r 
0.9090; P  .001) between serum
bilirubin level and transcutaneous
bilirubin level. In the babies
requiring phototherapy, there
was significant (P  .001) linear
correlation between prephoto-
therapy and postphototherapy
readings, group 1 (r  0.69) and
group 2 (r  0.80).




compared with standard laboratory
estimation of bilirubin level in normal
jaundiced newborns (n  65).
Transcutaneous bilirubinometry
was not very effective in
recognizing hyperbilirubinemia in
comparison with biochemical
testing, especially among dark
infants. Although the correlation
between the 2 methods was
significant (r  0.66; P  .01), the
scatter was wide and the speci-
ficity was only 53%.
Narayanan et al630 India; urban
hospital setting;
QT
Effectiveness of the icterometer was
evaluated in detecting neonatal
hyperbilirubinemia in newborn infants
(n  158).
There was positive correlation
between the readings on the nose
and serum bilirubin levels
(P  .05).
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trained midwife fell by 7% during the trial, con-
founding precise interpretation of the effect of TBA
training. In another study, perinatal mortality de-
creased by 19% among offspring of women delivered
by TBAs who had been trained in essential newborn
care and advanced resuscitation, including use of the
mucus extractor and bag-and-mask ventilation.639
In an uncontrolled study in India,438 CHWs iden-
tified and managed high-risk neonates in the home,
including preterm and LBW infants and those with
feeding problems, illness, or a history of prolonged
and difficult labor. Interventions included resuscita-
tion of asphyxiated newborns, including cleaning of
the mouth and pharynx and mouth-to-mouth respi-
ration; antiseptic cord care, including cutting; pro-
motion of breastfeeding; minimal handling to reduce
TABLE 39. TBA/CHW Training
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Alisjahbana733 Indonesia; urban
slums; PCS
TBAs (n  20) were provided
with a weighing scale with
color codes and also a
pictorial chart depicting
maternal and child con-
ditions. Using these, the
TBAs determined the risk of
a poor pregnancy outcome
for the mothers and their
neonates (n  178 mother-
infant pairs).
The weights determined by the
TBAs using the colored scale
were as accurate as the
weights determined by
midwives.






TBAs in the intervention group
(n  28) were provided 3
mo of basic training and 36
mo of supervised follow-up
training. They were com-
pared to a cohort of un-
trained TBAs (n  27).
Although there was a significant
difference between the trained and
untrained TBAs in the advice
provided to mothers regarding
immunization, oral rehydration
therapy use and breastfeeding
practices, there was no associated











(especially safe and clean
delivery) and neonatal care.
Mortality and morbidity
data for 1913 women over
the 3 y of the program were
compared to baseline data
from 673 women.
There was a 62% decrease in
maternal mortality in the
intervention area compared
with the preintervention
period. Such a decrease was
not observed in the non-
intervention areas. There was




mothers who went to a
trained TBA for delivery.
There was a significant 33% decrease
in NMR in the intervention area
compared to the nonintervention
area. This change was mainly
attributed to a decrease in rates of
late neonatal deaths, especially
those of infectious origin.
Daga et al441* See Table 26
Daga et al449* See Table 26






The program was designed to
improve working
relationships between TBAs
and other health providers





and postnatal periods and
were provided with a kit
containing midwifery and






care of the newborn and 5
nonobstetric primary health
care topics; family planning,
infant feeding, growth
monitoring, immunization
and control of diarrheal
diseases.
Training was protective against
postnatal fever (OR: 0.30; CI:
0.14–0.65), retained placenta
(OR: 0.35; CI: 0.13–0.96), and
labor 18 h (OR: 2.57; CI:
1.13–5.81).
Authors concluded that “the
evidence for a beneficial impact of
TBA training on the health of
mothers and newborns is not
compelling. Some moderate
beneficial effects may be
forthcoming, but it is unlikely that
TBA training will result in large
reductions in maternal and
perinatal morbidity and mortality.”
* Data are from the same trial.
590 COMMUNITY-BASED INTERVENTIONS FOR IMPROVING HEALTH OUTCOMES
 by guest on October 27, 2017http://pediatrics.aappublications.org/Downloaded from 
the risk of infection; postnatal home visitation and
provision of anticipatory guidance about routine
newborn care; and referral of sick newborns and
those with feeding problems to a hospital. Home care
of preterm and LBW infants also included keeping










Data was collected from a
random sample of women
who had recently delivered
over a 1-y period (n 
1961) to compare outcomes
of deliveries by family
members, by TBAs, and in
hospitals. TBAs in the
study were trained in local
hospitals or in the home of
a centrally located TBA
following the official
training plan of the local
teaching hospital, and had
regular supervision from a
physician or nurse. TBAs
primarily provided
assistance only during
delivery but were also
given training in prenatal
and postpartum care, as
well as referral criteria.
Over the course of 1 y, 139 out
of 1057 women who were
being seen by TBAs planned
to deliver at home but were
referred to a hospital
instead. An additional 119
women gave birth at home
without the assistance of a
TBA.
While the survival rate among
births to women having their first
delivery in a hospital was 4 times
that of a first delivery in a home,
hospital intervention did not
have a statistically significant
impact on the survival of infants
born to women who were most





Training programs for TBAs
with Haiti’s maternal and
child health family-
planning program were
integrated in order to
reduce maternal and
newborn mortality. As a
result, a manual for









midwives. The number of
midwives reached by the
training program increased
from 36 in 1968 to 175 in
1970.
In the Trou Chouchou area,
maternal mortality seemed
to be unaffected.
Neonatal mortality was eliminated
once the integrated training
program had been implemented.
Training of traditional midwives
at the Albert Schweitzer Hospital
resulted in an increased
acceptance of prenatal
consultations (80% after the
program was introduced,
compared with 37% at baseline)
along with fewer deaths from
neonatal tetanus (1 neonatal
death from tetanus post-
introduction, vs 15 neonatal
deaths from tetanus at baseline;






See Table 26 Neonatal, infant and PMRs in the
intervention area were
significantly reduced (62%, 46%,
and 71%, respectively) compared
to the control area. Case fatality
resulting from neonatal sepsis
significantly declined, from 16.6%
















A TBA training program to
improve relations between
hospital staff and TBAs, as
well as to improve
standards of care, was
implemented at a rural
hospital. Mothers referred
by TBAs were surveyed to
evaluate the program.
Apgar scores improved and PMR
declined, but the change was not
statistically significant.
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essary. In the absence of management of sepsis,
newborn mortality declined by 25% during the inter-
vention year compared with the year before imple-
mentation of the program.
Similar but less stringently evaluated success has
been reported by Daga et al441,449 from the Rural
Neonatal Care Project in Dahanu, India, where NMR
and PMR fell 41% and 62%, respectively, over a
3-year period. The project used TBAs as the means
for delivery of neonatal care. Maintenance of the
“warm chain,” resuscitation of asphyxiated new-
borns, and appropriate, early referral of high-risk
mothers and newborns (eg, LBW) were recognized
as the most important interventions.441 Anganwadi
workers also played an important role in bridging
the gap between TBAs and formal health workers.449
Overall, the IMR in the block to which these services
were introduced declined 70% over a 4-year period,
from 148 to 45 per 1000.449
As part of the Narangwal Nutrition Study, a con-
trolled trial in a rural area of Punjab, India, the Rural
Health Research Centre trained a cadre of villagers
as family health workers (FHWs) (lady health visi-
tors) to provide health services in the villages in
which they lived. All were given special training in
comprehensive primary care and surveillance tech-
niques and provided prevention, early diagnosis,
management of illnesses (including penicillin injec-
tions for suspected pneumonia in infants), and refer-
ral services in village clinics and homes.645 FHWs
were the principal providers of nutrition and medi-
cal care in the study and were data collectors for
longitudinal fertility and dietary surveys. They had
detailed, written standing orders and were given
weekly supervision by a doctor and a public health
nurse to provide support, facilitate referrals, and en-
sure quality data collection. FHWs spent at least half
their time performing home visits, which helped
them identify pregnancies early and provide basic
prenatal care to all women in service villages.244,645
The interventions significantly reduced perinatal
mortality. Analysis of service records revealed that
90% of patient contacts were handled capably by
FHWs, and the remainder were safely referred to
physicians.244
In another study in India, Society for Education,
Action and Research in Community Health
(SEARCH) trained TBAs in elements of clean deliv-
ery and CHWs in a variety of antenatal and postnatal
interventions including provision of health educa-
tion to caregivers in the home, promotion of breast-
feeding, management of birth asphyxia, identifica-
tion of premature and LBW (ie, high-risk) infants,
prevention and management of hypothermia, treat-
ment of skin and cord infections, identification of
sick newborns, and administration of oral and inject-
able antibiotics for cases of suspected sepsis.646 Al-
though the precise impact of the TBAs versus the
CHWs cannot be determined, there was little to no
input from the formal health sector; thus, the impact
apparently was largely facilitated by these trained
village-level workers alone. The NMR fell by 62%,
the PMR fell by 71%, and stillbirths were reduced by
18%.
A community-based trial conducted in Tanzania
and Kenya demonstrated that, for areas in which
maternal immunization was not a feasible method of
decreasing tetanus morbidity and mortality, mea-
sures such as TBA training for safe and clean deliv-
ery and cord care were effective in decreasing peri-
natal, neonatal, and infant mortality389 (Table 20).
Janowitz reported that trained TBAs in rural Brazil
identified and appropriately referred most high-risk
women.647 In another study evaluating the impact of
TBA training in Ghana, Smith et al648 found reduc-
tions in intrapartum fever, labor 18 hours, and
retained placenta, but the number of perinatal deaths
and tetanus cases were too low to evaluate. Clients of
trained TBAs were more likely than those of un-
trained TBAs to be referred for tetanus immuniza-
tion (58% vs 28%, respectively), and immunization
rates in both groups were high (87% vs 77%, respec-
tively). In this setting, in which health providers
other than TBAs were the primary antenatal care
contacts, the value of training TBAs in clean cord
care was questioned.648
O’Rourke642 reported a twofold increase over a
nearly 3-year period in referrals of women with
pregnancy complications after introduction of a TBA
training program in Guatemala. A 27% nonsignifi-
cant reduction in PMR was reported using a before-
after comparison.
A recent meta-analysis of TBA training showed
that there were statistically significant decreases of
11% in neonatal complications and 6% in perinatal
deaths in areas served by trained TBAs compared
with areas without trained TBAs.3
conclusions. The overall effects of TBA training
on perinatal and neonatal outcomes were generally
beneficial. Little evidence was found to support the
widely held notion that TBA training is futile. On the
contrary, training was associated with improved be-
haviors (ie, advice, skills) among birth attendants,
although it did not necessarily translate into im-
proved maternal behaviors regarding newborn care.
In some cases, caregiver behaviors did improve: the
meta-analysis by Sibley and Sipe3 showed improve-
ments in overall TBA and caregiver knowledge as
well as behaviors. Although there has been little
evaluation of the impact of TBA training on perinatal
and neonatal health outcomes, the weight of evi-
dence suggests that TBAs may make positive contri-
butions to newborn care, and further definition of
TBA and CHW roles and evaluation of the impact of
TBA training on perinatal and neonatal outcomes are
merited.
TBA training need not be seen in isolation from
other interventions, particularly interventions that
improve the skills of other caregivers. The Gadchiroli
trial successfully used both TBAs and CHWs work-
ing as a team along with the mother and other care-
givers, particularly the mother-in-law, to improve
domiciliary care for the mothers and newborn in-
fants.439 These interventions, therefore, may be con-
sidered for settings in which TBAs and CHWs will
remain an important group of care providers for the
foreseeable future. However, additional research is
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needed to define the interventions that TBAs and/or
CHWs can be trained to provide most effectively in
programs at scale, to delineate criteria for selection of
TBAs to be trained, to develop appropriate preser-
vice and in-service training programs, and to evalu-
ate the cost-effectiveness of such training programs.
Pneumonia Case Management
background. The true incidence of neonatal
pneumonia or ARI at the community level is not
known; however, a significant proportion of new-
born infants diagnosed with sepsis or serious infec-
tions may have associated pneumonia, and the clin-
ical presentations of these conditions have significant
overlap in the newborn. Recommended treatment of
serious systemic bacterial infections, including pneu-
monia, in neonates in developed countries includes
parenteral administration of antibiotics in a health
care facility. Similarly, in developing countries, the
WHO recommends parenteral antibiotic therapy (eg,
benzylpenicillin or ampicillin plus an aminoglyco-
side such as gentamicin) in a health facility for treat-
ment of serious neonatal infections.16,25,649,650 In re-
source-poor countries, however, the majority of
births and neonatal deaths take place in the home,
and families are often reluctant to seek care outside
the home for neonatal illness.439,569–571 In these set-
tings, facility-based care with use of parenteral anti-
biotics is currently infeasible for many neonates, and
alternative management strategies are needed. In-
sight into the role of oral antibiotic therapy as a
potentially simpler and more feasible regimen for
treatment of serious neonatal infections for situations
in which referral to a health facility for quality care
and parenteral therapy is not possible may be gained
by reviewing pneumonia case management trials
that included treatment of neonates.
community-based evidence. We identified 6 re-
ports654 and 2 meta-analyses of community-based
trials of pneumonia case management that included
neonates (Table 40). Sazawal and Black651,652 con-
ducted a meta-analysis of community-based inter-
vention trials on case management of pneumonia in
unselected preschool-aged children in developing
countries. The impact of pneumonia case manage-
ment on total neonatal mortality and pneumonia-
specific neonatal mortality was determined. The 5
studies comprising the neonatal mortality analysis
compared concurrent control and treatment
groups.653–660 In 4 of the studies, neonates with sus-
pected pneumonia were treated with oral co-trimox-
azole,653–656,659,661 and another used both injectable
penicillin and oral ampicillin.660 Uncorrected analy-
sis showed a 27% reduction in all-cause neonatal
mortality (CI: 18–35).652 After correction for per-
ceived biases that may have affected the study re-
sults, the estimated reduction in total and pneumo-
nia-specific neonatal mortality was 30% (CI: 15–42%;
OR: 0.70, 0.59–0.84) and 42% (CI: 20% to 64%; OR:
0.56, 0.37–0.83), respectively.
In an additional study in Indonesia, use of ampi-
cillin plus supportive care (eg, continued breastfeed-
ing, clearing of the nose, fever control) in children
with pneumonia had no measurable impact on cure
rates of mild disease at 1-week follow-up, and did
not halt progression to moderate disease at 1 week
compared with the use of supportive care alone in
the control group.662
conclusions. Several studies have shown that it
is possible to train CHWs to recognize and success-
fully treat pneumonia in newborn infants in commu-
nity-based settings.653–660,663 The impact of such
training on reducing neonatal mortality and morbid-
ity in community settings in developing countries is
significant. Available data clearly indicate that a case
management approach emphasizing essential new-
born care along with prompt recognition of serious
bacterial infections and treatment with oral antibiot-
ics is superior to no case management. In fact, the
reduction in neonatal mortality found in the meta-
analysis was comparable to estimates of the propor-
tion of neonatal deaths due to infections (ie, 32%18),
suggesting that a substantial proportion of these
deaths were averted through case management that
primarily included oral antibiotic therapy in the
home. However, the impact has its limits, given that
it is impossible in many cases to distinguish pneu-
monia from sepsis on clinical grounds, and these
conditions frequently coexist during the neonatal pe-
riod. Thus, pneumonia case management alone, in-
cluding use of oral antibiotics, will lead to under-
treatment of many infants with more widespread
infections (ie, sepsis) that require parenteral therapy.
It was this realization that led the group at SEARCH
to provide more comprehensive detection and man-
agement of serious neonatal infections with a com-
bination of oral and parenteral antibiotics (see “Neo-
natal Care Packages”). A host of factors, including
feasibility and cost-effectiveness of implementation,
as well as ethical standards, must be considered
when weighing the relative merits of neonatal pneu-
monia versus more comprehensive sepsis case
management.
Neonatal Care Packages
background. Given that the majority of births
take place at home in developing countries, fre-
quently in the hands of relatively untrained birth
attendants, there is considerable interest in the po-
tential of developing locally adapted packages of
newborn care in community-based settings. Whereas
the previous sections reviewed trials that focused on
use of trained TBAs/CHWs and on pneumonia case
management, this section discusses more compre-
hensive packages of care that may or may not have
included management of sick newborns.
community-based evidence. We identified 9
studies that were undertaken in community settings
and included a comprehensive neonatal care plan
rather than solitary interventions (Table 41). Several
of these studies used TBAs and/or CHWs to provide
care and thus were discussed in detail in “TBA/
CHW Training” (Table 39).
In India, Pratinidhi et al438 used VHWs to identify
and manage high-risk neonates in the home. Inter-
ventions addressed birth asphyxia, hypothermia pre-
vention, clean cord care, breastfeeding promotion,
postnatal visitation, and identification and referral of
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The project trained 86 TBAs in diagnosis and
management of under-5 children with
pneumonia (n  2568 attacks). They were
initially trained in visual judgment of fast
breathing or difficult breathing; later in the
project, 10 TBAs were trained in the use of
simple breath counters. Training in safe and
hygienic delivery and newborn care was
also given. Community acceptance of case
management by different workers was
assessed. Surveys were conducted every 6
mo and causes of death in children were
determined by verbal autopsy; see also Bang
et al.656,657
A significant decline in neonatal mortality due to
pneumonia (44%) was noted. The proportion of
error-free case management by TBA increased
continuously as the program progressed from
56.7% in the first year, to 68.6% in the second
year, and 83.4% in the third year (P  .0001).
The proportion of correct diagnoses by 10 TBAs






TBAs in the intervention area were trained to
diagnose and treat pneumonia, and care-
seeking for suspected pneumonia was
encouraged in families. Management of
neonatal pneumonia cases (n  65) included
continued breastfeeding, administration of
cotrimoxazole syrup, and paracetamol for
fever. Severe cases were promptly referred.
Case management led to a 40% reduction in
pneumonia-specific mortality in the neonatal
period, and a 78% reduction in mortality in the
second month of life. 80% reduction in mortality





TBAs, VHWs and paramedics diagnosed and
treated pneumonia in the community. TBAs
were also trained and provided with
necessary equipment to conduct safe
deliveries and to resuscitate asphyxiated
newborns using mouth-to-mouth breathing.
2180 women in villages were interviewed to
evaluate the effectiveness of the program.
Pneumonia-specific mortality rate decreased by
53.8% in the intervention area, and the case-
specific fatality rate declined by 62% in the





Primary health care workers in the
intervention area of 38 villages were
identified and trained in recognition,
treatment and referral of ARI. Additional
training material including self-learning
educational aids were developed and field
tested to ensure their suitability and
simplicity. Infants with moderate or severe
ARI were administered penicillin orally in 2
equal daily doses of 125 mg for 5 d.
Primary health care workers were contacted in 38%
of cases of ARIs in the intervention area as
opposed to 1% in the control area. Mean
duration of infections in the intervention area
was significantly lower (P  .01), whereas case






13 404 children were enrolled. Active case
detection by CHWs trained in WHO
pneumonia case management strategy.
Principal criteria for establishing a diagnosis
of pneumonia were a respiratory rate of 50
breaths per minute or greater or chest
indrawing, measured through a specially
developed battery-operated beeper timer to
assess respiratory rate accurately. Emphasis
was placed on maternal education for early
detection of signs of pneumonia. Parents of
presumed cases were given free
cotrimoxazole pediatric suspension (8 mg
trimethoprim/kg per d for 5 d) with
detailed instructions and workers watched
as parents administered the first dose.
Workers revisited households on the third
and sixth days to assess compliance and the
child’s status. Children who did not
improve after 4 doses of cotrimoxazole, or
relapsed, were treated with chloramphenicol
suspension as the sole second-line antibiotic.
Case referral by mothers increased from 15%
during the first year to 56% by the third year.
80% of pneumonia episodes were appropriately
detected and treated. A statistically significant
decreased risk of death (RR: 0.72; CI: 0.63–0.82)
was observed and by the third year of the
program. The greatest RR reduction was seen in
infants between 6 and 11 mo and those between
1 wk and 5 mo. In addition to reduction in the
deaths resulting from pneumonia, significant
reductions in deaths due to diarrhea and
measles were recorded, indicating that reduction













Meta-analysis found reduction in total under-5
mortality of 27% (CI: 18–35%), 20% (CI: 11–28%)
and 24% (CI: 14–33%) among neonates, infants
and children 0–4 y of age, respectively.
Pneumonia-specific mortality was reduced by
42% (OR: 22–57%), 36% (20–48%) and 36%
(20–49%), in the same groups, respectively.
* Data are from the same trial.
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TABLE 41. Neonatal Care Packages
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Bang et
al439






Groups followed a 4-stage community
action cycle to identify needs and
practical solutions to problems that
led to maternal and perinatal
mortality. The impact of this
intervention was evaluated by
comparing PMRs and obstetric
behavior among community women
(n  409) before and after the
intervention.
There was an increase in
the users of contraceptives
from an estimated
baseline of 0–1% to 27%.
There was a 71% increase
in tetanus immunization
in women. An increase in
attendance at antenatal
clinics was observed.
Women resorted more to
trained Dais (trained birth
attendants) as opposed to
untrained Dais for
delivery.
There was a 63% decrease in
PMR after the intervention
compared to baseline (44
deaths/1000 births vs 117
deaths/1000 births,







Local female facilitators in
intervention villages were trained to
lead discussions within village
development committees and
women’s groups about perinatal
health issues. The groups then
developed participatory action
plans to solve perinatal health
problems in an iterative process to
reach 28 000 married women of
reproductive age. Common goals of
the action plans included
surveillance of birth outcomes,
caregiver recognition of danger
signs, improved health worker
knowledge and skills, clean





compared to the control
clusters (OR: 022; CI:
0.05–0.90).
A 30% reduction in IMR
was observed in the
intervention clusters
compared to the control
clusters (OR: 0.70; CI:
0.53–0.94).
Daga492 India; rural setting;
PCS
6 babies with a foot length of 6 cm,
whose mothers were not willing for
hospital care, were managed at
home using trained health workers.
All 6 newborn infants
survived and did not






100 cases were obtained through a
random sample of all perineonatal
deaths. 120 controls were selected
by enrolling the next registered
birth after the study case in which
the infant lived for at least 28 d).
Mothers were interviewed, and data
were reviewed by physicians to
identify probable cause of death. 2
analyses were performed, first to
identify predictors of perineonatal
mortality and, second, to compare
baseline characteristics between
women who elected traditional as























All pregnant women identified in the
community over a period of 1 y
were enrolled. Newborns (n  320)
were seen weekly in the first month
and biweekly in months 2 and 3.
Mothers were taught routine
newborn care by fieldworkers. A
physician examined the infants
biweekly in the first month and
monthly in months 2 and 3. For
minor illnesses, physicians provided
treatment in the community. For
complicated cases, physicians
provided immediate treatment in
the community, followed by
referral.
Mortality rate in the first 3
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sick newborns and those with feeding problems to
health facilities. Newborn mortality declined by 25%
during the intervention year, compared with the year
before implementation of the program (Tables 26
and 39).
In Narangwal, a town in Rural Punjab, India, 3
service groups received nutrition care (nutrition ed-
ucation, surveillance, and food supplementation of
1674 J and 11 g/day of protein through special feed-
ing centers), medical care (immunization, health ed-
ucation, and early diagnosis and treatment of illness
through frequent surveillance), or both nutrition care
and medical care.118,244,645 A fourth group served as
the control group. Results showed significant im-
provements in growth (weight and height) and Hb
levels of children. Medical care significantly reduced
postneonatal morbidity and mortality in the 1- to
3-year-old age groups and decreased illness duration
of all 6 conditions examined in this study. Prenatal
nutrition care to pregnant women was most effective
in preventing perinatal deaths, followed by medical
care for infants (Table 41).
Two decades ago in a rural area of The Gambia, a
package of primary health care interventions was
introduced by the Gambian government to improve
maternal and neonatal birth outcomes.644 A VHW
and a TBA from each village were trained to provide
antenatal care (especially malarial prophylaxis), risk
assessment and subsequent referral, intrapartum
care (especially safe and clean delivery), and neona-
tal care. Alongside significant declines in maternal
mortality over the 3 years after the program was
introduced (from 2716 to 1051 of 100 000; 2: 5.9; P 
.05), the program documented statistically signifi-
cantly lower rates of neonatal deaths in intervention
villages relative to nonintervention villages (46.6 vs
69.6 of 1000, respectively; 2: 4.3; P  .05), primarily
due to a reduction in late neonatal deaths due to
infections.
In Guatemala, pregnant women were taught rou-
tine infant care and care seeking for illness, and
when symptoms of severe illnesses were detected,
immediate empiric treatment was begun in the com-
munity with accompanied referral to an area hospi-
tal.664 The mortality rate among infants enrolled in
the study was reduced by 85% compared with his-
torical controls.
















shorter in villages with
MC (or NUT  MC) than
in NUT or control villages
(P  .02). Postneonatal
mortality was lower in
villages receiving MC or
NUT  MC (23.3/1000
and 35.2/1000 live births
for MC and NUT  MC
groups, respectively) than





(MC and NUT  MC) and
the control villages was
statistically significant
(P  .05). The difference
between 1 and 7 d
mortality in the 3
intervention groups
relative to the control
group was highly







Groups and interventions were the
same as Kielmann et al (See Table
6).
Mothers in the intervention
group prolonged breast-
feeding by about 2 mo
because of nutrition
education given to them.
IMR was lowest in the MC
group (70/1000 live
births), second in the MC
 NUT group (81/1000
live births) and third in
the NUT group (89/1000
live births) as compared to
the control group (129/
1000 live births).
* Data are from the same trial.
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suscitation of asphyxiated newborns, prevention of
hypothermia, and referral of sick newborns and
achieved 41% and 62% reductions in NMR and PMR,
respectively, compared with baseline data over a
3-year period. The administration cost of the pro-
gram was considered “affordable,” because it was
based on inexpensive domiciliary neonatal care by
TBAs supported by relatively low-cost facilities for
neonatal care. This intervention was acceptable to the
community and the TBAs because it was simple to
carry out and did not involve technology that causes
“culture shock”441 (Tables 26, 39, and 41).
An uncontrolled trial (the “Warmi” Project) to im-
prove maternal and child health in the rural province
of Inquisivi, Bolivia, included training TBAs, offering
tetanus immunizations to women of reproductive
age, ensuring a clean birthing surface and hygienic
cord care, providing antibiotic eye drops, encourag-
ing immediate breastfeeding, and ensuring thermal
control.642 Family-planning services and community
funds and mechanisms for transport of women in
need of care to secondary health facilities were es-
tablished also. The program emphasized community
participation in identifying and solving problems.
This approach led to a 67% reduction in perinatal
mortality over a 3-year period, an increased propor-
tion of women receiving prenatal care, and an in-
creased number of women initiating breastfeeding
on the first day after birth compared with baseline
(from 25% to 50%).
In rural India, SEARCH trained VHWs in interven-
tion areas to provide a package of home-based neo-
natal care, including health education to pregnant
women, diagnosis and management of birth as-
phyxia, identification of high-risk (premature and
LBW) neonates for more intensive surveillance, tem-
perature maintenance, promotion of breastfeeding,
administration of vitamin K, treatment of skin infec-
tions, and identification of sick newborns suspected
of having septicemia, meningitis, and/or pneumonia
and administration of antibiotics (oral co-trimox-
azole and IM gentamicin) in the home.439 Neonatal
mortality due to sepsis was reduced 76% and overall
neonatal mortality declined by 62%, compared with
the control, nonintervention area.
More recently, in the rural district of Makwanpur,
Nepal, Osrin et al69 conducted a cluster-randomized
trial to evaluate a community-based participatory
intervention to improve essential newborn care. The
intervention, which covered a population of 28 000
married women of reproductive age, trained local
female facilitators in intervention villages to lead
discussions within village-development committees
about perinatal health issues. These facilitators also
helped the groups develop participatory action plans
in an iterative process. Mothers’ groups within each
village-development committee met monthly to
identify perinatal health problems, design and im-
plement solutions, monitor birth outcomes, and
share results with others. Common goals of the ac-
tion plans included community surveillance of births
and birth outcomes, improved caregiver recognition
of danger signs, proper care seeking, improved
knowledge and skills of health workers, clean deliv-
ery practices, increased rates of early breastfeeding,
and improved referral patterns. Infant mortality was
reduced by 30% (OR: 0.70; CI: 0.53–0.44) and mater-
nal mortality was reduced by 78% (OR: 0.22; CI:
0.05–0.90).665
conclusions. These data strongly support imple-
mentation of packages of essential newborn care. For
settings in which health facility capacity is limited
and referral is not possible, the data also support the
utilization of trained community-based workers in
the screening and preventive and curative care of
newborn infants. These interventions have not been
evaluated in effectiveness trials using available staff
and infrastructure. Thus, there are legitimate con-
cerns regarding the replicability and sustainability of
these comprehensive programs of care. Additional
cost-effectiveness evaluations of this approach must
be undertaken in larger trials in diverse geographic
locations.
Creation of linkages to referral facilities and facil-
itation of referral pathways and improvement in
quality of care at referral facilities were essential
aspects of most community-based newborn care pro-
grams reporting improved survival. Nevertheless,
some programs118,244,439,642,665 reduced neonatal
mortality with little health systems, capacity, primar-
ily through provision of improved antenatal and
neonatal care in a context of community empower-
ment.
Care in Peripheral Health Facilities
background. In many settings, a primary strategy
to improve neonatal outcomes will be to increase
healthful essential newborn care practices in the
home, while also seeking to improve care seeking for
newborn illness, and stabilization and referral of sick
infants to health care facilities as close to the com-
munity as possible, where better-quality care may be
available.
community-based evidence. We identified 9
studies that described and evaluated various postna-
tal interventions in primary or secondary health fa-
cilities in community settings (Table 42). Most of the
facilities described were community-based and had
limited resources. Also included was a study that
evaluated postdischarge follow-up of neonates in a
community setting.666
Various approaches to improving neonatal care
and outcomes were evaluated in these studies, which
focused primarily on training caregivers and health
providers in essential newborn care. Although no
study used a randomized, controlled design, im-
provements were reported in survival441,494,667–669
and immunization rates,669 and reductions were
noted in length of hospitalization and number of
readmissions after discharge.666
conclusions. Strengthening health facilities and
health systems is an essential aspect of community-
based programs to improve neonatal health. How-
ever, given the barriers that exist to care seeking for
neonatal illness,439,569–571 it is unlikely that utilization
of facility-based services for newborn care in many
communities will increase in the absence of demand
creation, improved referral pathways, and quality of
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care. Although it is unlikely that interventions based
in facility settings alone will make a major difference
in situations in which the bulk of deliveries take
place in domiciliary settings, they are nevertheless an
essential adjunct to such care.
There are few existing guidelines for the care of
sick newborn infants in health care institutions with
limited facilities and manpower.548,670 Thus, there is
an urgent need to improve and strengthen referral
pathways and linkages between domiciliary-based
interventions and facility-based care for sick neo-
nates. There are considerable opportunities to reduce
cost of care and improve efficiency by such an ap-
proach. Despite the limited information, we would
strongly endorse incorporation of basic guidelines
for improved secondary care of newborns in health




background. During the last few decades, signif-
icant reductions in perinatal and neonatal mortality
have been achieved in the context of studies evalu-
TABLE 42. Neonatal Care in Peripheral Health Facilities
Source Location and
Type of Trial
Intervention Maternal Outcome Perinatal/Neonatal Outcome
Arif et al736 Pakistan; urban
hospital setting;
RCT
362 babies were randomly assigned to
either an incubator or heated cot by
the mother’s side (n  151), or to the
special care baby unit (n  211).
Mothers were trained by nurses.
Weight gain from admission to
discharge was significantly
higher among newborn infants in
the maternal care group
(P  .001). Mortality in the fair
and poor babies was significantly
lower (44%) in the maternal care
group (P  .001). Overall,
mortality in the maternal care
group was 57% lower than the
special care unit, irrespective of
condition at admission.
Bose et al666 India; rural setting;
RCS
At the Community Health and
Development Hospital, a low-cost
nursery for newborns (n  175) was
established with facilities for photo-
therapy, heat cradles and other basic
nursing facilities.
Of 175 newborns admitted, 6 died
and 8 were transferred to






Staff at a community hospital was
taught special care for newborns
(n  2266), comprised of provision of
optimal warmth, resuscitation of
asphyxiated neonates, proper feeding
and oxygen administration when
indicated.
For a 5-y period, survival was
61.5% in the 1000–1500 g birth
weight category and 92.5% in the
1520–2000 g category of
admissions. No comparable
historical data was reported.
Dutt et al669 India; rural setting;
PCS
Jawaharlal Institute Rural Health
Center served as a treatment as well
as a referral center in the rural area
for births (n  356).
94% of the deliveries were
conducted by trained
personnel, as compared to
16% in 1967. All mothers
were immunized against
tetanus.
IMR decreased by 68%
(comparative neonatal mortality
rates were not specified). In the
postnatal period, 98% of the
children had received the full
courses of DPT, oral polio, and
BCG immunizations. There were







Care of neonates (n  567) was done
under limited resources by training
mothers and nurses in basic newborn
care
Survival rates of infants weighing
1500 g and for those weighing
1500–2000 g were 52% and 90%,
respectively.
Wilkinson668 South Africa; rural
hospital setting;
QT
The pilot study was based on an
analysis of consecutive hospital and
clinic deliveries (n  640). A
subsequent study included 2193
consecutive hospital and clinic births.
Basic interventions (including a
community obstetrics guide for local
midwives, a policy change to admit
all pre-eclamptic women with high
diastolic blood pressure to the
hospital, a managed system for blood
collection and result delivery, and
training for midwives and skilled
birth attendants in neonatal
resuscitation and management of
labor emergencies) were introduced
in the hospital to tackle problems
identified through a pilot study.
A 32% decrease in NMR was seen
during the intervention period.
598 COMMUNITY-BASED INTERVENTIONS FOR IMPROVING HEALTH OUTCOMES
 by guest on October 27, 2017http://pediatrics.aappublications.org/Downloaded from 
ating a variety of interventions in developing-coun-
try communities, as reviewed above. For some inter-
ventions or packages of care, promising results in
efficacy trials have included, or subsequently led to,
evaluations of their cost-effectiveness.671,672 In gen-
eral, however, attempts at costing interventions
have included posthoc data collection or extrapola-
tion, which are not optimal for this kind of
analysis.673
Studies in developed countries have shown that
early initiation of antenatal care is among the most
cost-effective strategies for reducing neonatal mor-
tality. In contrast, neonatal intensive care, despite its
impact on mortality of the sickest patients, has been
found to be one of the least cost-effective and feasible
approaches.81,674 Several interventions in pregnancy
such as the preterm birth–prevention program in
urban Los Angeles675 and management of gesta-
tional diabetes mellitus676 have also been shown to
be cost-effective. Well-defined efforts in developed
countries to estimate the cost-effectiveness of various
other interventions have been reported, such as pre-
vention of preterm births,675 reorganization of peri-
natal services,677 and establishment of perinatal
databases.678 In addition, certain specific postnatal
interventions such as neonatal resuscitation,679 indo-
methacin therapy for premature infants,680 surfac-
tant replacement therapy,681 prevention of respira-
tory syncytial virus infections,682 or therapy for
apnea of prematurity683 have been shown to be cost-
effective interventions in the context of developed
countries. Most available information on cost-effec-
tiveness of interventions refers to hospital or facility-
based interventions, and these cost-effectiveness
evaluations have used variable methods; only rarely
have maternal and infant benefits together been
evaluated.
community-based evidence. Cost-effectiveness
models and analyses of interventions to improve
perinatal and neonatal outcomes have been infre-
quently applied in emerging economies684 and are
rarer still in developing countries. Examples of cost-
effectiveness assessment of intervention strategies in
developing countries have largely included hospital-










Changes were made to the admission
and discharge criteria in the
neonatal special care unit (NSCU),
to encourage keeping the baby with
the mother and early hospital
discharge for home care. Rather
than be kept in the NSCU (where
mothers were not allowed), more
high-risk babies stayed with their
mothers. Outcomes for infants kept
in the NSCU (n  165) were
compared to infants who were
cared for alongside their mothers (n
 127).
After changes were made to the
admission and discharge
criteria, fewer newborn infants
who were cared for outside the
NSCU alongside their mothers
died (7/127), as compared to
those admitted to the NSCU
(57/165). Neonatal mortality in
babies weighing 2 kg declined
significantly over a 13-y period
(7.94% in 1986 vs 12.88% in
1973; P  .005), and over the
same period, mortality fell
among preterm babies from
26.88 to 11.5% (P  .001). This
was achieved despite a two- to
threefold increase in the high-
risk babies and without any
increase in the number of







A conservative neonatal care unit was
established in J J Hospital, Bombay,
having 4 main features: 1) room
warming, 2) exclusive
breastfeeding, 3) maternal
involvement in infant care, and 4)
minimum handling and minimum
intervention. Birth outcomes for a
cohort of infants (n  21) in 3
different weight groups (1000–1250
g, 1260–1500 g, and 1510–2000 g)
were measured and compared to
historical controls.
3 neonates were admitted with
birth weights of 1000–1250 g,
and the survival was 33% in
this group compared to a
previous best of 50%. In the
birth weight group of 1260–
1500 g, 8 neonates were
admitted and their survival was
75%, compared to 66% as a
previous best in this weight
group. For the weight group
1510–2000 g (n  10 admitted),
a 90% survival rate was found,







A group of VLBW infants (n  19)
was fed a formula specifically
developed for such infants, while
another group (n  20) was fed
expressed breast milk (EBM).
Time to reach a weight of 1800 g
was 28 d for the formula-fed
group, vs 40 d for those
receiving EBM. The allocation
groups were not strictly
randomized for severity of
illness.
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phy,685 surfactant replacement therapy,686 preven-
tion of respiratory syncytial virus infections,687 and
(more recently) the successful WHO-modified ante-
natal care package.84,688 In other instances, organiza-
tion of basic neonatal care services in referral hospi-
tals has been shown to be cost-effective.689
Cost-effectiveness data are also available from de-
veloping-country communities for selected interven-
tions focusing on antenatal interventions to prevent
infectious complications of pregnancy and their
impact on neonatal outcomes. These interventions
include antenatal screening and treatment for syph-
ilis,324 syphilis prevention,690 toxoplasmosis treat-
ment,691,692 TT-immunization administration,693 ma-
laria-prevention programs,694 and screening and
treatment for asymptomatic bacteriuria.695 These
evaluations reported a wide range of cost-benefit
ratios, with estimates ranging from $14 to $115 per
neonatal death or adverse outcome averted
(Table 43).
There has been much interest in recent years in the
cost-effectiveness of community-based strategies for
perinatal care. Such data, however, are almost exclu-
sively available from developed countries and in-
clude the institution of community-based nurse-mid-
wifery services, culturally adapted perinatal care,696
and earlier discharge and community care for pre-
mature infants.697,698 The strongest body of evidence
for the impact and cost-effectiveness of community-
based interventions in developed countries pertains
to smoking-cessation699–701 and other LBW-preven-
tion programs (for example, nutrition-related inter-
ventions such as the WIC program),702–704 indicating
substantial benefits.
In contrast, there are almost no systematic studies
of the cost-effectiveness of community-based inter-
ventions to improve perinatal and neonatal out-
comes in developing countries, with the exception of
studies in Nepal and rural India439,665 and several
evaluations of malaria prophylaxis and thera-
py.283,694,705 Studies to evaluate even well-estab-
lished strategies for the improvement of perinatal
and neonatal health outcomes, such as breastfeeding
promotion in large effectiveness trials, are only now
being commissioned.706
conclusions. Critical steps in the development of
effective community-based health interventions in-
clude the demonstration of efficacy and effective-
ness. To convince policy makers to support the
programmatic implementation of promising inter-
ventions, however, cost-effectiveness data are
needed to inform the feasibility of the intervention at
scale and its expected benefits relative to other ser-
vices. Even for interventions considered to be of
proven benefit for perinatal and/or neonatal health,
little such data are available and are primarily from
facility-based evaluations and, moreover, from de-
veloped countries. Cost-effectiveness data for com-
munity-based perinatal/neonatal health interven-
tions in developing countries are almost nonexistent.
However, with the recent development of guidelines
for costing of maternal and newborn interventions
by the WHO709 and the Saving Newborn Lives Ini-
tiative (Saving Newborn Lives, Saving Newborn
Lives Initiative: Project Costing Guidelines, Wash-
ington, DC, Save the Children/USA, unpublished
data) and with the establishment of Marginal Bud-
geting for Bottlenecks and CHOICE activities to in-
form public health resource allocation, more such
data are expected.707,708 For example, several trials of
the impact of antenatal, intrapartum, and postnatal
interventions on perinatal and neonatal health that
are currently underway have included evaluation of
cost-effectiveness as a key objective. Moreover, data
are beginning to emerge from Marginal Budgeting
for Bottlenecks on the marginal costs of introducing
certain interventions relevant to perinatal and neo-
natal health to existing programs.
SUMMARY
Implications for Programs
This review of evidence from developing-country
community-based trials for the impact of antenatal,
intrapartum, and postnatal interventions on perina-
tal and neonatal health outcomes has highlighted the
paucity of available information, particularly from
RCTs. Only 31 studies were RCTs that reported pri-
mary perinatal/neonatal health status outcomes (eg,
stillbirth rate, PMR, NMR), and only 40 were RCTs
that reported secondary perinatal/neonatal health
outcomes (eg, LBW, preterm births, morbidities, or
breastfeeding rates) (Table 1). Still fewer (only 10)
were interventions conducted in health system set-
tings or were effectiveness trials.
TABLE 43. Available Cost-effectiveness Data for Antenatal, Intrapartum, and Postnatal Interventions
Intervention Cost-Effectiveness Data Evidence of Cost-Effectiveness*
Malaria chemoprophylaxis or intermittent
therapy
2-dose regimen of SP cost $9.66 per case of LBW
averted705
3
Malaria prevention using PIBs $4–43 per discounted life-year lost740 3
Syphilis screening and treatment $1.05 per neonatal discounted life-year gained324 4
TT immunization $27–115 per neonatal death averted693 4
Package of antenatal, intrapartum and
postnatal interventions
1 y of care cost $5.30 per newborn and averted 1
neonatal death for every 18 neonates cared for439
3
Participatory neonatal care women’s
groups
$3442 per neonatal death averted ($4397 including
health services strengthening); $111 per life-year
saved665
3
* Rankings are based on a scale of 1–4 as follows: 1 indicates evidence of poor cost-effectiveness (leave out of programs); 2, uncertain
evidence of cost-effectiveness (need additional data before including in programs); 3, some evidence of cost-effectiveness (may include
in programs, but further evaluation is warranted); 4, strong evidence of cost-effectiveness (include in programs). Note that cost-
effectiveness data from community-based trials was available only for selected interventions (see cost-effectiveness section).
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To broaden the relevance of the conclusions that
can be drawn from the available data, we placed the
evidence in the context of biological plausibility, data
from studies in developed countries, programmatic
experience, and recommendations by the WHO and
other leading child health agencies. Recommenda-
tions based on this review are broadly applicable to
developing-country communities but are particu-
larly germane to the most impoverished populations
with high NMRs (eg, 40 per 1000 live births).
It is clear that the level of evidence for benefit of a
number of interventions (Table 2) warrants their
broad programmatic implementation (Fig 1). Inter-
estingly, this group of evidence-based interventions
closely resembles those identified through a strategic
planning process at the international and multiple-
country levels and outlined in a conceptual frame-
work for community-based maternal and newborn
care recently advanced by Save the Children/USA.17
Moreover, these elements of essential newborn care
are highlighted in recent recommendations for rou-
tine and sick newborn care by the WHO.14–16 Thus,
there seems to be broad convergence of expert opin-
ion and the evidence base regarding priority inter-
ventions to advance perinatal and neonatal health
and survival at the community level in developing
countries. Considering past experience of child
health programs in implementation of various inter-
ventions, and current recommendations of the WHO
and leading child health agencies, a few additional
interventions not covered in this review have been
added to Fig 1 (marked with an asterisk). These
interventions include birth preparedness and recog-
nition of and appropriate response to danger signs in
the antenatal and intrapartum periods; skilled health
care at delivery (evidence reviewed elsewhere); early
postnatal visitation for provision of anticipatory
guidance and recognition and management of ma-
ternal and newborn illness; and birth spacing. Many
of these interventions have been included in compre-
hensive packages of maternal and newborn interven-
tions but have not been rigorously evaluated per se
for their specific contribution to the total impact of
the package of care.
Effective interventions span maternal and neonatal
care, as anticipated when one considers that preg-
nancy-related causes, delivery-related causes, and
infections each account for approximately one third
of neonatal deaths.18 Moreover, although not empha-
sized here, many of the interventions of proven ben-
efit for neonates also lead to improved maternal
health (detailed in Tables 4–42),45,710 which serves to
illustrate the importance of integrating maternal and
neonatal care while avoiding vertical programs for
either the mother or the newborn. Although data on
cost-effectiveness are particularly lacking, an ap-
proach that integrates maternal and neonatal health
into Safe Motherhood and Child Survival programs
and bridges the gap between these programs will not
only establish continuity of care across the life cycle
but will also enhance the cost-effectiveness of inter-
vention packages.
Research Gaps
Although a number of interventions have been
shown to reduce perinatal and/or neonatal mortality
and to have the potential to reduce global neonatal
mortality by approximately half through wide-scale
implementation of evidence-based interventions,10
there are fundamental gaps in our knowledge of how
to most effectively improve perinatal and neonatal
outcomes in developing-country communities.711 Al-
though we know that implementation of comprehen-
sive neonatal care programs can reduce perinatal
and/or neonatal mortality substantially, failure to
empower and mobilize communities to accept inter-
ventions712 and lack of understanding of community
practices and culture are major barriers. Thus, there
is an urgent need to adapt and evaluate culturally
and regionally appropriate packages of interventions
in a variety of settings. Pivotal questions regarding
implementation of neonatal health care programs
that demand additional operational research include:
Which cadre of health workers in various settings
can most effectively deliver the needed services for
mothers and newborns at the community level? How
will these workers be trained and supervised in a
sustainable manner at scale, and what are the most
effective methods for preservice and in-service train-
ing? What will be the scope of their service delivery
(eg, with regard to client age, breadth of services, and
geographic reach)? Is a team of skilled birth atten-
dants and newborn care providers needed at the
community level to provide simultaneous care for
the mother and newborn during the critical intrapar-
tum period, particularly to address birth asphyxia?
The conceptual framework for newborn care at the
community level advanced by Save the Children/
USA17 calls for provision of both preventive and
curative care, particularly for birth asphyxia and in-
fections. However, in many settings, provision of
curative care for these major causes of neonatal mor-
tality is beyond the capacity of current health care
systems. Thus, critical unanswered questions are:
Can effective implementation of a behavior-change
communications package at the domiciliary level,
without active case management of newborn illness
by health workers, improve neonatal outcomes?
What is the added benefit and cost-effectiveness of
active identification and management of neonatal
illness, particularly serious bacterial infections and
intrapartum hypoxia/birth asphyxia? What are the
most feasible and effective ways to deliver life-sav-
ing newborn resuscitation and antibiotic therapy in
the community? How can barriers to care seeking for
newborn illness be overcome most effectively so that
home-based care and care seeking can be effectively
linked with referral-level care at facilities? What is
the impact and cost-effectiveness of postnatal visita-
tion for promotion of healthful behaviors and recog-
nition of neonatal illness? Can the same worker ad-
dress the postnatal needs of both mothers and
newborns? What is the optimal timing and number
of routine visits with a health care provider?
Skilled care during delivery is universally recog-
nized as a major long-term priority for improving the
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care of mothers and newborns, and plans for advanc-
ing health system capabilities for providing this care
are paramount. Based on a consideration of the fact
that most births and neonatal deaths in developing
countries still occur at home during the early neona-
tal period, due to birth asphyxia and/or infections
and primarily among LBW infants, the following
emerge as major research gaps:
1. Understanding and improving household and
community practices and their determinants: Lo-
cal formative research is needed to better under-
stand local beliefs and practices and the reasons
behind them so that effective behavior-change
strategies can be developed and evaluated.23 This
must be followed by appropriate research to de-
velop intervention strategies to improve care-
seeking behaviors at the household and commu-
nity levels.
2. Improving the capacity of health systems for pro-
viding essential preventive and special curative
neonatal health care: As noted above, some of the
most challenging questions in neonatal health care
relate to how to deliver services most effectively
to newborns in an integrated way within existing
programs for maternal and child health.20–22 Al-
though difficult, answering these questions re-
quires that many packages and combinations of
interventions be tested through effectiveness trials
in health system settings.
3. Preventing and improving recognition and man-
agement of birth asphyxia: Identification of sus-
tainable interventions for management of intra-
partum hypoxia/birth asphyxia is urgently
needed at the community level.24 Solutions must
allow for immediate response at the time of deliv-
ery in a cost-effective manner and necessarily will
require integration with skilled health care for
mothers at delivery and links with referral facili-
ties.16
4. Preventing and improving recognition and man-
agement of infections: There is an urgent need to
identify how the burden and severity of maternal
infections relate to perinatal outcomes. These in-
fections may range from subclinical intrauterine
infection and bacterial vaginosis to overt genital
tract infections that may lead to preterm labor.
The true burden of bacterial neonatal infections in
community settings is also unclear, because many
clinical bacterial infections may represent viral
infections. Narrowing this information gap is vi-
tal: to devise optimal antibiotic-treatment strate-
gies for neonatal infections,25 we need to know the
agents of life-threatening infections in the commu-
nity and their antibiotic-susceptibility patterns.26
There is additional need for validated algorithms
for accurate and rapid identification of infected
neonates by CHWs and caregivers. We also must
advance antibiotic-treatment strategies for serious
infections, which may include simplified antibiot-
ic-delivery systems and/or regimens. The poten-
tial development and evaluation of simplified oral
treatment regimens that include oral administra-
tion will be a major advance for public health
programs.
5. Preventing and improving care for LBW infants:
Given that the majority of newborns who die in
many developing countries are LBW, improved
strategies for both prevention of and care for LBW
infants are urgently needed. These strategies in-
clude interventions to reduce preterm births, re-
duce the incidence of IUGR, or a combination of
both. Prevention may be achieved by improved
maternal nutrition and detection and treatment of
maternal infections. Improved postnatal care of
LBW infants may be achieved in part by behavior-
change communications, topical emollient ther-
apy, breastfeeding promotion, and widespread
implementation of culturally adapted methods
for skin-to-skin care (or variations thereof) with
the mother and, when indicated, other household
members. The development, validation, and avail-
ability of low-cost technology for the care of LBW
infants in primary and secondary health care fa-
cilities are important adjuncts to community-
based management strategies.
6. Improving information on the magnitude and
causes of neonatal mortality: Lack of accurate
global, regional, and country-specific data on the
magnitude and causes of perinatal and neonatal
morbidity and mortality currently is limiting ad-
vocacy and program planning in newborn health.
Strengthening of information systems, including
birth and death registration and dissemination of
information at local levels about causes of new-
born morbidity and mortality (and their determi-
nants), are needed to guide resource allocation
and program and research priorities. Moreover, as
programs incorporate newborn care, their impact
must be monitored and accurate data fed back to
those involved in health policy and program de-
cision-making to enable them to use scarce re-
sources more effectively. Integral to documenting
and monitoring newborn health status is the need
for improved verbal autopsy instruments to en-
able more accurate determination of causes of
perinatal and neonatal deaths in the community
and to assess the contribution of sociocultural and
logistic factors. Perinatal audit may also be a pow-
erful tool for identifying avoidable factors in
deaths, and mobilizing change in communities to
improve maternal and neonatal health care.
7. Cost-effectiveness analyses: Assessment of cost-
effectiveness must be incorporated into neonatal
health research to guide selection of interventions
and stimulate investment in neonatal health.
8. Development of indicators and simple manage-
ment tools for assessing and monitoring health
system performance for perinatal and newborn
care at the national level: An important impedi-
ment to wider implementation of neonatal health
programming is lack of inclusion of perinatal and
neonatal health indicators among global indica-
tors for measuring progress in Child Survival (eg,
Millennium Development goals). Moreover, pro-
grams too often fail to monitor adequately and
demonstrate the effectiveness of their programs.
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Tools for rapid situational analysis, prioritization
of program activities, and accurate monitoring
and documentation of program effectiveness are
urgently needed.
A major factor currently limiting our ability to
identify effective interventions is the wide variation
in study designs and indicators for assessing impact
and the almost complete absence of cost-effective-
ness data. In 2001, a group of neonatal health re-
searchers met to discuss a common agenda and
methodologies for neonatal health research in devel-
oping-country communities.27 This review further
highlights the need, as recommended at the 2001
meeting, for dialogue among researchers, policy
makers, program managers, and donors regarding
the selection of research priorities; the use of com-
mon (and, whenever possible, rigorous) study de-
signs; and for sharing of data-collection instruments
and research results. Reporting of indicators of neo-
natal health at global and national levels is essential
for monitoring large-scale success.
CONCLUSIONS
A paucity of community-based data are available
from developing countries on health status impact,
principally perinatal and/or neonatal mortality, for
many interventions that are currently being consid-
ered for inclusion in neonatal health programs. How-
ever, a review of the evidence and consideration of
the broader context of knowledge, experience, and
recommendations regarding these interventions en-
abled us to categorize the interventions according to
the strength of the evidence base and confidence
with which the intervention could be included now
in programs. As a result, a package of priority inter-
ventions for inclusion in programs was identified,
and research priorities for advancing the state-of-the-
art in neonatal health care were formulated. Thus,
this review can serve as a guide for development of
evidence-based maternal and newborn health care
programming at the community level and for selec-
tion of research to advance the state-of-the-art in
community-based neonatal care. It also may facilitate
dialogue with policy makers about the importance of
investing in neonatal health.
Clearly there is ample evidence for benefit of a
number of antenatal, intrapartum, and postnatal in-
terventions. Operational questions of how to imple-
ment the intervention(s) in an affordable and accept-
able manner at scale were an overriding concern for
many interventions. Thus, although there is great
need for continued research on the cost-effectiveness
of a number of interventions, particularly for preven-
tion and care of LBW infants, prevention of fresh
stillbirths, and prevention and management of birth
asphyxia, it must not hamper implementation now of
many interventions of known impact at a wider
scale. For many of these proven interventions, how-
ever, critical questions remain regarding how to im-
plement them in a cost-effective manner at scale.
Close monitoring of the impact of these programs is
imperative. Finally, close communication between
program managers who document experience with
intervention implementation; the researchers who
generate answers to operational questions and de-
vise new, innovative interventions and approaches;
and the donors who promote the research will be
critical to advancing maternal and neonatal health
care at the community level.
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